Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Bladder Cancer, January 2018

Free Subscription


Abstracts

Retrieve all available abstracts of the following 1132 articles:
HTML format


 

Single Articles

  1. PENG F, Li H, Xiao H, Li L, et al
    Identification of a three miRNA signature as a novel potential prognostic biomarker in patients with bladder cancer.
    Oncotarget. 2017;8:105553-105560.
    Abstract     Related articles   

  2. HO JN, Kang M, Lee S, Oh JJ, et al
    Anticancer effect of S-allyl-L-cysteine via induction of apoptosis in human bladder cancer cells.
    Oncol Lett. 2018;15:623-629.
    Abstract     Related articles   

  3. SELINSKI S
    Discovering urinary bladder cancer risk variants: Status quo after almost ten years of genome-wide association studies.
    EXCLI J. 2017;16:1288-1296.
    Abstract     Related articles   

  4. SUNDAHL N, Rottey S, De Maeseneer D, Ost P, et al
    Pembrolizumab for the treatment of bladder cancer.
    Expert Rev Anticancer Ther. 2017 Dec 29:1-8. doi: 10.1080/14737140.2018.1421461.
    Abstract     Related articles   

  5. AFSHARMOGHADAM N, Haghighatian Z, Mazdak H, Mirkheshti N, et al
    Concentration- Dependent Effects of Curcumin on 5-Fluorouracil Efficacy in Bladder Cancer Cells
    Asian Pac J Cancer Prev. 2017;18:3225-3230.
    Abstract     Related articles   

  6. NEOH CA, Wu WT, Dai GF, Su JH, et al
    Flaccidoxide-13-Acetate Extracted from the Soft Coral Cladiella kashmani Reduces Human Bladder Cancer Cell Migration and Invasion through Reducing Activation of the FAK/PI3K/AKT/mTOR Signaling Pathway.
    Molecules. 2017;23.
    Abstract     Related articles   

  7. GUERCIO V, Turati F, Bosetti C, Polesel J, et al
    Bladder cancer risk in users of selected drugs for cardiovascular disease prevention.
    Eur J Cancer Prev. 2017 Dec 26. doi: 10.1097/CEJ.0000000000000419.
    Abstract     Related articles   

  8. ZHANG Q, Wang W, Xu W, DU M, et al
    Genetic Variations in the 3'-untranslated Regions of Genes Involved in the Cell Cycle and Apoptosis Pathways Affect Bladder Cancer Risk.
    Cancer Genomics Proteomics. 2018;15:67-72.
    Abstract     Related articles   

  9. SIRACUSANO S, D'Elia C, Cerruto MA, Saleh O, et al
    Quality of Life in Patients with Bladder Cancer Undergoing Ileal Conduit: A Comparison of Women Versus Men.
    In Vivo. 2018;32:139-143.
    Abstract     Related articles   

  10. LEE YH, Yeh CH
    Laminar shear stress inhibits high glucose-induced migration and invasion in human bladder cancer cells.
    In Vitro Cell Dev Biol Anim. 2017 Dec 22. pii: 10.1007/s11626-017-0217.
    Abstract     Related articles   

  11. SUSSMAN RD, Han CJ, Marchalik D, Carvahlo FL, et al
    To oophorectomy or not to oophorectomy: Practice patterns among urologists treating bladder cancer.
    Urol Oncol. 2017 Dec 19. pii: S1078-1439(17)30606.
    Abstract     Related articles   

  12. JUNG YL, Tompa E, Longo C, Kalcevich C, et al
    The Economic Burden of Bladder Cancer due to Occupational Exposure.
    J Occup Environ Med. 2017 Dec 21. doi: 10.1097/JOM.0000000000001242.
    Abstract     Related articles   

  13. LI B, Xie F, Zheng FX, Jiang GS, et al
    Overexpression of CircRNA BCRC4 regulates cell apoptosis and MicroRNA-101/EZH2 signaling in bladder cancer.
    J Huazhong Univ Sci Technolog Med Sci. 2017;37:886-890.
    Abstract     Related articles   

  14. PRICE L, Glynn P, Zarkar A
    Interstitial lung disease secondary to Cetuximab in bladder cancer: an Oncologist's perspective.
    BMJ Case Rep. 2017;2017.
    Abstract     Related articles   

  15. PAVANELLO S, Carta A, Mastrangelo G, Campisi M, et al
    Relationship between Telomere Length, Genetic Traits and Environmental/Occupational Exposures in Bladder Cancer Risk by Structural Equation Modelling.
    Int J Environ Res Public Health. 2017;15.
    Abstract     Related articles   

  16. SAADI A, Bouzouita A, Rebai MH, Cherif M, et al
    Superselective embolisation of bilateral superior vesical arteries for management of intractable hematuria in context of metastatic bladder cancer.
    Asian J Urol. 2017;4:131-134.
    Abstract     Related articles   

  17. OKHOLM TLH, Nielsen MM, Hamilton MP, Christensen LL, et al
    Circular RNA expression is abundant and correlated to aggressiveness in early-stage bladder cancer.
    NPJ Genom Med. 2017;2:36.
    Abstract     Related articles   

  18. LIU D, Abbosh P, Keliher D, Reardon B, et al
    Mutational patterns in chemotherapy resistant muscle-invasive bladder cancer.
    Nat Commun. 2017;8:2193.
    Abstract     Related articles   

  19. DHAINI HR, El Hafi B, Khamis AM
    NAT1 genotypic and phenotypic contribution to urinary bladder cancer risk: a systematic review and meta-analysis.
    Drug Metab Rev. 2017 Dec 19:1-12. doi: 10.1080/03602532.2017.1415928.
    Abstract     Related articles   

  20. KANDEMIRLI SG, Dikici AS, Nurili F, Tutar O, et al
    Bladder cancer in an inguinal vesical hernia.
    J Med Ultrason (2001). 2017 Dec 18. pii: 10.1007/s10396-017-0854.
    Abstract     Related articles   

  21. HURST CD, Knowles MA
    Bladder cancer: Multi-omic profiling refines the molecular view.
    Nat Rev Clin Oncol. 2017 Dec 19. pii: nrclinonc.2017.
    Abstract     Related articles   

  22. MATSUMOTO K, Tabata KI, Hirayama T, Shimura S, et al
    Robot-assisted laparoscopic radical cystectomy is a safe and effective procedure for patients with bladder cancer compared to laparoscopic and open surgery: Perioperative outcomes of a single-center experience.
    Asian J Surg. 2017 Dec 15. pii: S1015-9584(17)30518.
    Abstract     Related articles   

  23. BOOTH CM, Karim S, Brennan K, Siemens DR, et al
    Perioperative chemotherapy for bladder cancer in the general population: Are practice patterns finally changing?
    Urol Oncol. 2017 Dec 15. pii: S1078-1439(17)30603.
    Abstract     Related articles   

  24. XU X, Li J, Zhu Y, Xie B, et al
    CRISPR-ON-Mediated KLF4 overexpression inhibits the proliferation, migration and invasion of urothelial bladder cancer in vitro and in vivo.
    Oncotarget. 2017;8:102078-102087.
    Abstract     Related articles   

  25. KLITON J, Polgar C, Tenke P, Kovacs G, et al
    [Image-guided radiotherapy for muscle invasive bladder cancer with intravesical lipiodol injection. A new option for bladder sparing treatment].
    Orv Hetil. 2017;158:2041-2047.
    Abstract     Related articles   

  26. CIAMPORCERO E, Daga M, Pizzimenti S, Roetto A, et al
    Crosstalk between Nrf2 and YAP contributes to maintaining the antioxidant potential and chemoresistance in bladder cancer.
    Free Radic Biol Med. 2017 Dec 14. pii: S0891-5849(17)31237.
    Abstract     Related articles   

  27. WANG Z, Que H, Suo C, Han Z, et al
    Evaluation of the NMP22 BladderChek test for detecting bladder cancer: a systematic review and meta-analysis.
    Oncotarget. 2017;8:100648-100656.
    Abstract     Related articles   

  28. KO K, Jeong CW, Kwak C, Kim HH, et al
    Significance of Ki-67 in non-muscle invasive bladder cancer patients: a systematic review and meta-analysis.
    Oncotarget. 2017;8:100614-100630.
    Abstract     Related articles   

  29. CHAN OTM, Furuya H, Pagano I, Shimizu Y, et al
    Association of MMP-2, RB and PAI-1 with decreased recurrence-free survival and overall survival in bladder cancer patients.
    Oncotarget. 2017;8:99707-99721.
    Abstract     Related articles   

  30. XIAOQIANG L, Xuerong Z, Juan L, Mathew BS, et al
    Efficacy of pudendal nerve block for alleviation of catheter-related bladder discomfort in male patients undergoing lower urinary tract surgeries: A randomized, controlled, double-blind trial.
    Medicine (Baltimore). 2017;96:e8932.
    Abstract     Related articles   

  31. TOUZANI MA, Yddoussalah O
    [Cavernous metastasis from blader tumor].
    Pan Afr Med J. 2017;28:60.
    Abstract     Related articles   

  32. SAXE JS
    Denial.
    Ann Intern Med. 2017;167:828-829.
    Abstract     Related articles   

  33. DAVIDSSON S, Andren O, Ohlson AL, Carlsson J, et al
    FOXP3+ regulatory T cells in normal prostate tissue, postatrophic hyperplasia, prostatic intraepithelial neoplasia, and tumor histological lesions in men with and without prostate cancer.
    Prostate. 2017 Nov 6. doi: 10.1002/pros.23442.
    Abstract     Related articles   

  34. INOUE A, Maeda S, Kinoshita R, Tsuboi M, et al
    Density of tumor-infiltrating granzyme B-positive cells predicts favorable prognosis in dogs with transitional cell carcinoma.
    Vet Immunol Immunopathol. 2017;190:53-56.
    Abstract     Related articles   

  35. CHARGARI C, Martelli H, Guerin F, Bacorro W, et al
    Pulsed-dose rate brachytherapy for pediatric bladder prostate rhabdomyosarcoma: Compliance and early clinical results.
    Radiother Oncol. 2017;124:285-290.
    Abstract     Related articles   

  36. INAMURA K, Kobayashi M, Nagano H, Sugiura Y, et al
    A novel fusion of HNRNPA1-ALK in inflammatory myofibroblastic tumor of urinary bladder.
    Hum Pathol. 2017;69:96-100.
    Abstract     Related articles   

  37. DIETRICH F, Figueiro F, Filippi-Chiela EC, Cappellari AR, et al
    Ecto-5'-nucleotidase/CD73 contributes to the radiosensitivity of T24 human bladder cancer cell line.
    J Cancer Res Clin Oncol. 2018 Jan 5. pii: 10.1007/s00432-017-2567.
    Abstract     Related articles   

  38. YU Z, Yue W, Jiuzhi L, Youtao J, et al
    The risk of bladder cancer in patients with urinary calculi: a meta-analysis.
    Urolithiasis. 2018 Jan 5. pii: 10.1007/s00240-017-1033.
    Abstract     Related articles   

  39. WU S, Ye J, Wang Z, Lin SX, et al
    Expression of aromatase in tumor related stroma is associated with human bladder cancer progression.
    Cancer Biol Ther. 2018 Jan 5:0. doi: 10.1080/15384047.2017.1414762.
    Abstract     Related articles   

  40. COLLINS SD, Leech MM
    A review of plan library approaches in adaptive radiotherapy of bladder cancer.
    Acta Oncol. 2018 Jan 4:1-8. doi: 10.1080/0284186X.2017.1420908.
    Abstract     Related articles   

  41. ROSAS S, Sabeh K, Kurowicki J, Buller L, et al
    National use of total hip arthroplasty among patients with a history of breast, lung, prostate, colon or bladder cancer-an analysis of the Medicare population.
    Ann Transl Med. 2017;5.
    Abstract     Related articles   

  42. SEGOVIA C, Paramio JM
    Ezh2-dependent therapies in bladder cancer: synthetic lethality.
    Ann Transl Med. 2017;5:494.
    Abstract     Related articles   

  43. JUENGEL E, Najafi R, Rutz J, Maxeiner S, et al
    HDAC inhibition as a treatment concept to combat temsirolimus-resistant bladder cancer cells.
    Oncotarget. 2017;8:110016-110028.
    Abstract     Related articles   

  44. LIAO XZ, Tao LT, Liu JH, Gu YY, et al
    Matrine combined with cisplatin synergistically inhibited urothelial bladder cancer cells via down-regulating VEGF/PI3K/Akt signaling pathway.
    Cancer Cell Int. 2017;17:124.
    Abstract     Related articles   

  45. ZHANG L, Xu J, Yang G, Li H, et al
    miR-202 inhibits cell proliferation, migration, and invasion by targeting EGFR in human bladder cancer.
    Oncol Res. 2018 Jan 3. doi: 10.3727/096504018X15149787144385.
    Abstract     Related articles   

  46. THOMA C
    Bladder cancer: IMvigor211 trial outcomes reported.
    Nat Rev Urol. 2018 Jan 3. pii: nrurol.2017.225. doi: 10.1038/nrurol.2017.
    Abstract     Related articles   

  47. THOMA C
    Bladder cancer: Chemotherapy and checkpoint blockade.
    Nat Rev Urol. 2018 Jan 3. pii: nrurol.2017.224. doi: 10.1038/nrurol.2017.
    Abstract     Related articles   

  48. THOMA C
    Bladder cancer: Activity and safety of avelumab in JAVELIN.
    Nat Rev Urol. 2018 Jan 3. pii: nrurol.2017.227. doi: 10.1038/nrurol.2017.
    Abstract     Related articles   

  49. ZUIVERLOON TCM, de Jong FC, Theodorescu D
    Clinical Decision Making in Surveillance of Non-Muscle-Invasive Bladder Cancer: The Evolving Roles of Urinary Cytology and Molecular Markers.
    Oncology (Williston Park). 2017;31.
    Abstract     Related articles   

  50. KIM SJ, Koo PJ, Pak K, Kim IJ, et al
    Diagnostic accuracy of C-11 choline and C-11 acetate for lymph node staging in patients with bladder cancer: a systematic review and meta-analysis.
    World J Urol. 2018 Jan 2. pii: 10.1007/s00345-017-2168.
    Abstract     Related articles   

  51. HARSHMAN LC, Tripathi A, Kaag M, Efstathiou JA, et al
    Contemporary Patterns of Multidisciplinary Care in Patients With Muscle-invasive Bladder Cancer.
    Clin Genitourin Cancer. 2017 Dec 6. pii: S1558-7673(17)30364.
    Abstract     Related articles   

  52. ROSE TL, Lotan Y
    Advancements in optical techniques and imaging in the diagnosis and management of bladder cancer.
    Urol Oncol. 2017 Dec 26. pii: S1078-1439(17)30602.
    Abstract     Related articles   

  53. YOSHIDA T, Kates M, Sopko NA, Liu X, et al
    Ex vivo culture of tumor cells from N-methyl-N-nitrosourea-induced bladder cancer in rats: Development of organoids and an immortalized cell line.
    Urol Oncol. 2017 Dec 26. pii: S1078-1439(17)30618.
    Abstract     Related articles   

  54. ALJABERY F, Olsson H, Gimm O, Jahnson S, et al
    M2-macrophage infiltration and macrophage traits of tumor cells in urinary bladder cancer.
    Urol Oncol. 2017 Dec 26. pii: S1078-1439(17)30608.
    Abstract     Related articles   

  55. OSTERMAN CK, Alanzi J, Lewis JD, Kaufman EL, et al
    Association Between Symptomatic Versus Asymptomatic Recurrence and Survival in Bladder Cancer.
    Clin Genitourin Cancer. 2017 Dec 6. pii: S1558-7673(17)30361.
    Abstract     Related articles   

  56. NKWAM N, Trecarten S, Momcilovic S, Bazo AE, et al
    Isolated red patches seen during endoscopic surveillance of bladder cancer - when should we biopsy?
    J Endourol. 2017 Dec 29. doi: 10.1089/end.2017.0744.
    Abstract     Related articles   

  57. GOLABEK T, Socha K, Kudelski J, Darewicz B, et al
    Chromium in urothelial carcinoma of the bladder.
    Ann Agric Environ Med. 2017;24:602-605.
    Abstract     Related articles   

  58. HEIN DW, Zhang X, Doll MA
    Role of N-acetyltransferase 2 acetylation polymorphism in 4, 4'-methylene bis (2-chloroaniline) biotransformation.
    Toxicol Lett. 2018;283:100-105.
    Abstract     Related articles   

  59. ARIAS-STELLA JA 3RD, Shah AB, Gupta NS, Williamson SR, et al
    CK20 and p53 Immunohistochemical Staining Patterns in Urinary Bladder Specimens With Equivocal Atypia.
    Arch Pathol Lab Med. 2018;142:64-69.
    Abstract     Related articles   

  60. YANG G, Wang Z, Liu S, Wu F, et al
    A Rare Case of Urachal Carcinoma Metastatic to Thoracic Vertebra Detected by FDG PET/CT.
    Clin Nucl Med. 2017 May 5. doi: 10.1097/RLU.0000000000001680.
    Abstract     Related articles   

  61. ROY SG, Parida GK, Tripathy S, Singhal A, et al
    In Vivo Demonstration of PSMA Expression in Adenocarcinoma Urinary Bladder Using 68Ga-PSMA 11 PET/CT.
    Clin Nucl Med. 2017 May 6. doi: 10.1097/RLU.0000000000001683.
    Abstract     Related articles   

  62. YANG AW, Pooli A, Lele SM, Kim IW, et al
    Lymphoepithelioma-like, a variant of urothelial carcinoma of the urinary bladder: a case report and systematic review for optimal treatment modality for disease-free survival.
    BMC Urol. 2017;17:34.
    Abstract     Related articles   

  63. TAN WS, Lamb BW, Sridhar A, Briggs TP, et al
    A comprehensive guide to perioperative management and operative technique for robotic cystectomy with intracorporeal urinary diversion.
    Urologia. 2017;84:71-78.
    Abstract     Related articles   

  64. CHANG E, Sabichi AL, Sada YH
    Myasthenia Gravis After Nivolumab Therapy for Squamous Cell Carcinoma of the Bladder.
    J Immunother. 2017;40:114-116.
    Abstract     Related articles   

  65. LIZEE D, Salas RS, Barret E, Galiano M, et al
    Impact of neoadjuvant chemotherapy on complications of minimally invasive radical cystectomy.
    Actas Urol Esp. 2017;41:88-96.
    Abstract     Related articles   

  66. KANASHIRO A, Gaya JM, Palou J, Gausa L, et al
    Robot-assisted radical cystoprostatectomy: Analysis of the complications and oncological and functional aspects.
    Actas Urol Esp. 2017;41:267-273.
    Abstract     Related articles   

  67. LIU J, Bi J, Li Z, Li Z, et al
    miR214 reduces cisplatin resistance by targeting netrin1 in bladder cancer cells.
    Int J Mol Med. 2018 Jan 10. doi: 10.3892/ijmm.2018.3374.
    Abstract     Related articles   

  68. GLEICHENHAGEN J, Arndt C, Casjens S, Meinig C, et al
    Evaluation of a New Survivin ELISA and UBC((R)) Rapid for the Detection of Bladder Cancer in Urine.
    Int J Mol Sci. 2018;19.
    Abstract     Related articles   

  69. BAKER SC, Arlt VM, Indra R, Joel M, et al
    Differentiation-associated urothelial cytochrome P450 oxidoreductase predicates the xenobiotic-metabolising activity of "luminal" muscle-invasive bladder cancers.
    Mol Carcinog. 2018 Jan 11. doi: 10.1002/mc.22784.
    Abstract     Related articles   

  70. POLETAJEW S, Biernacki R, Buraczynski P, Chojnacki J, et al
    Predictors and prognostic implications of clinical decisions in patients with primary high-risk non-muscle-invasive bladder cancer - results of a cross country retrospective study.
    Neoplasma. 2018;65:147-152.
    Abstract     Related articles   

  71. GAO L, Yan P, Guo FF, Liu HJ, et al
    MiR-1-3p inhibits cell proliferation and invasion by regulating BDNF-TrkB signaling pathway in bladder cancer.
    Neoplasma. 2018;65:89-96.
    Abstract     Related articles   

  72. WANG B, Wan F, Sheng H, Zhu Y, et al
    Identification and validation of an 18-gene signature highly-predictive of bladder cancer metastasis.
    Sci Rep. 2018;8:374.
    Abstract     Related articles   

  73. GUO P, Zhang G, Meng J, He Q, et al
    Upregulation of long non-coding RNA TUG1 promotes bladder cancer cell 5 proliferation, migration and invasion by inhibiting miR-29c.
    Oncol Res. 2018 Jan 10. doi: 10.3727/096504018X15152085755247.
    Abstract     Related articles   

  74. ZHAI X, Xu W
    Long noncoding RNA ATB promotes proliferation, migration and invasion in bladder cancer by suppressing microRNA-126.
    Oncol Res. 2018 Jan 10. doi: 10.3727/096504018X15152072098476.
    Abstract     Related articles   

  75. WALKER M, Doiron RC, French SD, Feldman-Stewart D, et al
    Perioperative chemotherapy for bladder cancer: A qualitative study of physician knowledge, attitudes, and behaviour.
    Can Urol Assoc J. 2017 Dec 22. pii: cuaj.4791. doi: 10.5489/cuaj.4791.
    Abstract     Related articles   

  76. YOO CH
    The Author's Response: Bioinformatics Analysis in Downstream Genes of the mTOR Pathway to Predict Recurrence and Progression of Bladder Cancer.
    J Korean Med Sci. 2018;33:e32.
    Abstract     Related articles   

  77. LI C, Liu H, Xu Y
    Letter to the Editor: Bioinformatics Analysis in Downstream Genes of the mTOR Pathway to Predict Recurrence and Progression of Bladder Cancer.
    J Korean Med Sci. 2018;33:e31.
    Abstract     Related articles   

  78. LONG Q, Lin TY, Huang Y, Li X, et al
    Imaging-guided photo-therapeutic nanoporphyrin synergized HSP90 inhibitor in patient-derived xenograft bladder cancer model.
    Nanomedicine. 2018 Jan 6. pii: S1549-9634(17)30592.
    Abstract     Related articles   

  79. WANG F, Tang J, Li P, Si S, et al
    Chloroquine Enhances the Radiosensitivity of Bladder Cancer Cells by Inhibiting Autophagy and Activating Apoptosis.
    Cell Physiol Biochem. 2017;45:54-66.
    Abstract     Related articles   

  80. SALEM J, Paffenholz P, Bolenz C, von Brandenstein M, et al
    Websites on Bladder Cancer: an Appropriate Source of Patient Information?
    J Cancer Educ. 2018 Jan 8. pii: 10.1007/s13187-017-1316.
    Abstract     Related articles   

  81. VAN DER POL CB, Shinagare AB, Tirumani SH, Preston MA, et al
    Bladder cancer local staging: multiparametric MRI performance following transurethral resection.
    Abdom Radiol (NY). 2018 Jan 9. pii: 10.1007/s00261-017-1449.
    Abstract     Related articles   

  82. ZHANG L, Yang G, Chen H, Huang Y, et al
    Depletion of astrocyte elevated gene-1 suppresses tumorigenesis through inhibition of Akt activity in bladder cancer cells.
    Am J Transl Res. 2017;9:5422-5431.
    Abstract     Related articles   

  83. SAAD FT, Hincal E, Kaymakamzade B
    Dynamics of Immune Checkpoints, Immune System, and BCG in the Treatment of Superficial Bladder Cancer.
    Comput Math Methods Med. 2017;2017:3573082.
    Abstract     Related articles   

  84. GHATE K, Brennan K, Karim S, Siemens DR, et al
    Concurrent chemoradiotherapy for bladder cancer: Practice patterns and outcomes in the general population.
    Radiother Oncol. 2018 Jan 3. pii: S0167-8140(17)32764.
    Abstract     Related articles   

  85. COSTA-MARTINEZ MA, Prieto Vita M, Garces Proano LE, Carro Rubias C, et al
    [Neurofibromas in the urogenital system: Report of two cases and literature review.]
    Arch Esp Urol. 2017;70:796-799.
    Abstract     Related articles   

  86. JING Y, Zhang R, Ma P, Cai MC, et al
    Prevalence and clonality of synchronous primary carcinomas in the bladder and prostate.
    J Pathol. 2018;244:5-10.
    Abstract     Related articles   

  87. YU SS, Ballas LK, Skinner EC, Dorff TB, et al
    Immunotherapy in urothelial cancer, part 2: adjuvant, neoadjuvant, and adjunctive treatment.
    Clin Adv Hematol Oncol. 2017;15:543-551.
    Abstract     Related articles   

  88. PFARR N, Darb-Esfahani S, Leichsenring J, Taube E, et al
    Mutational profiles of Brenner tumors show distinctive features uncoupling urothelial carcinomas and ovarian carcinoma with transitional cell histology.
    Genes Chromosomes Cancer. 2017;56:758-766.
    Abstract     Related articles   

  89. NGUYEN VP, Park S, Oh J, Wook Kang H, et al
    Biocompatible astaxanthin as novel contrast agent for biomedical imaging.
    J Biophotonics. 2017;10:1053-1061.
    Abstract     Related articles   

  90. MAO XW, Xiao JQ, Li ZY, Zheng YC, et al
    Effects of microRNA-135a on the epithelial-mesenchymal transition, migration and invasion of bladder cancer cells by targeting GSK3beta through the Wnt/beta-catenin signaling pathway.
    Exp Mol Med. 2018;50:e429.
    Abstract     Related articles   

  91. LI YP, Jia XP, Jiang YQ, Wang W, et al
    Differential expression of cytokeratin 14 and 18 in bladder cancer tumorigenesis.
    Exp Biol Med (Maywood). 2018 Jan 1:1535370218754493.
    Abstract     Related articles   

  92. YANG HJ, Liu GL, Liu B, Liu T, et al
    GP73 promotes invasion and metastasis of bladder cancer by regulating the epithelial-mesenchymal transition through the TGF-beta1/Smad2 signalling pathway.
    J Cell Mol Med. 2018 Jan 19. doi: 10.1111/jcmm.13442.
    Abstract     Related articles   

  93. SINGH R, Mandhani A, Agrawal V, Garg M, et al
    Positive Correlation between Matrix Metalloproteinases and Epithelial-to-Mesenchymal Transition and its Association with Clinical Outcome in Bladder Cancer Patients.
    Cancer Microenviron. 2018 Jan 18. pii: 10.1007/s12307-017-0199.
    Abstract     Related articles   

  94. JI L, Zhong B, Jiang X, Mao F, et al
    Actein induces autophagy and apoptosis in human bladder cancer by potentiating ROS/JNK and inhibiting AKT pathways.
    Oncotarget. 2017;8:112498-112515.
    Abstract     Related articles   

  95. WONG MCS, Fung FDH, Leung C, Cheung WWL, et al
    The global epidemiology of bladder cancer: a joinpoint regression analysis of its incidence and mortality trends and projection.
    Sci Rep. 2018;8:1129.
    Abstract     Related articles   

  96. PHELAN A, Lopez-Beltran A, Montironi R, Zhang S, et al
    Inherited forms of bladder cancer: a review of lynch syndrome and other inherited conditions.
    Future Oncol. 2018 Jan 18. doi: 10.2217/fon-2017-0346.
    Abstract     Related articles   

  97. KITCHEN MO, Bryan RT, Emes RD, Luscombe CJ, et al
    HumanMethylation450K Array-Identified Biomarkers Predict Tumour Recurrence/Progression at Initial Diagnosis of High-risk Non-muscle Invasive Bladder Cancer.
    Biomark Cancer. 2018;10:1179299X17751920.
    Abstract     Related articles   

  98. PATEL SG, Weiner AB, Keegan K, Morgan T, et al
    Oncologic outcomes in patients with nonurothelial bladder cancer.
    Indian J Urol. 2018;34:39-44.
    Abstract     Related articles   

  99. RAYN KN, Hale GR, Grave GP, Agarwal PK, et al
    New therapies in nonmuscle invasive bladder cancer treatment.
    Indian J Urol. 2018;34:11-19.
    Abstract     Related articles   

  100. CHOI JB, Lee EJ, Han KD, Hong SH, et al
    Estimating the impact of body mass index on bladder cancer risk: Stratification by smoking status.
    Sci Rep. 2018;8:947.
    Abstract     Related articles   

  101. MCCONKEY DJ, Choi W
    Subtyping Bladder Cancers: Biology vs Bioinformatics.
    J Natl Cancer Inst. 2018 Jan 12. pii: 4804358. doi: 10.1093.
    Abstract     Related articles   

  102. OGIHARA K, Kikuchi E, Watanabe K, Kufukihara R, et al
    Can urologists introduce the concept of "oligometastasis" for metastatic bladder cancer after total cystectomy?
    Oncotarget. 2017;8:111819-111835.
    Abstract     Related articles   

  103. WANG C, Chen L, Yang Y, Zhang M, et al
    Identification of bladder cancer prognostic biomarkers using an ageing gene-related competitive endogenous RNA network.
    Oncotarget. 2017;8:111742-111753.
    Abstract     Related articles   

  104. XIN Z, Yang Z, Xu J, Li C, et al
    Gene expression profiling and construction of a putative gene regulatory network of bladder cancer tumor-initiating cells.
    Oncotarget. 2017;8:111271-111280.
    Abstract     Related articles   

  105. WEINER AB, Keeter MK, Manjunath A, Meeks JJ, et al
    Discrepancies in staging, treatment, and delays to treatment may explain disparities in bladder cancer outcomes: An update from the National Cancer Data Base (2004-2013).
    Urol Oncol. 2018 Jan 12. pii: S1078-1439(17)30644.
    Abstract     Related articles   

  106. PENG D, Zhang CJ, Gong YQ, Hao H, et al
    Prognostic significance of HALP (hemoglobin, albumin, lymphocyte and platelet) in patients with bladder cancer after radical cystectomy.
    Sci Rep. 2018;8:794.
    Abstract     Related articles   

  107. ZAPALA P, Dybowski B, Poletajew S, Bialek L, et al
    Clinical rationale and safety of restaging transurethral resection in indication-stratified patients with high-risk non-muscle-invasive bladder cancer.
    World J Surg Oncol. 2018;16:6.
    Abstract     Related articles   

  108. MACLENNAN MS, Kok MGM, Soliman L, So A, et al
    Capillary electrophoresis-mass spectrometry for targeted and untargeted analysis of the sub-5kDa urine metabolome of patients with prostate or bladder cancer: A feasibility study.
    J Chromatogr B Analyt Technol Biomed Life Sci. 2018;1074-1075:79-85.
    Abstract     Related articles   

  109. HEINER SM, Viers BR, Rivera ME, Linder BJ, et al
    What is the fate of artificial urinary sphincters among men undergoing repetitive bladder cancer treatment?
    Investig Clin Urol. 2018;59:44-48.
    Abstract     Related articles   

  110. BOLT HM
    Highlight report: Occupational urinary bladder cancer.
    EXCLI J. 2017;16:1319-1320.
    Abstract     Related articles   

  111. ARAUJO JE, Lopez-Fernandez H, Diniz MS, Baltazar PM, et al
    Dithiothreitol-based protein equalization technology to unravel biomarkers for bladder cancer.
    Talanta. 2018;180:36-46.
    Abstract     Related articles   

  112. YANG X, Zhao L, Li M, Yan L, et al
    Lidocaine enhances the effects of chemotherapeutic drugs against bladder cancer.
    Sci Rep. 2018;8:598.
    Abstract     Related articles   

  113. YU SS, Dorff TB, Ballas LK, Sadeghi S, et al
    Immunotherapy in urothelial cancer, part 1: T-cell checkpoint inhibition in advanced or metastatic disease.
    Clin Adv Hematol Oncol. 2017;15:466-477.
    Abstract     Related articles   

  114. CANNIOTO R, Etter JL, Guterman LB, Joseph JM, et al
    The association of lifetime physical inactivity with bladder and renal cancer risk: A hospital-based case-control analysis.
    Cancer Epidemiol. 2017;49:24-29.
    Abstract     Related articles   

  115. QAMAR S, Inam QA, Ashraf S, Khan MS, et al
    Prognostic Value of p53 Expression Intensity in Urothelial Cancers.
    J Coll Physicians Surg Pak. 2017;27:232-236.
    Abstract     Related articles   

  116. CALISKAN S, Sungur M
    Bladder Leiomyoma.
    J Coll Physicians Surg Pak. 2017;27:189-190.
    Abstract     Related articles   

  117. MARIEN A, Rock A, Maadarani KE, Francois C, et al
    Urothelial Tumors and Dual-Band Imaging: A New Concept in Confocal Laser Endomicroscopy.
    J Endourol. 2017;31:538-544.
    Abstract     Related articles   

  118. LE GOUX C, Damotte D, Vacher S, Sibony M, et al
    Correlation between messenger RNA expression and protein expression of immune checkpoint-associated molecules in bladder urothelial carcinoma: A retrospective study.
    Urol Oncol. 2017;35:257-263.
    Abstract     Related articles   

  119. USAWACHINTACHIT M, Isaacson DS, Taguchi K, Tzou DT, et al
    A Prospective Case-Control Study Comparing LithoVue, a Single-Use, Flexible Disposable Ureteroscope, with Flexible, Reusable Fiber-Optic Ureteroscopes.
    J Endourol. 2017;31:468-475.
    Abstract     Related articles   

  120. CASADIO V, Salvi S, Martignano F, Gunelli R, et al
    Cell-Free DNA Integrity Analysis in Urine Samples.
    J Vis Exp. 2017;.
    Abstract     Related articles   

  121. KARABULUT YY, Erdogan S, Sayar H, Ergen A, et al
    Primary malignant melanoma of the urinary bladder: clinical, morphological, and molecular analysis of five cases.
    Melanoma Res. 2016.
    Abstract     Related articles   

  122. MITHANI MH, Khan SA, Khalid SE, Siddique R, et al
    Awareness of risk factors and fallacies associated with urinary bladder cancer in our population: A prospective survey.
    J Pak Med Assoc. 2018;68:55-58.
    Abstract     Related articles   

  123. LI Y, Diao F, Shi S, Li K, et al
    Computed tomography and magnetic resonance imaging evaluation of pelvic lymph node metastasis in bladder cancer.
    Chin J Cancer. 2018;37:3.
    Abstract     Related articles   

  124. MOSCHINI M, Mattei A, Cornelius J, Shariat SF, et al
    Surgical treatment for clinical node-positive bladder cancer patients treated with radical cystectomy without neoadjuvant chemotherapy.
    World J Urol. 2018 Jan 24. pii: 10.1007/s00345-018-2190.
    Abstract     Related articles   

  125. KHANDELWAL M, Anand V, Appunni S, Seth A, et al
    Decitabine augments cytotoxicity of cisplatin and doxorubicin to bladder cancer cells by activating hippo pathway through RASSF1A.
    Mol Cell Biochem. 2018 Jan 24. pii: 10.1007/s11010-018-3278.
    Abstract     Related articles   

  126. BUTT SU, Malik L
    Role of immunotherapy in bladder cancer: past, present and future.
    Cancer Chemother Pharmacol. 2018 Jan 24. pii: 10.1007/s00280-018-3518.
    Abstract     Related articles   

  127. CHU M, Zhang C
    Inhibition of angiogenesis by leflunomide via targeting the soluble ephrin-A1/EphA2 system in bladder cancer.
    Sci Rep. 2018;8:1539.
    Abstract     Related articles   

  128. NIWA N, Matsumoto K, Ide H, Nagata H, et al
    Prognostic Value of Pretreatment Albumin-to-Globulin Ratio in Patients With Non-Muscle-Invasive Bladder Cancer.
    Clin Genitourin Cancer. 2018 Jan 4. pii: S1558-7673(18)30001.
    Abstract     Related articles   

  129. GOGALIC S, Sauer U, Doppler S, Preininger C, et al
    Investigating Colorimetric Protein Array Assay Schemes for Detection of Recurrence of Bladder Cancer.
    Biosensors (Basel). 2018;8.
    Abstract     Related articles   

  130. POLETAJEW S, Wolinska E, Wasiutynski A, Dybowski B, et al
    [Immunohistochemical differentiation between muscularis mucosae and muscularis propria for improving the staging of bladder cancer in patients undergoing transurethral resection of bladder tumours].
    Pol J Pathol. 2017;68:218-224.
    Abstract     Related articles   

  131. JURACEK J, Peltanova B, Dolezel J, Fedorko M, et al
    Genome-wide identification of urinary cell-free microRNAs for non-invasive detection of bladder cancer.
    J Cell Mol Med. 2018 Jan 24. doi: 10.1111/jcmm.13487.
    Abstract     Related articles   

  132. CORMICK BPM, Langle Y, Belgorosky D, Vanzulli S, et al
    Flavonoid Silybin improves the response to radiotherapy in invasive bladder cancer.
    J Cell Biochem. 2018 Jan 24. doi: 10.1002/jcb.26693.
    Abstract     Related articles   

  133. SANGUEDOLCE F, Cormio A, Massenio P, Pedicillo MC, et al
    Altered expression of HER-2 and the mismatch repair genes MLH1 and MSH2 predicts the outcome of T1 high-grade bladder cancer.
    J Cancer Res Clin Oncol. 2018 Jan 23. pii: 10.1007/s00432-018-2593.
    Abstract     Related articles   

  134. KIMURA G
    [IV .The Role of Immune Checkpoint Blockade in the Treatment of Bladder Cancer].
    Gan To Kagaku Ryoho. 2018;45:38-43.
    Abstract     Related articles   

  135. MIYAZAKI J
    [III .Current Status of Bladder Preservation Therapy for Muscle Invasive Bladder Cancer].
    Gan To Kagaku Ryoho. 2018;45:33-37.
    Abstract     Related articles   

  136. OZONO S, Furuse H
    [II .Problems of Treatment for Non-Muscle Invasive Bladder Cancer].
    Gan To Kagaku Ryoho. 2018;45:30-32.
    Abstract     Related articles   

  137. ONOZAWA M
    [I .Recent Trends in Bladder Cancer Mortality in Japan].
    Gan To Kagaku Ryoho. 2018;45:26-29.
    Abstract     Related articles   

  138. AKAZA H
    [Genitourinary Tumor Four Questions about Bladder Cancer].
    Gan To Kagaku Ryoho. 2018;45:25.
    Abstract     Related articles   

  139. SANLI O, Lotan Y
    Current approaches for identifying high-risk non-muscle invasive bladder cancer.
    Expert Rev Anticancer Ther. 2018 Jan 23. doi: 10.1080/14737140.2018.1432358.
    Abstract     Related articles   

  140. RODRIGUEZ LOPEZ S, Damas Arroyo F, Perez-Utrilla Perez MA, Lopez Sanchez D, et al
    Metastasis of Ta low-grade bladder cancer into the lung and paraneoplastic syndrome without local invasion: A case report and literature review.
    Urol Case Rep. 2017;17:17-18.
    Abstract     Related articles   

  141. LIN ZR, Wang MY, He SY, Cai ZM, et al
    TACC3 transcriptionally upregulates E2F1 to promote cell growth and confer sensitivity to cisplatin in bladder cancer.
    Cell Death Dis. 2018;9:72.
    Abstract     Related articles   

  142. CHENG W, Fu D, Xu F, Zhang Z, et al
    Unwrapping the genomic characteristics of urothelial bladder cancer and successes with immune checkpoint blockade therapy.
    Oncogenesis. 2018;7:2.
    Abstract     Related articles   

  143. HE W, Zhong G, Jiang N, Wang B, et al
    Long noncoding RNA BLACAT2 promotes bladder cancer-associated lymphangiogenesis and lymphatic metastasis.
    J Clin Invest. 2018 Jan 22. pii: 96218. doi: 10.1172/JCI96218.
    Abstract     Related articles   

  144. BOTELHO MC, Alves H, Richter J
    Halting Schistosoma haematobium - associated bladder cancer.
    Int J Cancer Manag. 2017;10.
    Abstract     Related articles   

  145. BUTTERFIELD A, Gupta S
    Next-generation sequencing in non-muscle-invasive bladder cancer-a step towards personalized medicine for a superficial bladder tumor.
    Transl Androl Urol. 2017;6:1198-1202.
    Abstract     Related articles   

  146. RIETHDORF S, Soave A, Rink M
    The current status and clinical value of circulating tumor cells and circulating cell-free tumor DNA in bladder cancer.
    Transl Androl Urol. 2017;6:1090-1110.
    Abstract     Related articles   

  147. MARI A, D'Andrea D, Abufaraj M, Foerster B, et al
    Genetic determinants for chemo- and radiotherapy resistance in bladder cancer.
    Transl Androl Urol. 2017;6:1081-1089.
    Abstract     Related articles   

  148. WEZEL F, Vallo S, Roghmann F
    Do we have biomarkers to predict response to neoadjuvant and adjuvant chemotherapy and immunotherapy in bladder cancer?
    Transl Androl Urol. 2017;6:1067-1080.
    Abstract     Related articles   

  149. INEICHEN GB, Rothlisberger R, Johner KF, Seiler R, et al
    Different stages in drug development for muscle-invasive bladder cancer.
    Transl Androl Urol. 2017;6:1060-1066.
    Abstract     Related articles   

  150. PRADERE B, Thibault C, Vetterlein MW, Leow JJ, et al
    Peri-operative chemotherapy for muscle-invasive bladder cancer: status-quo in 2017.
    Transl Androl Urol. 2017;6:1049-1059.
    Abstract     Related articles   

  151. PANG KH, Esperto F, Noon AP
    Opportunities of next-generation sequencing in non-muscle invasive bladder cancer outcome prediction.
    Transl Androl Urol. 2017;6:1043-1048.
    Abstract     Related articles   

  152. DUQUESNE I, Weisbach L, Aziz A, Kluth LA, et al
    The contemporary role and impact of urine-based biomarkers in bladder cancer.
    Transl Androl Urol. 2017;6:1031-1042.
    Abstract     Related articles   

  153. RINK M
    The landscape of genetics and biomarkers in bladder cancer.
    Transl Androl Urol. 2017;6:1027-1030.
    Abstract     Related articles   


  154. Erratum to: Hafeez S, McDonald F, Lalondrelle S, et al. Clinical outcomes of image guided adaptive hypofractionated weekly radiation therapy for bladder cancer in patients unsuitable for radical treatment. Int J Radiat Oncol Biol Phys 2017;98:115-122.
    Int J Radiat Oncol Biol Phys. 2018;100:532-533.
    Abstract     Related articles   

  155. OUSATI ASHTIANI Z, Mehrsai AR, Pourmand MR, Pourmand GR, et al
    High Resolution Melting Analysis for Rapid Detection of PIK3CA Gene Mutations in Bladder Cancer: A Mutated Target for Cancer Therapy.
    Urol J. 2018 Jan 21. pii: 3987/1201.
    Abstract     Related articles   

  156. HORVAT N, Ragucci M, Mannelli L
    Hepatic Mass in a Patient With Bladder Cancer History.
    Gastroenterology. 2018 Jan 16. pii: S0016-5085(17)35643.
    Abstract     Related articles   

  157. ZHANG ZF, Zhang HR, Zhang QY, Lai SY, et al
    High expression of TMEM40 is associated with the malignant behavior and tumorigenesis in bladder cancer.
    J Transl Med. 2018;16:9.
    Abstract     Related articles   

  158. BROUGHTON BL, Baron B, Kiernan M, Baack-Kukreja J, et al
    Cystectomy-Enhanced Recovery Program: Nursing Implications.
    Urol Nurs. 2017;37:9-14.
    Abstract     Related articles   

  159. NITTA S, Sakka S, Endo T, Komine M, et al
    [Fever, Hepatic Dysfunction and Interstitial Pneumonia Caused by Intravesical Bacillus Calmette-Guerin (BCG) Instillation after Urethral Bougie : A Case Report].
    Hinyokika Kiyo. 2017;63:427-430.
    Abstract     Related articles   

  160. OZAWA M, Kuromoto A, Morozumi K, Satou M, et al
    [Two Cases of Urachal Carcinoma Treated by TS-1/CDDP as Adjuvant Chemotherapy].
    Hinyokika Kiyo. 2017;63:413-419.
    Abstract     Related articles   

  161. IKEUCHI R, Sunada T, Yoshikawa T, Yoshida T, et al
    [Reactive Arthritis during the Second Course of Intravesical BCG Therapy Requiring Administration of Methotrexate : A Case Report].
    Hinyokika Kiyo. 2017;63:329-332.
    Abstract     Related articles   

  162. MATSUMOTO Y, Waku N, Kawai K, Ikeda A, et al
    [A Case of Primary Schwannoma of the Urinary Bladder].
    Hinyokika Kiyo. 2017;63:323-328.
    Abstract     Related articles   

  163. MINATO A, Fujimoto N, Kubo T
    Squamous Differentiation Predicts Poor Response to Cisplatin-Based Chemotherapy and Unfavorable Prognosis in Urothelial Carcinoma of the Urinary Bladder.
    Clin Genitourin Cancer. 2017;15:e1063-e1067.
    Abstract     Related articles   

  164. LEE CH, Ku JY, Jeong CW, Ku JH, et al
    Predictors for Intravesical Recurrence Following Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A National Multicenter Analysis.
    Clin Genitourin Cancer. 2017;15:e1055-e1061.
    Abstract     Related articles   

  165. SASAKI K, Wada K, Araki M, Kobayashi Y, et al
    Diagnostic Ureteroscopy for Cases Clinically Suspected of Carcinoma in Situ of the Upper Urinary Tract.
    Acta Med Okayama. 2017;71:227-232.
    Abstract     Related articles   

  166. MATOS J, Mussetto I, Podesta R, Schettini D, et al
    Bladder cancer presenting with acrometastases: a different cause of foot pain.
    Skeletal Radiol. 2018 Feb 1. pii: 10.1007/s00256-018-2888.
    Abstract     Related articles   

  167. TANIMOTO R, Saika T, Ebara S, Kobayashi Y, et al
    Prospective randomized controlled trial of postoperative early intravesical chemotherapy with pirarubicin (THP) for solitary non-muscle invasive bladder cancer comparing single and two-time instillation.
    World J Urol. 2018 Jan 31. pii: 10.1007/s00345-018-2196.
    Abstract     Related articles   

  168. TAN YG, Eu E, Lau Kam On W, Huang HH, et al
    Pretreatment neutrophil-to-lymphocyte ratio predicts worse survival outcomes and advanced tumor staging in patients undergoing radical cystectomy for bladder cancer.
    Asian J Urol. 2017;4:239-246.
    Abstract     Related articles   

  169. YANG C, Yuan W, Yang X, Li P, et al
    Circular RNA circ-ITCH inhibits bladder cancer progression by sponging miR-17/miR-224 and regulating p21, PTEN expression.
    Mol Cancer. 2018;17:19.
    Abstract     Related articles   

  170. COMPERAT E, Varinot J, Moroch J, Eymerit-Morin C, et al
    A practical guide to bladder cancer pathology.
    Nat Rev Urol. 2018 Jan 31. pii: nrurol.2018.2. doi: 10.1038/nrurol.2018.
    Abstract     Related articles   

  171. BIZHANI F, Hashemi M, Danesh H, Nouralizadeh A, et al
    Association between single nucleotide polymorphisms in the PI3K/AKT/mTOR pathway and bladder cancer risk in a sample of Iranian population.
    EXCLI J. 2018;17:3-13.
    Abstract     Related articles   

  172. CHRISTENSEN E, Nordentoft I, Vang S, Birkenkamp-Demtroder K, et al
    Optimized targeted sequencing of cell-free plasma DNA from bladder cancer patients.
    Sci Rep. 2018;8:1917.
    Abstract     Related articles   

  173. ORYWAL K, Jelski W, Werel T, Szmitkowski M, et al
    The Activity of Class I-IV Alcohol Dehydrogenase Isoenzymes and Aldehyde Dehydrogenase in Bladder Cancer Cells.
    Cancer Invest. 2018 Jan 30:1-7. doi: 10.1080/07357907.2017.1422511.
    Abstract     Related articles   

  174. BUSS JH, Begnini KR, Bender CB, Pohlmann AR, et al
    Nano-BCG: A Promising Delivery System for Treatment of Human Bladder Cancer.
    Front Pharmacol. 2018;8:977.
    Abstract     Related articles   

  175. SWEENEY SK, Luo Y, O'Donnell MA, Assouline JG, et al
    Peptide-Mediated Targeting Mesoporous Silica Nanoparticles: A Novel Tool for Fighting Bladder Cancer.
    J Biomed Nanotechnol. 2017;13:232-42.
    Abstract     Related articles   

  176. HAN Y, Jin X, Zhou H, Liu B, et al
    Identification of key genes associated with bladder cancer using gene expression profiles.
    Oncol Lett. 2018;15:297-303.
    Abstract     Related articles   

  177. JIANG K, Chen H, Tang K, Guan W, et al
    Puerarin inhibits bladder cancer cell proliferation through the mTOR/p70S6K signaling pathway.
    Oncol Lett. 2018;15:167-174.
    Abstract     Related articles   

  178. COLIN R, Grzebyk M, Wild P, Hedelin G, et al
    Bladder cancer and occupational exposure to metalworking fluid mist: a counter-matched case-control study in French steel-producing factories.
    Occup Environ Med. 2018 Jan 26. pii: oemed-2017-104666.
    Abstract     Related articles   

  179. HANG JF, Pan CC
    Response to: Absence of GNAS and BRAF mutations but presence of KRAS mutation in urachal adenocarcinoma: author reply.
    Pathology. 2017;49:562-563.
    Abstract     Related articles   

  180. REIS H, Niedworok C, Szarvas T
    Response to: Absence of GNAS and BRAF mutations but presence of KRAS mutation in urachal adenocarcinoma.
    Pathology. 2017;49:561-562.
    Abstract     Related articles   

  181. WINDER M, Vesela R, Aronsson P, Patel B, et al
    Autonomic Receptor-mediated Regulation of Production and Release of Nitric Oxide in Normal and Malignant Human Urothelial Cells.
    Basic Clin Pharmacol Toxicol. 2017;121:257-265.
    Abstract     Related articles   

  182. BELLMUNT J, Kerst JM, Vazquez F, Morales-Barrera R, et al
    A randomized phase II/III study of cabazitaxel versus vinflunine in metastatic or locally advanced transitional cell carcinoma of the urothelium (SECAVIN).
    Ann Oncol. 2017;28:1517-1522.
    Abstract     Related articles   

  183. LI X, Wang W, Zhu G, He W, et al
    Risk factors, follow-up, and treatment of urethral recurrence following radical cystectomy and urinary diversion for bladder cancer: a meta-analysis of 9498 patients.
    Oncotarget. 2017;9:2782-2796.
    Abstract     Related articles   

  184. WACH S, Weigelt K, Michalke B, Lieb V, et al
    Diagnostic potential of major and trace elements in the serum of bladder cancer patients.
    J Trace Elem Med Biol. 2018;46:150-155.
    Abstract     Related articles   

  185. CATTRINI C, Boccardo F
    Atezolizumab and bladder cancer: facing a complex disease.
    Lancet. 2018;391:305-306.
    Abstract     Related articles   

  186. WANG W, Li C, Chen Y, Teng L, et al
    Increased expression of GGN promotes tumorigenesis in bladder cancer and is correlated with poor prognosis.
    Gene. 2018 Feb 2. pii: S0378-1119(18)30127-6. doi: 10.1016/j.gene.2018.
    Abstract     Related articles   

  187. JOBCZYK M, Pikala M, Rozanski W, Maniecka-Bryla I, et al
    Years of life lost due to bladder cancer among the inhabitants of Poland in the years 2000 to 2014.
    Cent European J Urol. 2017;70:338-343.
    Abstract     Related articles   

  188. WU K, Tan MY, Jiang JT, Mu XY, et al
    Cisplatin inhibits the progression of bladder cancer by selectively depleting G-MDSCs: A novel chemoimmunomodulating strategy.
    Clin Immunol. 2018 Feb 1. pii: S1521-6616(17)30473.
    Abstract     Related articles   

  189. LIN Y, Wang Y, Wu Q, Jin H, et al
    Association between obesity and bladder cancer recurrence: A meta-analysis.
    Clin Chim Acta. 2018;480:41-46.
    Abstract     Related articles   

  190. MASSARI F, Di Nunno V, Cubelli M, Santoni M, et al
    Immune checkpoint inhibitors for metastatic bladder cancer.
    Cancer Treat Rev. 2018;64:11-20.
    Abstract     Related articles   

  191. XU T, Yin J, Chen S, Zhang D, et al
    Elevated 8-oxo-7,8-dihydro-2'-deoxyguanosine in genome of T24 bladder cancer cells induced by halobenzoquinones.
    J Environ Sci (China). 2018;63:133-139.
    Abstract     Related articles   

  192. ARORA HC, Fascelli M, Zhang JH, Isharwal S, et al
    Kidney, Ureteral, and Bladder Cancer: A Primer for the Internist.
    Med Clin North Am. 2018;102:231-249.
    Abstract     Related articles   

  193. SAYYID RK, Sayyid AK, Klaassen Z, Hersey K, et al
    Replacing surveillance cystoscopy with urinary biomarkers in followup of patients with non-muscle-invasive bladder cancer: Patients' and urologic oncologists' perspectives.
    Can Urol Assoc J. 2018 Feb 6. pii: cuaj.4922. doi: 10.5489/cuaj.4922.
    Abstract     Related articles   

  194. ALIVAND M, Soufi RT, Madani AH, Esmaeili SN, et al
    Histonedeacetylase 1 mRNA has elevated expression in clinical specimen of bladder cancer.
    Bratisl Lek Listy. 2018;119:12-16.
    Abstract     Related articles   

  195. THOMA C
    Bladder cancer: Improving NMIBC risk stratification.
    Nat Rev Urol. 2018 Feb 6. pii: nrurol.2018.13. doi: 10.1038/nrurol.2018.
    Abstract     Related articles   

  196. YANG YL, Li MY, Liu L, Wang L, et al
    Perceived stress and its associated demographic-clinical characteristics and positive expectations among Chinese cervical, kidney, and bladder cancer patients.
    Support Care Cancer. 2018 Feb 5. pii: 10.1007/s00520-018-4081.
    Abstract     Related articles   

  197. LI C, Zeng X, Liu Z, Li F, et al
    BDNF VAL66MET Polymorphism Elevates the Risk of Bladder Cancer via MiRNA-146b in Micro-Vehicles.
    Cell Physiol Biochem. 2018;45:366-377.
    Abstract     Related articles   

  198. AGHAMOHAMMADI D, Gargari RM, Fakhari S, Bilehjani E, et al
    Classic versus Inguinal Approach for Obturator Nerve Block in Transurethral Resection of Bladder Cancer under Spinal Anesthesia: A Randomized Controlled Trial.
    Iran J Med Sci. 2018;43:75-80.
    Abstract     Related articles   

  199. ROH YG, Mun MH, Jeong MS, Kim WT, et al
    Drug resistance of bladder cancer cells through activation of ABCG2 by FOXM1.
    BMB Rep. 2018 Feb 5. pii: 4050.
    Abstract     Related articles   

  200. PRESLER M, Wojtczyk-Miaskowska A, Schlichtholz B, Kaluzny A, et al
    Increased expression of the gene encoding stearoyl-CoA desaturase 1 in human bladder cancer.
    Mol Cell Biochem. 2018 Feb 2. pii: 10.1007/s11010-018-3306.
    Abstract     Related articles   

  201. ADAMIETZ IA
    [Complications instead of improved survival and local freedom from recurrence after early radical cystectomy in muscle-invasive bladder cancer compared to multimodal maintenance therapy].
    Strahlenther Onkol. 2018 Feb 2. pii: 10.1007/s00066-018-1274.
    Abstract     Related articles   

  202. SCHROECK FR, Smith N, Shelton JB
    Implementing risk-aligned bladder cancer surveillance care.
    Urol Oncol. 2018 Jan 26. pii: S1078-1439(17)30645.
    Abstract     Related articles   

  203. GUO CC, Al-Ahmadie HA, Flaig TW, Kamat AM, et al
    Contribution of bladder cancer pathology assessment in planning clinical trials.
    Urol Oncol. 2018 Jan 29. pii: S1078-1439(18)30001.
    Abstract     Related articles   

  204. GODWIN JL, Hoffman-Censits J, Plimack E
    Recent developments in the treatment of advanced bladder cancer.
    Urol Oncol. 2018 Jan 26. pii: S1078-1439(17)30647.
    Abstract     Related articles   

  205. HUPE MC, Vahlensieck W, Ozimek T, Struck JP, et al
    Diarrhea and flatulence are major bowel disorders after radical cystectomy: Results from a cross-sectional study in bladder cancer patients.
    Urol Oncol. 2018 Jan 21. pii: S1078-1439(17)30643.
    Abstract     Related articles   

  206. KLAASSEN Z, Goldberg H, Chandrasekar T, Arora K, et al
    Changing Trends for Suicidal Death in Patients With Bladder Cancer: A 40+ Year Population-level Analysis.
    Clin Genitourin Cancer. 2018 Jan 5. pii: S1558-7673(18)30004.
    Abstract     Related articles   

  207. KILTIE AE, Southby R, LeMonnier K, Binnee J, et al
    High Levels of Patient Satisfaction in Joint Uro-oncology Clinics to Assist Patient Choice in Early Prostate Cancer and Muscle-invasive Bladder Cancer.
    Clin Oncol (R Coll Radiol). 2018 Jan 25. pii: S0936-6555(18)30006.
    Abstract     Related articles   

  208. LIAO G, Chen F, Zhong J, Jiang X, et al
    MicroRNA539 inhibits the proliferation and invasion of bladder cancer cells by regulating IGF1R.
    Mol Med Rep. 2018 Jan 25. doi: 10.3892/mmr.2018.8497.
    Abstract     Related articles   

  209. RUTHERFORD C, Patel MI, Tait MA, Smith DP, et al
    Assessment of content validity for patient-reported outcome measures used in patients with non-muscle invasive bladder cancer: a systematic review.
    Support Care Cancer. 2018 Feb 1. pii: 10.1007/s00520-018-4058.
    Abstract     Related articles   

  210. RAZIK A, Das CJ, Sharma S, Seth A, et al
    Diagnostic performance of diffusion-weighted MR imaging at 3.0 T in predicting muscle invasion in urinary bladder cancer: utility of evaluating the morphology of the reactive tumor stalk.
    Abdom Radiol (NY). 2018 Feb 1. pii: 10.1007/s00261-018-1458.
    Abstract     Related articles   

  211. ASAI S, Miura N, Sawada Y, Noda T, et al
    Silencing of ECHDC1 inhibits growth of gemcitabine-resistant bladder cancer cells.
    Oncol Lett. 2018;15:522-527.
    Abstract     Related articles   

  212. WU H, Wang X, Mo N, Zhang L, et al
    B7-homolog 4 promotes epithelial-mesenchymal transition and invasion of bladder cancer cells via activation of nuclear factor-kappaB.
    Oncol Res. 2018 Feb 1. doi: 10.3727/096504018X15172227703244.
    Abstract     Related articles   

  213. LI H, Liu L, Shi Q, Stemmer A, et al
    Bladder cancer: detection and image quality compared among iShim, RESOLVE, and ss-EPI diffusion-weighted MR imaging with high b value at 3.0 T MRI.
    Medicine (Baltimore). 2017;96:e9292.
    Abstract     Related articles   

  214. QIU X, Cao K, Lin T, Chen W, et al
    Drug delivery system based on dendritic nanoparticles for enhancement of intravesical instillation.
    Int J Nanomedicine. 2017;12:7365-7374.
    Abstract     Related articles   

  215. FARLEY A, Koshiaris C, Oke J, Ryan R, et al
    Physician Support of Smoking Cessation After Diagnosis of Lung, Bladder, or Upper Aerodigestive Tract Cancer.
    Ann Fam Med. 2017;15:443-450.
    Abstract     Related articles   

  216. HODGSON A, Xu B, Satkunasivam R, Downes MR, et al
    Tumour front inflammation and necrosis are independent prognostic predictors in high-grade urothelial carcinoma of the bladder.
    J Clin Pathol. 2018;71:154-160.
    Abstract     Related articles   

  217. KWON JE, Cho NH, Choi YJ, Lim SD, et al
    Level of mitoses in non-muscle invasive papillary urothelial carcinomas (pTa and pT1) at initial bladder biopsy is a simple and powerful predictor of clinical outcome: a multi-center study in South Korea.
    Diagn Pathol. 2017;12:54.
    Abstract     Related articles   

  218. VIRK RK, Abro S, de Ubago JMM, Pambuccian SE, et al
    The value of the UroVysion(R) FISH assay in the risk-stratification of patients with "atypical urothelial cells" in urinary cytology specimens.
    Diagn Cytopathol. 2017;45:481-500.
    Abstract     Related articles   

  219. GUO H, Xu W, Chen J, Yan L, et al
    Positively charged polypeptide nanogel enhances mucoadhesion and penetrability of 10-hydroxycamptothecin in orthotopic bladder carcinoma.
    J Control Release. 2017;259:136-148.
    Abstract     Related articles   

  220. KIM JK, Cho MC, Ku JH, Paick JS, et al
    Preperitoneal placement of an inflatable penile prosthesis reservoir for postoperative erectile dysfunction after radical cystoprostatectomy with orthotopic neobladder.
    Investig Clin Urol. 2016;57:364-6.
    Abstract     Related articles   

  221. MIJNES J, Veeck J, Gaisa NT, Burghardt E, et al
    Promoter methylation of DNA damage repair (DDR) genes in human tumor entities: RBBP8/CtIP is almost exclusively methylated in bladder cancer.
    Clin Epigenetics. 2018;10:15.
    Abstract     Related articles   

  222. WANG M, Guo C, Wang L, Luo G, et al
    Long noncoding RNA GAS5 promotes bladder cancer cells apoptosis through inhibiting EZH2 transcription.
    Cell Death Dis. 2018;9:238.
    Abstract     Related articles   

  223. SU F, He W, Chen C, Liu M, et al
    The long non-coding RNA FOXD2-AS1 promotes bladder cancer progression and recurrence through a positive feedback loop with Akt and E2F1.
    Cell Death Dis. 2018;9:233.
    Abstract     Related articles   

  224. HIROBE M, Tanaka T, Shindo T, Ichihara K, et al
    Complications within 90 days after radical cystectomy for bladder cancer: results of a multicenter prospective study in Japan.
    Int J Clin Oncol. 2018 Feb 13. pii: 10.1007/s10147-018-1245.
    Abstract     Related articles   

  225. HUANG XX, Wang RX, Lin Q, Chen W, et al
    Inhibitory effects of 2-methoxyestradiol on cell growth and invasion in human bladder cancer T-24 cells.
    Pharmazie. 2017;72:87-90.
    Abstract     Related articles   

  226. ZHOU YM, Feng X, Zhou BC, Fan YF, et al
    Evaluation of therapeutic effects of (125)I particles brachytherapy for recurrent bladder cancer.
    Oncol Lett. 2018;15:3453-3457.
    Abstract     Related articles   

  227. XIANG X, Huang J, Mo W, Jiang L, et al
    Long non-coding RNA cartilage injury-related promotes malignancy in bladder cancer.
    Oncol Lett. 2018;15:3049-3055.
    Abstract     Related articles   

  228. LI Z, Zhang TB, Jia DH, Sun WQ, et al
    Genipin inhibits the growth of human bladder cancer cells via inactivation of PI3K/Akt signaling.
    Oncol Lett. 2018;15:2619-2624.
    Abstract     Related articles   

  229. MA Z, Xue S, Zeng B, Qiu D, et al
    lncRNA SNHG5 is associated with poor prognosis of bladder cancer and promotes bladder cancer cell proliferation through targeting p27.
    Oncol Lett. 2018;15:1924-1930.
    Abstract     Related articles   

  230. MEMON AA, Gilliver SC, Borre M, Sundquist J, et al
    Soluble HER3 predicts survival in bladder cancer patients.
    Oncol Lett. 2018;15:1783-1788.
    Abstract     Related articles   

  231. KELSEY R
    Bladder cancer: BBN mouse model mimics human MIBC.
    Nat Rev Urol. 2018 Feb 13. pii: nrurol.2018.17. doi: 10.1038/nrurol.2018.
    Abstract     Related articles   

  232. XU M, Li J, Wang X, Meng S, et al
    MiR-22 suppresses epithelial-mesenchymal transition in bladder cancer by inhibiting Snail and MAPK1/Slug/vimentin feedback loop.
    Cell Death Dis. 2018;9:209.
    Abstract     Related articles   

  233. PAQUETTE M, Beaudoin S, Tremblay MA, Jean S, et al
    NLS-cholic acid conjugation to IL-5Ralpha-specific antibody improves cellular accumulation and in vivo tumor-targeting properties in a bladder cancer model.
    Bioconjug Chem. 2018 Feb 13. doi: 10.1021/acs.bioconjchem.8b00077.
    Abstract     Related articles   

  234. MESSING EM
    Molecular Landscape of Non-Muscle Invasive Bladder Cancer.
    Bladder Cancer. 2018;4:131-132.
    Abstract     Related articles   

  235. GARG T, Connors JN, Ladd IG, Bogaczyk TL, et al
    Defining Priorities to Improve Patient Experience in Non-Muscle Invasive Bladder Cancer.
    Bladder Cancer. 2018;4:121-128.
    Abstract     Related articles   

  236. FARBER NJ, Faiena I, Dombrovskiy V, Tabakin AL, et al
    Disparities in the Use of Continent Urinary Diversions after Radical Cystectomy for Bladder Cancer.
    Bladder Cancer. 2018;4:113-120.
    Abstract     Related articles   

  237. WESTHOFF E, Witjes JA, Fleshner NE, Lerner SP, et al
    Body Mass Index, Diet-Related Factors, and Bladder Cancer Prognosis: A Systematic Review and Meta-Analysis.
    Bladder Cancer. 2018;4:91-112.
    Abstract     Related articles   

  238. TAMURA S, Wang Y, Veeneman B, Hovelson D, et al
    Molecular Correlates of In Vitro Responses to Dacomitinib and Afatinib in Bladder Cancer.
    Bladder Cancer. 2018;4:77-90.
    Abstract     Related articles   

  239. WALKER M, Doiron RC, French SD, Brennan K, et al
    Peri-Operative Chemotherapy for Bladder Cancer: A Survey of Providers to Determine Barriers and Enablers.
    Bladder Cancer. 2018;4:49-65.
    Abstract     Related articles   

  240. LI R, Metcalfe M, Kukreja J, Navai N, et al
    Role of Radical Cystectomy in Non-Organ Confined Bladder Cancer: A Systematic Review.
    Bladder Cancer. 2018;4:31-40.
    Abstract     Related articles   

  241. TODENHOFER T, Struss WJ, Seiler R, Wyatt AW, et al
    Liquid Biopsy-Analysis of Circulating Tumor DNA (ctDNA) in Bladder Cancer.
    Bladder Cancer. 2018;4:19-29.
    Abstract     Related articles   

  242. ABBOSH PH, Plimack ER
    Molecular and Clinical Insights into the Role and Significance of Mutated DNA Repair Genes in Bladder Cancer.
    Bladder Cancer. 2018;4:9-18.
    Abstract     Related articles   

  243. SHERIF A, Winerdal M, Winqvist O
    Immune Responses to Neoadjuvant Chemotherapy in Muscle Invasive Bladder Cancer.
    Bladder Cancer. 2018;4:1-7.
    Abstract     Related articles   

  244. MUKHERJEE N, Svatek RS, Mansour AM
    Role of immunotherapy in bacillus Calmette-Guerin-unresponsive non-muscle invasive bladder cancer.
    Urol Oncol. 2018 Feb 8. pii: S1078-1439(17)30649.
    Abstract     Related articles   

  245. MARCHIONI M, Nazzani S, Preisser F, Bandini M, et al
    Therapeutic strategies for organ-confined and non-organ-confined bladder cancer after radical cystectomy.
    Expert Rev Anticancer Ther. 2018 Feb 15:1-11. doi: 10.1080/14737140.2018.1439744
    Abstract     Related articles   

  246. LI WL, Ji GH, Zhang XZ, Yu HY, et al
    [The influence and mechanisms of purple sweet potato anthocyanins on the growth of bladder cancer BIU87 cell].
    Zhonghua Yi Xue Za Zhi. 2018;98:457-459.
    Abstract     Related articles   

  247. ZHANG S, Wang Y, Bondaruk J, Majewski T, et al
    Detection of Bladder Cancer in Urine Sediments by a Novel Multicolor Fluorescence In Situ Hybridization (Quartet) Test.
    Eur Urol Focus. 2018 Feb 7. pii: S2405-4569(18)30018.
    Abstract     Related articles   

  248. FANG CW, Liao CH, Wu SC, Muo CH, et al
    Association of benign prostatic hyperplasia and subsequent risk of bladder cancer: an Asian population cohort study.
    World J Urol. 2018 Feb 9. pii: 10.1007/s00345-018-2216.
    Abstract     Related articles   

  249. ALLIONE A, Pardini B, Viberti C, Oderda M, et al
    The prognostic value of basal DNA damage level in peripheral blood lymphocytes of patients affected by bladder cancer.
    Urol Oncol. 2018 Feb 6. pii: S1078-1439(18)30006.
    Abstract     Related articles   

  250. RIVERO GUERRA A, Fernandez Aparicio T, Barcelo Bayonas I, Pardo Martinez A, et al
    Outpatient Holmium laser fulguration: A safe procedure for treatment of recurrence of nonmuscle invasive bladder cancer.
    Actas Urol Esp. 2018 Feb 5. pii: S0210-4806(18)30003.
    Abstract     Related articles   

  251. LIU X, Li S, Li Y, Cheng B, et al
    Puerarin inhibits proliferation and induces apoptosis by up-regulation of miR-16 in bladder cancer cell line T24.
    Oncol Res. 2018 Feb 8. doi: 10.3727/096504018X15178736525106.
    Abstract     Related articles   

  252. CORMIO L, Mancini V, Calo B, Selvaggio O, et al
    Asymptomatic solitary bladder plasmocytoma: A case report and literature review.
    Medicine (Baltimore). 2017;96:e9347.
    Abstract     Related articles   

  253. FEDUS T, Ras R, Ksiazek M, Filipowska J, et al
    Primary vaginal squamous cell carcinoma with bladder involvement in uterine prolapsed patient: Case report.
    Medicine (Baltimore). 2017;96:e8993.
    Abstract     Related articles   

  254. EL BOTE H, Atik S, Fares R, Hage E, et al
    [Inverted papilloma of the bladder: a rare benign tumor: a case report].
    Pan Afr Med J. 2017;26:204.
    Abstract     Related articles   

  255. KIM HC, Park HP, Lee J, Jeong MH, et al
    Sevoflurane vs. propofol in post-operative catheter-related bladder discomfort: a prospective randomized study.
    Acta Anaesthesiol Scand. 2017;61:773-780.
    Abstract     Related articles   

  256. MOHANTY BD, Mohanty S, Hussain Y, Padmaraju C, et al
    Management of ischemic coronary disease in patients receiving chemotherapy: an uncharted clinical challenge.
    Future Cardiol. 2017;13:247-257.
    Abstract     Related articles   

  257. MANIG L, Janssen S, Schild SE, Rades D, et al
    A New Prognostic Instrument Specifically Designed for Patients Irradiated for Recurrent Carcinoma of the Bladder.
    In Vivo. 2017;31:435-438.
    Abstract     Related articles   

  258. WU GX, Nelson RA, Kim JY, Raz DJ, et al
    Non-Small Cell Lung Cancer as a Second Primary Among Patients With Previous Malignancy: Who Is at Risk?
    Clin Lung Cancer. 2017 Mar 2. pii: S1525-7304(17)30050.
    Abstract     Related articles   

  259. DUTTA R, Yoon R, Patel RM, Spradling K, et al
    Clinical Comparison of Conventional and Mobile Endockscope Videocystoscopy Using an Air or Fluid Medium.
    J Endourol. 2017;31:593-597.
    Abstract     Related articles   

  260. KOESTLER DC, Usset J, Christensen BC, Marsit CJ, et al
    DNA Methylation-Derived Neutrophil-to-Lymphocyte Ratio: An Epigenetic Tool to Explore Cancer Inflammation and Outcomes.
    Cancer Epidemiol Biomarkers Prev. 2017;26:328-338.
    Abstract     Related articles   

  261. FREMEREY J, Balzer S, Brozou T, Schaper J, et al
    Embryonal rhabdomyosarcoma in a patient with a heterozygous frameshift variant in the DICER1 gene and additional manifestations of the DICER1 syndrome.
    Fam Cancer. 2017;16:401-405.
    Abstract     Related articles   

  262. CHEN QN, Wei CC, Wang ZX, Sun M, et al
    Long non-coding RNAs in anti-cancer drug resistance.
    Oncotarget. 2017;8:1925-1936.
    Abstract     Related articles   

  263. SHIBA S, Wakatsuki M, Kato S, Ohno T, et al
    Carbon-ion radiotherapy for locally advanced cervical cancer with bladder invasion.
    J Radiat Res. 2016.
    Abstract     Related articles   

  264. LIN T, Zhao X, Zhao S, Yu H, et al
    O2-generating MnO2 nanoparticles for enhanced photodynamic therapy of bladder cancer by ameliorating hypoxia.
    Theranostics. 2018;8:990-1004.
    Abstract     Related articles   

  265. MAHE M, Dufour F, Neyret-Kahn H, Moreno-Vega A, et al
    An FGFR3/MYC positive feedback loop provides new opportunities for targeted therapies in bladder cancers.
    EMBO Mol Med. 2018 Feb 20. pii: emmm.201708163. doi: 10.15252/emmm.201708163.
    Abstract     Related articles   

  266. DU Y, Wang L, Wang W, Guo T, et al
    Novel Application of Cell Penetrating R11 Peptide for Diagnosis of Bladder Cancer.
    J Biomed Nanotechnol. 2018;14:161-167.
    Abstract     Related articles   

  267. SUN X, Zhang T, Deng Q, Zhou Q, et al
    Benzidine Induces Epithelial-Mesenchymal Transition of Human Bladder Cancer Cells through Activation of ERK5 Pathway.
    Mol Cells. 2018 Feb 21. pii: molcells.2018.2113.
    Abstract     Related articles   

  268. LIU Z, Ye Y, Li X, Guo S, et al
    The effects of intra-arterial chemotherapy on bladder preservation in patients with T1 stage bladder cancer.
    World J Urol. 2018 Feb 19. pii: 10.1007/s00345-018-2199.
    Abstract     Related articles   

  269. FLETCHER SA, Gild P, Cole AP, Vetterlein MW, et al
    The effect of treatment at minority-serving hospitals on outcomes for bladder cancer.
    Urol Oncol. 2018 Feb 14. pii: S1078-1439(18)30010.
    Abstract     Related articles   

  270. CEYLAN C, Yahsi S, Dogan S, OztUrk E, et al
    Emphasis of FAS/FASL gene polymorphism in patients with non-muscle invasive bladder cancer.
    Ir J Med Sci. 2018 Feb 16. pii: 10.1007/s11845-018-1764.
    Abstract     Related articles   

  271. DECAESTECKER K, Lumen N, Van Camp C, Oosterlinck W, et al
    Single ablative intravesical electromotive mitomycin C administration for small non-muscle-invasive bladder cancer: a prospective study.
    Acta Clin Belg. 2018 Feb 16:1-4. doi: 10.1080/17843286.2018.1440706.
    Abstract     Related articles   

  272. BHANDARI P, Novikova G, Goergen CJ, Irudayaraj J, et al
    Ultrasound beam steering of oxygen nanobubbles for enhanced bladder cancer therapy.
    Sci Rep. 2018;8:3112.
    Abstract     Related articles   

  273. HU C, Liu Y, Lin Y, Liang JK, et al
    Intravenous injections of the oncolytic virus M1 as a novel therapy for muscle-invasive bladder cancer.
    Cell Death Dis. 2018;9:274.
    Abstract     Related articles   

  274. CHEN WS, Townsend JP, Yu JB
    Radiation-Specific Clinical Data Should Be Included in Existing Large-Scale Genomic Datasets.
    Int J Radiat Oncol Biol Phys. 2017;98:8-10.
    Abstract     Related articles   

  275. GERAILY G, Sharafi N, Shirazi A, Esfehani M, et al
    Comparison of beam hardening effect of physical and enhanced dynamic wedges at bladder inhomogeneity using EBT3 film dosimeter.
    J Cancer Res Ther. 2017;13:97-101.
    Abstract     Related articles   

  276. LEWIS S, Murthy V, Mahantshetty U, Shrivastava SK, et al
    Incidental Dose to Pelvic Nodes in Bladder-Only Radiotherapy: Is It Clinically Relevant?
    Technol Cancer Res Treat. 2017;16:382-387.
    Abstract     Related articles   

  277. CHO YM, Hasumura M, Imai T, Takami S, et al
    Horseradish extract promotes urinary bladder carcinogenesis when administered to F344 rats in drinking water.
    J Appl Toxicol. 2017;37:853-862.
    Abstract     Related articles   

  278. BAO Z, Zhang W, Dong D
    A potential prognostic lncRNA signature for predicting survival in patients with bladder urothelial carcinoma.
    Oncotarget. 2017;8:10485-10497.
    Abstract     Related articles   

  279. LEE MS, Lee J, Lee S, Yoo SM, et al
    Clinical, prognostic, and therapeutic significance of heat shock protein 27 in bladder cancer.
    Oncotarget. 2018;9:7961-7974.
    Abstract     Related articles   

  280. BAJAJ A, Martin B, Bhasin R, Hentz C, et al
    The Impact of Academic Facility Type and Case Volume on Survival in Patients Undergoing Curative Radiation Therapy for Muscle-Invasive Bladder Cancer.
    Int J Radiat Oncol Biol Phys. 2018;100:851-857.
    Abstract     Related articles   

  281. RICHARD PO, Ahmad AE, Bashir S, Zlotta A, et al
    Impact of oral hypoglycemic agents on mortality among diabetic patients with non-muscle-invasive bladder cancer: A population-based analysis.
    Can Urol Assoc J. 2018 Feb 23. pii: cuaj.4870. doi: 10.5489/cuaj.4870.
    Abstract     Related articles   

  282. ZENG XT, Liu TZ, Gong K, He DL, et al
    The BPSC: A prospective study investigating the clinical effect of interventional therapy and the risk factors for bladder cancer and benign prostatic hyperplasia in Chinese population.
    J Evid Based Med. 2018;11:64-67.
    Abstract     Related articles   

  283. BOYUK A, Sanli O, Erdem S, Tefik T, et al
    The association between variant urothelial histologies, pathological stage and disease specific survival in patients with bladder cancer.
    Turk J Urol. 2018;44:24-30.
    Abstract     Related articles   

  284. YANG SL, Wang JJ, Chen M, Xu L, et al
    Pioglitazone Use and Risk of Bladder Cancer: an In Vitro Study.
    Int J Med Sci. 2018;15:228-237.
    Abstract     Related articles   

  285. BAGREZAEI F, Hassanshahi G, Mahmoodi M, Khanamani Falahati-Pour S, et al
    Expression of Inhibitor of Apoptosis Gene Family Members in Bladder Cancer Tissues and the 5637 Tumor Cell Line
    Asian Pac J Cancer Prev. 2018;19:529-532.
    Abstract     Related articles   

  286. MAYR R, Gierth M, Zeman F, Reiffen M, et al
    Sarcopenia as a comorbidity-independent predictor of survival following radical cystectomy for bladder cancer.
    J Cachexia Sarcopenia Muscle. 2018 Feb 25. doi: 10.1002/jcsm.12279.
    Abstract     Related articles   

  287. SHAN G, Tang T, Qian H, Xia Y, et al
    Certain BCG-reactive responses are associated with bladder cancer prognosis.
    Cancer Immunol Immunother. 2018 Feb 24. pii: 10.1007/s00262-018-2127.
    Abstract     Related articles   

  288. MULDERS PFA, Martinez-Pineiro L, Heidenreich A, Babjuk M, et al
    Adjuvant recMAGE-A3 Immunotherapy After Cystectomy for Muscle-invasive Bladder Cancer: Lessons Learned from the Phase 2 MAGNOLIA Clinical Trial.
    Eur Urol Focus. 2018 Feb 21. pii: S2405-4569(18)30033.
    Abstract     Related articles   

  289. KRIEGMAIR MC, Wirtz RM, Worst TS, Breyer J, et al
    Prognostic Value of Molecular Breast Cancer Subtypes based on Her2, ESR1, PGR and Ki67 mRNA-Expression in Muscle Invasive Bladder Cancer.
    Transl Oncol. 2018;11:467-476.
    Abstract     Related articles   

  290. TANG H, Shi W, Fu S, Wang T, et al
    Pioglitazone and bladder cancer risk: a systematic review and meta-analysis.
    Cancer Med. 2018 Feb 24. doi: 10.1002/cam4.1354.
    Abstract     Related articles   

  291. NEAL DS
    Are You Developing an ABC: Advanced Bladder Cancer Clinic?
    Rev Urol. 2017;19:246-247.
    Abstract     Related articles   

  292. CHENG ML, Iyer G
    Novel biomarkers in bladder cancer.
    Urol Oncol. 2018 Feb 19. pii: S1078-1439(18)30009.
    Abstract     Related articles   

  293. MITA K, Kobatake K, Ohara S, Kato M, et al
    [Clinical Benefits of Transurethral Resection Under Narrow Band Imaging for Non-Muscle Invasive Bladder Cancer].
    Hinyokika Kiyo. 2018;64:1-6.
    Abstract     Related articles   

  294. GROEBEN C, Koch R, Baunacke M, Schmid M, et al
    Urinary Diversion After Radical Cystectomy for Bladder Cancer: Comparing Trends in the US and Germany from 2006 to 2014.
    Ann Surg Oncol. 2018 Feb 21. pii: 10.1245/s10434-018-6381.
    Abstract     Related articles   

  295. MASUDA N, Ogawa O, Park M, Liu AY, et al
    Meta-analysis of a 10-plex urine-based biomarker assay for the detection of bladder cancer.
    Oncotarget. 2018;9:7101-7111.
    Abstract     Related articles   

  296. ZHANG X, Chen Y, Dong L, Shi B, et al
    Effect of selective inhibition of aquaporin 1 on chemotherapy sensitivity of J82 human bladder cancer cells.
    Oncol Lett. 2018;15:3864-3869.
    Abstract     Related articles   

  297. XU T, Du XW, Hu JB, Zhu YF, et al
    Anticancer effect of miR-96 inhibitor in bladder cancer cell lines.
    Oncol Lett. 2018;15:3814-3819.
    Abstract     Related articles   

  298. ZHU J, Huang Z, Zhang M, Wang W, et al
    HIF-1alpha promotes ZEB1 expression and EMT in a human bladder cancer lung metastasis animal model.
    Oncol Lett. 2018;15:3482-3489.
    Abstract     Related articles   

  299. BERNARD-TESSIER A, Bonnet C, Lavaud P, Gizzi M, et al
    [Atezolizumab (Tecentriq((R))): Activity, indication and modality of use in advanced or metastatic urinary bladder carcinoma].
    Bull Cancer. 2018;105:140-145.
    Abstract     Related articles   

  300. YANG H, Wang N, Han S, Male M, et al
    Comparison of the efficacy and feasibility of laser enucleation of bladder tumor versus transurethral resection of bladder tumor: a meta-analysis.
    Lasers Med Sci. 2017;32:2005-2012.
    Abstract     Related articles   

  301. MOLLER KL, Brauer C, Mikkelsen S, Loft S, et al
    Copenhagen Airport Cohort: air pollution, manual baggage handling and health.
    BMJ Open. 2017;7:e012651.
    Abstract     Related articles   

  302. MIRZAEI MR, Mahmoodi M, Hassanshahi G, Ahmadi Z, et al
    Down-regulation of anti-apoptotic genes in tumor cell lines is facilitated by suppression of OCT4B1.
    Adv Med Sci. 2017;62:97-102.
    Abstract     Related articles   

  303. SONG W, Sung HH, Han DH, Jeong BC, et al
    The effect of contralateral kidney volume on renal function after radical nephroureterectomy: Implications for eligibility for neoadjuvant chemotherapy for upper tract urothelial cancer.
    Urol Oncol. 2017;35:114.
    Abstract     Related articles   

  304. LU DD, Boorjian SA, Raman JD
    Intravesical chemotherapy use after radical nephroureterectomy: A national survey of urologic oncologists.
    Urol Oncol. 2017;35:113.
    Abstract     Related articles   

  305. TEOH JY, Chan ES, Yip SY, Tam HM, et al
    Comparison of Detrusor Muscle Sampling Rate in Monopolar and Bipolar Transurethral Resection of Bladder Tumor: A Randomized Trial.
    Ann Surg Oncol. 2017;24:1428-1434.
    Abstract     Related articles   

  306. PACKIAM VT, Agrawal VA, Cohen AJ, Pariser JJ, et al
    Lessons from 151 ureteral reimplantations for postcystectomy ureteroenteric strictures: A single-center experience over a decade.
    Urol Oncol. 2017;35:112.
    Abstract     Related articles   

  307. CHAPPIDI MR, Chalfin HJ, Johnson DJ, Kates M, et al
    Longer average blood storage duration is associated with increased risk of infection and overall morbidity following radical cystectomy.
    Urol Oncol. 2017;35:38.
    Abstract     Related articles   

  308. MYLONAS KS, O Malley P, Ziogas IA, El-Kabab L, et al
    Malignant urachal neoplasms: A population-based study and systematic review of literature.
    Urol Oncol. 2017;35:33.
    Abstract     Related articles   

  309. FROEHNER M, Koch R, Heberling U, Novotny V, et al
    An easily applicable single condition-based mortality index for patients undergoing radical prostatectomy or radical cystectomy.
    Urol Oncol. 2017;35:32.
    Abstract     Related articles   

  310. MAO SY, Xiong DB, Huang TB, Zheng JH, et al
    Expression of CUL1 correlates with tumour-grade and recurrence in urothelial carcinoma.
    ANZ J Surg. 2017;87.
    Abstract     Related articles   

  311. UNA OREJON R, Mateo Torres E, Huercio Martinez I, Jofre Escudero C, et al
    Application of ERAS (Enhanced Recovery After Surgery) and laparoscopic surgery in the management of patients with bladder cancer.
    Arch Esp Urol. 2018;71:178-186.
    Abstract     Related articles   

  312. ASANO T, Ohnishi K, Shiota T, Motoshima T, et al
    CD169-positive sinus macrophages in the lymph nodes determine bladder cancer prognosis.
    Cancer Sci. 2018 Mar 9. doi: 10.1111/cas.13565.
    Abstract     Related articles   

  313. MAYR R, Fritsche HM, Zeman F, Reiffen M, et al
    Sarcopenia predicts 90-day mortality and postoperative complications after radical cystectomy for bladder cancer.
    World J Urol. 2018 Mar 8. pii: 10.1007/s00345-018-2259.
    Abstract     Related articles   

  314. BAYNE CE, Farah D, Herbst KW, Hsieh MH, et al
    Role of urinary tract infection in bladder cancer: a systematic review and meta-analysis.
    World J Urol. 2018 Mar 8. pii: 10.1007/s00345-018-2257.
    Abstract     Related articles   

  315. PIAO XM, Byun YJ, Kim WJ, Kim J, et al
    Unmasking molecular profiles of bladder cancer.
    Investig Clin Urol. 2018;59:72-82.
    Abstract     Related articles   

  316. EL-BABOULY IM, Desoky EAE, El Sayed D, Ali MM, et al
    The role of neural precursor cell-expressed developmentally down-regulated protein 9 in predicting bacillus Calmette-Guerin response in nonmuscle invasive bladder cancer.
    Urol Oncol. 2018 Mar 5. pii: S1078-1439(18)30042.
    Abstract     Related articles   

  317. DONG L, Li Y, Xue D, Liu Y, et al
    PCMT1 is an unfavorable predictor and functions as an oncogene in bladder cancer.
    IUBMB Life. 2018 Mar 8. doi: 10.1002/iub.1717.
    Abstract     Related articles   

  318. ZENG XT, Liu XP, Liu TZ, Wang XH, et al
    The clinical significance of COL5A2 in patients with bladder cancer: A retrospective analysis of bladder cancer gene expression data.
    Medicine (Baltimore). 2018;97:e0091.
    Abstract     Related articles   

  319. UN S, Turk H, Dindar AS, Zorlu F, et al
    Does preoperative neutrophil/lymphocyte rate have an effect on survival of the bladder cancer patients who received radical cystectomy?
    J Cancer Res Ther. 2018;14:432-436.
    Abstract     Related articles   

  320. DU L, Duan W, Jiang X, Zhao L, et al
    Cell-free lncRNA expression signatures in urine serve as novel non-invasive biomarkers for diagnosis and recurrence prediction of bladder cancer.
    J Cell Mol Med. 2018 Mar 8. doi: 10.1111/jcmm.13578.
    Abstract     Related articles   

  321. SU Q, Tao T, Tang L, Deng J, et al
    Down-regulation of PKM2 enhances anticancer efficiency of THP on bladder cancer.
    J Cell Mol Med. 2018 Mar 7. doi: 10.1111/jcmm.13571.
    Abstract     Related articles   

  322. ALTUNKOL A, Savas M, Dilmec F, Utangac MM, et al
    Detection of CYP1A1 and GSTP1 gene polymorphisms in bladder cancer patients in a Turkish population using a polymerase chain reaction-restriction fragment length polymorphism method.
    Turk J Urol. 2018;44:125-131.
    Abstract     Related articles   

  323. SEFIK E, Gunlusoy B, Aydogdu O, Topcu YK, et al
    Predictive role of neutrophil-to-lymphocyte ratio on upstaging of organ-confined invasive urothelial bladder cancer to non-organ-confined disease.
    Turk J Urol. 2018;44:119-124.
    Abstract     Related articles   

  324. YANG X, Shi Y, Yan J, Fan H, et al
    Downregulation of FoxM1 inhibits cell growth and migration and invasion in bladder cancer cells.
    Am J Transl Res. 2018;10:629-638.
    Abstract     Related articles   

  325. WU J, Wang J
    HMGN5 expression in bladder cancer tissue and its role on prognosis.
    Eur Rev Med Pharmacol Sci. 2018;22:970-975.
    Abstract     Related articles   

  326. THOMA C
    Bladder cancer: Mechanisms of anti-PDL1 resistance.
    Nat Rev Urol. 2018 Mar 6. pii: nrurol.2018.28. doi: 10.1038/nrurol.2018.
    Abstract     Related articles   

  327. ESCORCIA FE, Steckler JM, Abdel-Atti D, Price EW, et al
    Tumor-Specific Zr-89 Immuno-PET Imaging in a Human Bladder Cancer Model.
    Mol Imaging Biol. 2018 Mar 5. pii: 10.1007/s11307-018-1177.
    Abstract     Related articles   

  328. KITTLER R, Shiang C, Hutchinson R, Kollipara RK, et al
    Grade progression in urothelial carcinoma can occur with high or low mutational homology: a first-step toward tumor-specific care in initial low-grade bladder cancer.
    Oncotarget. 2018;9:9415-9424.
    Abstract     Related articles   

  329. D ANDREA D, Abufaraj M, Susani M, Ristl R, et al
    Accurate prediction of progression to muscle-invasive disease in patients with pT1G3 bladder cancer: A clinical decision-making tool.
    Urol Oncol. 2018 Mar 2. pii: S1078-1439(18)30040.
    Abstract     Related articles   

  330. VON LANDENBERG N, Aziz A, von Rundstedt FC, Dobruch J, et al
    Conditional analyses of recurrence and progression in patients with TaG1 non-muscle-invasive bladder cancer.
    Urol Oncol. 2018 Mar 2. pii: S1078-1439(18)30039.
    Abstract     Related articles   

  331. ZHANG Y, Li F, Yang F, Zeng WL, et al
    [Prognostic value of preoperative serum albumin in patients with non-muscle-invasive bladder cancer undergoing transurethral resection of bladder tumor].
    Nan Fang Yi Ke Da Xue Xue Bao. 2018;38:192-197.
    Abstract     Related articles   

  332. SEABRA AB, Duran N
    Nitric oxide donors for prostate and bladder cancers: Current state and challenges.
    Eur J Pharmacol. 2018 Mar 1. pii: S0014-2999(18)30126.
    Abstract     Related articles   

  333. AQUILA L, Ohm J, Woloszynska-Read A
    The role of STAG2 in bladder cancer.
    Pharmacol Res. 2018 Mar 1. pii: S1043-6618(18)30004.
    Abstract     Related articles   

  334. XIE H, Zhan H, Gao Q, Jianfa Li, et al
    Synthetic artificial "long non-coding RNAs" targeting oncogenic microRNAs and transcriptional factors inhibit malignant phenotypes of bladder cancer cells.
    Cancer Lett. 2018 Mar 1. pii: S0304-3835(18)30179.
    Abstract     Related articles   

  335. CHEN S, Zhang N, Shao J, Wang X, et al
    Maintenance versus non-maintenance intravesical Bacillus Calmette-Guerin instillation for non-muscle invasive bladder cancer: A systematic review and meta-analysis of randomized clinical trials.
    Int J Surg. 2018;52:248-257.
    Abstract     Related articles   

  336. GRAMANN T, Schwab C, Zumstein V, Betschart P, et al
    Transurethral resection of bladder cancer on the lateral bladder wall without obturator nerve block: extent of adductor spasms using the monopolar versus bipolar technique-a prospective randomised study.
    World J Urol. 2018 Mar 1. pii: 10.1007/s00345-018-2248.
    Abstract     Related articles   

  337. CHEN J, Zhang H, Sun G, Zhang X, et al
    Comparison of the prognosis of primary and progressive muscle-invasive bladder cancer after radical cystectomy: A systematic review and meta-analysis.
    Int J Surg. 2018 Feb 26. pii: S1743-9191(18)30580.
    Abstract     Related articles   

  338. ZUIVERLOON TCM, van Kessel KEM, Bivalacqua TJ, Boormans JL, et al
    Recommendations for follow-up of muscle-invasive bladder cancer patients: A consensus by the international bladder cancer network.
    Urol Oncol. 2018 Feb 26. pii: S1078-1439(18)30036.
    Abstract     Related articles   

  339. BOURLON MT, Velazquez HE, Luna-Santiago R, Vazquez-Manjarrez S, et al
    Is This Patient With Metastatic Bladder Cancer a Candidate for Second-Line Immunotherapy Treatment?
    Oncology (Williston Park). 2018;32:64-8.
    Abstract     Related articles   

  340. CHAAYA G, Morales J, Castiglioni A, Subhani N, et al
    Paraganglioma of the Urinary Bladder: A Rare Cause of Hypertension and Urinary Tract Infections.
    Am J Med Sci. 2018;355:191-194.
    Abstract     Related articles   

  341. LIU C, Shui CL, Wang Q, Luo H, et al
    Mechanism of hif-1alpha mediated hypoxia-induced permeability changes in bladder endothelial cells.
    Braz J Med Biol Res. 2017;51:e6768.
    Abstract     Related articles   

  342. GLASS R, Rosen L, Chau K, Sheikh-Fayyaz S, et al
    Analysis of the Cytomorphological Features in Atypical Urine Specimens following Application of The Paris System for Reporting Urinary Cytology.
    Acta Cytol. 2018;62:54-61.
    Abstract     Related articles   

  343. RENSHAW AA, Gould EW
    High-Grade Urothelial Carcinoma on Urine Cytology Resembling Umbrella Cells.
    Acta Cytol. 2018;62:62-67.
    Abstract     Related articles   

  344. ALTOK M, Sahin AF, Gokce MI, Ekin GR, et al
    Ureteral orifice involvement by urothelial carcinoma: long term oncologic and functional outcomes.
    Int Braz J Urol. 2017;43:1052-1059.
    Abstract     Related articles   

  345. GWYNN ME, DeRemer DL
    The Emerging Role of PD-1/PD-L1-Targeting Immunotherapy in the Treatment of Metastatic Urothelial Carcinoma.
    Ann Pharmacother. 2018;52:60-68.
    Abstract     Related articles   

  346. ZEQUI SC
    The Middle Term.
    Int Braz J Urol. 2017;43:577-578.
    Abstract     Related articles   

  347. PAREKH A, Hagan I, Capaldi L, Lyburn I, et al
    Incidental Papillary Bladder Carcinoma on 18F-Fluoromethylcholine PET/CT Undertaken to Evaluate Prostate Malignancy.
    Clin Nucl Med. 2017 Jul 6. doi: 10.1097/RLU.0000000000001754.
    Abstract     Related articles   

  348. CHEN PY, Chiang PH
    Comparisons of Quality of Life and Functional and Oncological Outcomes after Orthotopic Neobladder Reconstruction: Prostate-Sparing Cystectomy versus Conventional Radical Cystoprostatectomy.
    Biomed Res Int. 2017;2017:1983428.
    Abstract     Related articles   

  349. MUTO S, Kitamura K, Ieda T, Shimizu F, et al
    A preliminary oncologic outcome and postoperative complications in patients undergoing robot-assisted radical cystectomy: Initial experience.
    Investig Clin Urol. 2017;58:171-178.
    Abstract     Related articles   

  350. MIN J, Geng H, Liu Z, Liang Z, et al
    ERK5 regulates tobacco smokeinduced urocystic epithelialmesenchymal transition in BALB/c mice.
    Mol Med Rep. 2017;15:3893-3897.
    Abstract     Related articles   

  351. MIAO C, Liang C, Zhu J, Xu A, et al
    Prognostic role of matrix metalloproteinases in bladder carcinoma: a systematic review and meta-analysis.
    Oncotarget. 2017;8:32309-32321.
    Abstract     Related articles   

  352. FIETKAU R
    [When is a nonsurgical approach possible for metastatic primary tumors and lymph node metastases of the urinary bladder and prostate?]
    Urologe A. 2017;56:570-578.
    Abstract     Related articles   

  353. BOTTKE D, Bolenz C, Ott S, Cebulla A, et al
    [When should the primary tumor of metastatic bladder or prostate cancer be treated using a nonsurgical regimen?]
    Urologe A. 2017;56:579-584.
    Abstract     Related articles   

  354. NIEDWOROK C, Rubben H
    [When is surgical treatment indicated in metastatic urothelial carcinoma and what is the scientific rationale?]
    Urologe A. 2017;56:585-590.
    Abstract     Related articles   

  355. ELLINGER J, Hauser S, Kubler H, Muller SC, et al
    [When is surgical resection of the primary tumor indicated in metastatic urothelial carcinoma of the bladder and what is the scientific rationale?]
    Urologe A. 2017;56:564-569.
    Abstract     Related articles   

  356. JUNG K, Ghatalia P, Litwin S, Horwitz EM, et al
    Small-Cell Carcinoma of the Bladder: 20-Year Single-Institution Retrospective Review.
    Clin Genitourin Cancer. 2017;15:e337-e343.
    Abstract     Related articles   

  357. ABDEL-RAHMAN O
    Squamous Cell Carcinoma of the Bladder: A SEER Database Analysis.
    Clin Genitourin Cancer. 2017;15:e463-e468.
    Abstract     Related articles   

  358. MARTINI T, Gilfrich C, Mayr R, Burger M, et al
    The Use of Neoadjuvant Chemotherapy in Patients With Urothelial Carcinoma of the Bladder: Current Practice Among Clinicians.
    Clin Genitourin Cancer. 2017;15:356-362.
    Abstract     Related articles   

  359. SUNDARARAGHAVAN VL, Sindhwani P, Hinds TD Jr
    Glucuronidation and UGT isozymes in bladder: new targets for the treatment of uroepithelial carcinomas?
    Oncotarget. 2017;8:3640-3648.
    Abstract     Related articles   

  360. ILIJAZI D, Abufaraj M, Hassler MR, Ertl IE, et al
    Waiting in the wings: the emerging role of molecular biomarkers in bladder cancer.
    Expert Rev Mol Diagn. 2018 Mar 15. doi: 10.1080/14737159.2018.1453808.
    Abstract     Related articles   

  361. HUANG J, Ma X, Zhang L, Jia H, et al
    Diagnostic accuracy of optical coherence tomography in bladder cancer patients: A systematic review and meta-analysis.
    Mol Clin Oncol. 2018;8:609-612.
    Abstract     Related articles   

  362. YOSHIDA T, Sopko NA, Kates M, Liu X, et al
    Three-dimensional organoid culture reveals involvement of Wnt/beta-catenin pathway in proliferation of bladder cancer cells.
    Oncotarget. 2018;9:11060-11070.
    Abstract     Related articles   

  363. FENG Z, Wang B
    Long non-coding RNA HNF1A-AS1 promotes cell viability and migration in human bladder cancer.
    Oncol Lett. 2018;15:4535-4540.
    Abstract     Related articles   

  364. SUGAWARA S, Yamada Y, Arai T, Okato A, et al
    Dual strands of the miR-223 duplex (miR-223-5p and miR-223-3p) inhibit cancer cell aggressiveness: targeted genes are involved in bladder cancer pathogenesis.
    J Hum Genet. 2018 Mar 14. pii: 10.1038/s10038-018-0437.
    Abstract     Related articles   

  365. JORDAHL KM, Randolph TW, Song X, Sather CL, et al
    Genome-wide DNA methylation in pre-diagnostic blood and bladder cancer risk in the Women's Health Initiative.
    Cancer Epidemiol Biomarkers Prev. 2018 Mar 14. pii: 1055-9965.EPI-17-0951.
    Abstract     Related articles   

  366. JI D, Jiang L, Li Y
    MiR-192-5p suppresses the growth of bladder cancer cells via targeting Yin Yang 1.
    Hum Cell. 2018 Mar 13. pii: 10.1007/s13577-018-0201.
    Abstract     Related articles   

  367. STANIK M, Poprach A, Macik D, Capak I, et al
    Clinically node-positive bladder cancer: oncological results of induction chemotherapy and consolidative surgery.
    Neoplasma. 2018;65:287-291.
    Abstract     Related articles   

  368. KOLLARIK B, Zvarik M, Bujdak P, Weibl P, et al
    Urinary fluorescence analysis in diagnosis of bladder cancer.
    Neoplasma. 2018;65:234-241.
    Abstract     Related articles   

  369. TANG F, He Z, Lei H, Chen Y, et al
    Identification of differentially expressed genes and biological pathways in bladder cancer.
    Mol Med Rep. 2018 Mar 9. doi: 10.3892/mmr.2018.8711.
    Abstract     Related articles   

  370. WARLI SM, Kadar DD, Siregar GP
    Ki-67 Expression as a Predictive Factor of Muscle Invasion in Bladder Cancer.
    Open Access Maced J Med Sci. 2018;6:260-262.
    Abstract     Related articles   

  371. AZEVEDO R, Soares J, Peixoto A, Cotton S, et al
    Circulating tumor cells in bladder cancer: Emerging technologies and clinical implications foreseeing precision oncology.
    Urol Oncol. 2018 Mar 9. pii: S1078-1439(18)30044.
    Abstract     Related articles   

  372. NIWA N, Kikuchi E, Matsumoto K, Kosaka T, et al
    Does switching the bacillus Calmette-Guerin strain affect clinical outcome in patients with recurrent non-muscle-invasive bladder cancer after initial bacillus Calmette-Guerin therapy?
    Urol Oncol. 2018 Mar 9. pii: S1078-1439(18)30045.
    Abstract     Related articles   

  373. TU H, Dinney CP, Ye Y, Grossman HB, et al
    Is folic acid safe for non-muscle-invasive bladder cancer patients? An evidence-based cohort study.
    Am J Clin Nutr. 2018;107:208-216.
    Abstract     Related articles   

  374. OOSTERLINCK W, Decaestecker K
    Update on early instillation of chemotherapy after transurethral resection of non-muscle-invasive bladder cancer.
    Expert Rev Anticancer Ther. 2018 Mar 15:1-7. doi: 10.1080/14737140.2018.1451748.
    Abstract     Related articles   

  375. NAZARI A, Khorramdelazad H, Hassanshahi G
    Correction to: Biological/pathological functions of the CXCL12/CXCR4/CXCR7 axes in the pathogenesis of bladder cancer.
    Int J Clin Oncol. 2018 Mar 10. pii: 10.1007/s10147-018-1257.
    Abstract     Related articles   

  376. SANTI R, Cai T, Nobili S, Galli IC, et al
    Snail immunohistochemical overexpression correlates to recurrence risk in non-muscle invasive bladder cancer: results from a longitudinal cohort study.
    Virchows Arch. 2018 Mar 10. pii: 10.1007/s00428-018-2310.
    Abstract     Related articles   

  377. JUE JS, Koru-Sengul T, Moore KJ, Miao F, et al
    Sociodemographic and survival disparities for histologic variants of bladder cancer.
    Can J Urol. 2018;25:9179-9185.
    Abstract     Related articles   

  378. MANACH Q, Cussenot O, Roupret M, Game X, et al
    Analysis of bladder cancer subtypes in neurogenic bladder tumors.
    Can J Urol. 2018;25:9161-9167.
    Abstract     Related articles   

  379. DA SILVA JNL, Ranzi AD, Carvalho CT, Scheide TV, et al
    Cell Cycle Markers in the Evaluation of Bladder Cancer.
    Pathol Oncol Res. 2018 Mar 9. pii: 10.1007/s12253-018-0389.
    Abstract     Related articles   

  380. SAINT-JACQUES N, Brown P, Nauta L, Boxall J, et al
    Estimating the risk of bladder and kidney cancer from exposure to low-levels of arsenic in drinking water, Nova Scotia, Canada.
    Environ Int. 2018;110:95-104.
    Abstract     Related articles   

  381. SHELMERDINE SC, Lorenzo AJ, Gupta AA, Chavhan GB, et al
    Pearls and Pitfalls in Diagnosing Pediatric Urinary Bladder Masses.
    Radiographics. 2017;37:1872-1891.
    Abstract     Related articles   

  382. MACGREGOR-RAMIASA M, McNicholas K, Ostrikov K, Li J, et al
    A platform for selective immuno-capture of cancer cells from urine.
    Biosens Bioelectron. 2017;96:373-380.
    Abstract     Related articles   

  383. MADEC FX, Hedhli O, Perrouin-Verbe MA, Levesque A, et al
    Feasibility, Morbidity, and Functional Results of Supratrigonal Cystectomy with Augmentation Ileocystoplasty by Combined Robot-Assisted Laparoscopy and Mini-Laparotomy Approach.
    J Endourol. 2017;31:655-660.
    Abstract     Related articles   

  384. PLANELLES GOMEZ J, Olmos Sanchez L, Cardosa Benet JJ, Martinez Lopez E, et al
    Holmium YAG Photocoagulation: Safe and Economical Alternative to Transurethral Resection in Small Nonmuscle-Invasive Bladder Tumors.
    J Endourol. 2017;31:674-678.
    Abstract     Related articles   

  385. DU E, Zhang C, Qin Z, Yang K, et al
    Low expression of TMEM67 is a critical predictor of poor prognosis in human urothelial carcinoma of the bladder.
    Urol Oncol. 2017;35:152.
    Abstract     Related articles   

  386. MOSCHINI M, Shariat SF, Abufaraj M, Soria F, et al
    The presence of carcinoma in situ at radical cystectomy increases the risk of urothelial recurrence: Implications for follow-up schemes.
    Urol Oncol. 2017;35:151.
    Abstract     Related articles   

  387. VAN OSCH FHM, Jochems SHJ, Wesselius A, van Schooten FJ, et al
    A Stratified Meta-Analysis of the Association between Exposure to Environmental Tobacco Smoke during Childhood and Adulthood and Urothelial Bladder Cancer Risk.
    Int J Environ Res Public Health. 2018;15.
    Abstract     Related articles   

  388. DONG F, Shen Y, Xu T, Wang X, et al
    Effectiveness of urine fibronectin as a non-invasive diagnostic biomarker in bladder cancer patients: a systematic review and meta-analysis.
    World J Surg Oncol. 2018;16:61.
    Abstract     Related articles   

  389. RASSY EE, Bakouny Z, Aoun F, Haddad FG, et al
    A network meta-analysis of the PD(L)-1 inhibitors in the salvage treatment of urothelial bladder cancer.
    Immunotherapy. 2018 Mar 22. doi: 10.2217/imt-2017-0190.
    Abstract     Related articles   

  390. LEE J, McKinney KQ, Pavlopoulos AJ, Niu M, et al
    Altered Proteome of Extracellular Vesicles Derived from Bladder Cancer Patients Urine.
    Mol Cells. 2018 Mar 9. pii: molcells.2018.2110. doi: 10.14348/molcells.2018.2110
    Abstract     Related articles   

  391. XU R, Zhu X, Chen F, Huang C, et al
    LncRNA XIST/miR-200c regulates the stemness properties and tumourigenicity of human bladder cancer stem cell-like cells.
    Cancer Cell Int. 2018;18:41.
    Abstract     Related articles   

  392. ERDEM GU, Dogan M, Sakin A, Oruc Z, et al
    Non-Urothelial Bladder Cancer: Comparison of Clinicopathological and Prognostic Characteristics in Pure Adenocarcinoma and Non-Bilharzial Squamous Cell Carcinoma of the Bladder.
    Oncol Res Treat. 2018;41.
    Abstract     Related articles   

  393. CAI D, Liu Z, Kong G
    Molecular and Bioinformatics Analyses Identify 7 Circular RNAs Involved in Regulation of Oncogenic Transformation and Cell Proliferation in Human Bladder Cancer.
    Med Sci Monit. 2018;24:1654-1661.
    Abstract     Related articles   

  394. BESIROGLU H, Ozbek E
    Letter to the editor regarding the article "Association of benign prostatic hyperplasia and subsequent risk of bladder cancer: an Asian population cohort study".
    World J Urol. 2018 Mar 20. pii: 10.1007/s00345-018-2271.
    Abstract     Related articles   

  395. KUKREJA JB, Shi Q, Chang CM, Seif MA, et al
    Patient-Reported Outcomes Are Associated With Enhanced Recovery Status in Patients With Bladder Cancer Undergoing Radical Cystectomy.
    Surg Innov. 2018 Mar 1:1553350618764218. doi: 10.1177/1553350618764218.
    Abstract     Related articles   

  396. LUO KW, Lung WY, Chun-Xie, Luo XL, et al
    EGCG inhibited bladder cancer T24 and 5637 cell proliferation and migration via PI3K/AKT pathway.
    Oncotarget. 2018;9:12261-12272.
    Abstract     Related articles   

  397. LI B, Mao X, Wang H, Su G, et al
    Vasculogenic mimicry in bladder cancer and its association with the aberrant expression of ZEB1.
    Oncol Lett. 2018;15:5193-5200.
    Abstract     Related articles   

  398. NISHIYAMA N, Hotta H, Takahashi A, Yanase M, et al
    Upper tract urothelial carcinoma following intravesical bacillus Calmette-Guerin therapy for nonmuscle-invasive bladder cancer: Results from a multi-institutional retrospective study.
    Urol Oncol. 2018 Mar 14. pii: S1078-1439(18)30065.
    Abstract     Related articles   

  399. HUANG X, Zhu H, Gao Z, Li J, et al
    Wnt7a activates canonical Wnt signaling, promotes bladder cancer cell invasion, and is suppressed by miR-370-3p.
    J Biol Chem. 2018 Mar 16. pii: RA118.001689. doi: 10.1074/jbc.RA118.001689.
    Abstract     Related articles   

  400. BLACK PC, Goebell PJ, Kamat AM, Nawroth R, et al
    Editorial: Managing locally advanced bladder cancer. Third International Bladder Cancer Network seminars series.
    Urol Oncol. 2018 Mar 13. pii: S1078-1439(17)30591.
    Abstract     Related articles   

  401. KOUTROS S, Lenz P, Hewitt SM, Kida M, et al
    RE: Elevated Bladder Cancer in Northern New England: The Role of Drinking Water and Arsenic.
    J Natl Cancer Inst. 2018 Mar 14. pii: 4935099. doi: 10.1093.
    Abstract     Related articles   

  402. BONET M, Bonfill T, Nunez M, De Verdonces L, et al
    Correction to: Curative radiation therapy for very elderly bladder cancer patients with localized disease.
    Clin Transl Oncol. 2018 Mar 15. pii: 10.1007/s12094-018-1853.
    Abstract     Related articles   

  403. WANG C, Li A, Yang S, Qiao R, et al
    CXCL5 promotes mitomycin C resistance in non-muscle invasive bladder cancer by activating EMT and NF-kappaB pathway.
    Biochem Biophys Res Commun. 2018 Mar 16. pii: S0006-291X(18)30557.
    Abstract     Related articles   

  404. BILLIS A, Freitas LLL, Costa LBE, Barreto IS, et al
    Genitourinary Malignancies in Transplant or Dialysis Patients: The Frequency of Two Newly Described 2016 World Health Organization Histopathologic Types.
    Transplant Proc. 2017;49:1783-1785.
    Abstract     Related articles   

  405. LI Q, Li C, Chen J, Liu P, et al
    High expression of long noncoding RNA NORAD indicates a poor prognosis and promotes clinical progression and metastasis in bladder cancer.
    Urol Oncol. 2018 Mar 28. pii: S1078-1439(18)30076.
    Abstract     Related articles   

  406. KASSOUF W, Aprikian A, Saad F, Breau RH, et al
    Improving patient journey and quality of care: Summary from the 2nd Bladder Cancer Canada-Canadian Urological Association-Canadian Urologic Oncology Group (BCC-CUA-CUOG) bladder cancer quality of care consensus meeting.
    Can Urol Assoc J. 2018 Mar 19. pii: cuaj.5246. doi: 10.5489/cuaj.5246.
    Abstract     Related articles   

  407. GISLEFOSS RE, Stenehjem JS, Hektoen HH, Andreassen BK, et al
    Vitamin D, obesity and leptin in relation to bladder cancer incidence and survival: prospective protocol study.
    BMJ Open. 2018;8:e019309.
    Abstract     Related articles   

  408. MOSCHINI M, Arbelaez E, Cornelius J, Mattei A, et al
    Pattern of node metastases in patients treated with radical cystectomy and extended or superextended pelvic lymph node dissection due to bladder cancer.
    Urol Oncol. 2018 Mar 27. pii: S1078-1439(18)30078.
    Abstract     Related articles   

  409. ZHAO J, Shi L, Zeng S, Ma C, et al
    Importin-11 overexpression promotes the migration, invasion, and progression of bladder cancer associated with the deregulation of CDKN1A and THBS1.
    Urol Oncol. 2018 Mar 27. pii: S1078-1439(18)30077.
    Abstract     Related articles   

  410. ECKSTEIN M, Wirtz RM, Pfannstil C, Wach S, et al
    A multicenter round robin test of PD-L1 expression assessment in urothelial bladder cancer by immunohistochemistry and RT-qPCR with emphasis on prognosis prediction after radical cystectomy.
    Oncotarget. 2018;9:15001-15014.
    Abstract     Related articles   

  411. LIAN J, Lin SH, Ye Y, Chang DW, et al
    Serum microRNAs as predictors of risk for non-muscle invasive bladder cancer.
    Oncotarget. 2018;9:14895-14908.
    Abstract     Related articles   

  412. MOTA P, Sousa PM, Botelho F, Carvalho-Dias E, et al
    [Smoking Cessation after Bladder Cancer Diagnosis].
    Acta Med Port. 2018;31:101-108.
    Abstract     Related articles   

  413. WANG C, Xu Z, Li W, Jiao Y, et al
    [Analysis of the correlation between E2F3 expression and the number of tumor-infiltrating CD8(+)T cells in invasive bladder cancer tissues].
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2018;34:1-8.
    Abstract     Related articles   

  414. KIM WT, Seo SP, Byun YJ, Kang HW, et al
    The Anticancer Effects of Garlic Extracts on Bladder Cancer Compared to Cisplatin: A Common Mechanism of Action via Centromere Protein M.
    Am J Chin Med. 2018 Mar 29:1-17. doi: 10.1142/S0192415X18500362.
    Abstract     Related articles   

  415. LI Z, Niu Y
    Association between lncRNA H19 (rs217727, rs2735971 and rs3024270) polymorphisms and the risk of bladder cancer in Chinese population.
    Minerva Urol Nefrol. 2018 Mar 28. pii: S0393-2249.18.03004.
    Abstract     Related articles   

  416. WINERDAL ME, Krantz D, Hartana CA, Zirakzadeh AA, et al
    Urinary Bladder Cancer Tregs Suppress MMP2 and Potentially Regulate Invasiveness.
    Cancer Immunol Res. 2018 Mar 27. pii: 2326-6066.CIR-17-0466.
    Abstract     Related articles   

  417. HASHMI AA, Hussain ZF, Irfan M, Edhi MM, et al
    Cytokeratin 5/6 expression in bladder cancer: association with clinicopathologic parameters and prognosis.
    BMC Res Notes. 2018;11:207.
    Abstract     Related articles   

  418. KIM WT, Kim YH, Jeong P, Seo SP, et al
    Urinary cell-free nucleic acid IQGAP3: a new non-invasive diagnostic marker for bladder cancer.
    Oncotarget. 2018;9:14354-14365.
    Abstract     Related articles   

  419. HUANG L, Luan T, Chen Y, Bao X, et al
    LASS2 regulates invasion and chemoresistance via ERK/Drp1 modulated mitochondrial dynamics in bladder cancer cells.
    J Cancer. 2018;9:1017-1024.
    Abstract     Related articles   

  420. LIU TJ, Zhang JC, Gao XZ, Tan ZB, et al
    Clinical research of goal-directed fluid therapy in elderly patients with radical resection of bladder cancer.
    J Cancer Res Ther. 2018;14.
    Abstract     Related articles   

  421. WU GJ, Bao JS, Yue ZJ, Zeng FC, et al
    Elevated expression of matrix metalloproteinase-9 is associated with bladder cancer pathogenesis.
    J Cancer Res Ther. 2018;14.
    Abstract     Related articles   

  422. CHEN Y, Wang H, Zuo Y, Li N, et al
    A novel monoclonal antibody KMP1 has potential antitumor activity of bladder cancer by blocking CD44 in vivo and in vitro.
    Cancer Med. 2018 Mar 25. doi: 10.1002/cam4.1446.
    Abstract     Related articles   

  423. LENIS AT, Asanad K, Blaibel M, Donin NM, et al
    Association between Metabolic Syndrome and Recurrence of Nonmuscle Invasive Bladder Cancer following bacillus Calmette-Guerin Treatment.
    Urol Pract. 2018;5:132-138.
    Abstract     Related articles   

  424. KOSHKIN VS, Barata PC, Rybicki LA, Zahoor H, et al
    Feasibility of Cisplatin-Based Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer Patients With Diminished Renal Function.
    Clin Genitourin Cancer. 2018 Feb 22. pii: S1558-7673(18)30118.
    Abstract     Related articles   

  425. AUDENET F, Attalla K, Sfakianos JP
    The evolution of bladder cancer genomics: What have we learned and how can we use it?
    Urol Oncol. 2018 Mar 21. pii: S1078-1439(18)30074.
    Abstract     Related articles   

  426. KANG HW, Seo SP, Byun YJ, Piao XM, et al
    Molecular Progression Risk Score for Prediction of Muscle Invasion in Primary T1 High-Grade Bladder Cancer.
    Clin Genitourin Cancer. 2018 Feb 23. pii: S1558-7673(18)30117.
    Abstract     Related articles   

  427. ROSATO V, Negri E, Serraino D, Montella M, et al
    Processed Meat and Risk of Renal Cell and Bladder Cancers.
    Nutr Cancer. 2018 Mar 23:1-7. doi: 10.1080/01635581.2018.1445764.
    Abstract     Related articles   

  428. LEE MY, Yeon A, Shahid M, Cho E, et al
    Reprogrammed lipid metabolism in bladder cancer with cisplatin resistance.
    Oncotarget. 2018;9:13231-13243.
    Abstract     Related articles   

  429. LIAO CC, Chen SC, Huang HP, Wang CJ, et al
    Gallic acid inhibits bladder cancer cell proliferation and migration via regulating fatty acid synthase (FAS).
    J Food Drug Anal. 2018;26:620-627.
    Abstract     Related articles   

  430. TOMISAKI I, Kubo T, Minato A, Fujimoto N, et al
    Efficacy and Tolerability of Bacillus Calmette-Guerin Therapy as the First-Line Therapy for Upper Urinary Tract Carcinoma In Situ.
    Cancer Invest. 2018;36:152-157.
    Abstract     Related articles   

  431. MIYAMOTO K, Ito A, Wakabayashi M, Eba J, et al
    A Phase III trial of a single early intravesical instillation of pirarubicin to prevent bladder recurrence after radical nephroureterectomy for upper tract urothelial carcinoma (JCOG1403, UTUC THP Phase III).
    Jpn J Clin Oncol. 2018;48:94-97.
    Abstract     Related articles   

  432. TUO Z, Zhang J, Xue W
    LncRNA TP73-AS1 predicts the prognosis of bladder cancer patients and functions as a suppressor for bladder cancer by EMT pathway.
    Biochem Biophys Res Commun. 2018 Apr 3. pii: S0006-291X(18)30773.
    Abstract     Related articles   

  433. LEE SH, Hu W, Matulay JT, Silva MV, et al
    Tumor Evolution and Drug Response in Patient-Derived Organoid Models of Bladder Cancer.
    Cell. 2018;173:515-528.
    Abstract     Related articles   

  434. THOMA C
    Bladder cancer: Neuroendocrine disease genomics.
    Nat Rev Urol. 2018 Apr 5. pii: nrurol.2018.42. doi: 10.1038/nrurol.2018.
    Abstract     Related articles   

  435. SWEIS RF, Zha Y, Pass L, Heiss B, et al
    Pseudoprogression manifesting as recurrent ascites with anti-PD-1 immunotherapy in urothelial bladder cancer.
    J Immunother Cancer. 2018;6:24.
    Abstract     Related articles   

  436. GAO JM, Huang LZ, Huang ZG, He RQ, et al
    Clinical value and potential pathways of miR-183-5p in bladder cancer: A study based on miRNA-seq data and bioinformatics analysis.
    Oncol Lett. 2018;15:5056-5070.
    Abstract     Related articles   

  437. CRABB S, Danson SJ, Catto JWF, McDowell C, et al
    SPIRE - combining SGI-110 with cisplatin and gemcitabine chemotherapy for solid malignancies including bladder cancer: study protocol for a phase Ib/randomised IIa open label clinical trial.
    Trials. 2018;19:216.
    Abstract     Related articles   

  438. INAMURA K
    Bladder Cancer: New Insights into Its Molecular Pathology.
    Cancers (Basel). 2018;10.
    Abstract     Related articles   

  439. ZHU Z, Xu L, Wan Y, Zhou J, et al
    Inhibition of E-cadherin expression by lnc-RNA H19 to facilitate bladder cancer metastasis.
    Cancer Biomark. 2018 Mar 19. pii: CBM170998. doi: 10.3233/CBM-170998.
    Abstract     Related articles   

  440. LIANG Z, Xin R, Yu Y, Wang R, et al
    Diagnostic value of urinary survivin as a biomarker for bladder cancer: a systematic review and meta-analysis of published studies.
    World J Urol. 2018 Apr 2. pii: 10.1007/s00345-018-2285.
    Abstract     Related articles   

  441. MAMMEN S, Krishna S, Quon M, Shabana WM, et al
    Diagnostic Accuracy of Qualitative and Quantitative Computed Tomography Analysis for Diagnosis of Pathological Grade and Stage in Upper Tract Urothelial Cell Carcinoma.
    J Comput Assist Tomogr. 2018;42:204-210.
    Abstract     Related articles   

  442. WANG JS, Liu QH, Cheng XH, Zhang WY, et al
    The long noncoding RNA ZFAS1 facilitates bladder cancer tumorigenesis by sponging miR-329.
    Biomed Pharmacother. 2018;103:174-181.
    Abstract     Related articles   

  443. STRUCK JP, Karl A, Schwentner C, Herrmann TRW, et al
    [En bloc resection and vaporization techniques for the treatment of bladder cancer].
    Urologe A. 2018 Apr 12. pii: 10.1007/s00120-018-0625.
    Abstract     Related articles   

  444. TSELIS N, Prott FJ, Ott O, Weiss C, et al
    [Radiochemotherapy for invasive bladder cancer : An update].
    Urologe A. 2018 Apr 12. pii: 10.1007/s00120-018-0628.
    Abstract     Related articles   

  445. TEO MY, Rosenberg JE
    Perioperative Immunotherapy in Muscle-Invasive Bladder Cancer and Upper Tract Urothelial Carcinoma.
    Urol Clin North Am. 2018;45:287-295.
    Abstract     Related articles   

  446. ACHKAR T, Parikh RA
    Adjuvant Therapy in Muscle-Invasive Bladder Cancer and Upper Tract Urothelial Carcinoma.
    Urol Clin North Am. 2018;45:257-266.
    Abstract     Related articles   

  447. ZAINFELD D, Shah A, Daneshmand S
    Enhanced Recovery After Surgery Pathways: Role and Outcomes in the Management of Muscle Invasive Bladder Cancer.
    Urol Clin North Am. 2018;45:229-239.
    Abstract     Related articles   

  448. SATHIANATHEN NJ, Risk MC, Konety BR
    Lymphadenectomy for Muscle-Invasive Bladder Cancer and Upper Tract Urothelial Cell Carcinoma.
    Urol Clin North Am. 2018;45:215-228.
    Abstract     Related articles   

  449. TABAYOYONG W, Li R, Gao J, Kamat A, et al
    Optimal Timing of Chemotherapy and Surgery in Patients with Muscle-Invasive Bladder Cancer and Upper Urinary Tract Urothelial Carcinoma.
    Urol Clin North Am. 2018;45:155-167.
    Abstract     Related articles   

  450. MOSSANEN M, Chang SL, Kimm S, Sonpavde GP, et al
    Current Staging Strategies for Muscle-Invasive Bladder Cancer and Upper Tract Urothelial Cell Carcinoma.
    Urol Clin North Am. 2018;45:143-154.
    Abstract     Related articles   

  451. CRETA M, Longo N, Imbimbo C, Imperatore V, et al
    Health-related quality of life in bladder cancer patients undergoing radical cystectomy and urinary stoma: still many gaps.
    Transl Androl Urol. 2018;7.
    Abstract     Related articles   

  452. KIM AH, Kim SP
    Surviving travel or travelling to survive: the association of travel distance with survival in muscle invasive bladder cancer.
    Transl Androl Urol. 2018;7.
    Abstract     Related articles   

  453. SORIA F, Gontero P
    How to assess and improve health-related quality of life in bladder cancer patients.
    Transl Androl Urol. 2018;7.
    Abstract     Related articles   

  454. LIPPI G, Del Rio D
    Nutritional habits and bladder cancer.
    Transl Androl Urol. 2018;7.
    Abstract     Related articles   

  455. HAQUE W, Butler EB, Teh BS
    Clinical benefit to regionalization of care for muscle invasive bladder cancer.
    Transl Androl Urol. 2018;7.
    Abstract     Related articles   

  456. FONTEYNE V, Rammant E, Decaestecker K
    Selecting candidates for early discharge after radical cystectomy for bladder cancer.
    Transl Androl Urol. 2018;7.
    Abstract     Related articles   

  457. HAMEED DA, Yassa HA, Agban MN, Hanna RT, et al
    Genetic aberrations of the K-ras proto-oncogene and in bladder cancer in relation to pesticide exposure.
    Environ Sci Pollut Res Int. 2018 Apr 12. pii: 10.1007/s11356-018-1840.
    Abstract     Related articles   

  458. SYLVESTER R
    A single immediate instillation of chemotherapy for non-muscle invasive bladder cancer: in all patients?
    Transl Androl Urol. 2018;7.
    Abstract     Related articles   

  459. OOSTERLINCK W, Decaestecker K
    Editorial on the value of an immediate intravesical instillation of mitomycin C in patients with non-muscle-invasive bladder cancer.
    Transl Androl Urol. 2018;7.
    Abstract     Related articles   

  460. BANERJEE S, Banerjee S
    Robot-assisted laparoscopic implantation of brachytherapy catheters in bladder cancer recent interests and prospective.
    Transl Androl Urol. 2018;7.
    Abstract     Related articles   

  461. TAN WS, Tan WP
    Urinary biomarker for the detection of recurrence following non-muscle invasive bladder cancer: are we there yet?
    Transl Androl Urol. 2018;7.
    Abstract     Related articles   

  462. TAN Z, D'Costa NM, Raven PA, Chavez-Munoz C, et al
    Identification of hypoxic gene-signature as a prognostic and predictive biomarker to determine effective therapy in high risk bladder cancer patients.
    Transl Androl Urol. 2018;7.
    Abstract     Related articles   

  463. MORALES-BARRERA R, Gonzalez M, Suarez C, Carles J, et al
    Detection of circulating tumor DNA for advanced bladder cancer: where are we going?
    Transl Androl Urol. 2018;7.
    Abstract     Related articles   

  464. DOBBS RW, Abern MR
    A novel bladder cancer urinary biomarker: can it go where no marker has gone before?
    Transl Androl Urol. 2018;7.
    Abstract     Related articles   

  465. IKUEROWO SO, Ojewuyi OO, Bioku MJ, Abolarinwa AA, et al
    Outcome of Mainz II Pouch Urinary Diversion after Radical Cystectomy in Patients with Muscle-invasive Bladder Cancer: Our Experience.
    Niger J Surg. 2018;24:12-15.
    Abstract     Related articles   

  466. GORIKI A, Seiler R, Wyatt AW, Contreras-Sanz A, et al
    Unravelling disparate roles of NOTCH in bladder cancer.
    Nat Rev Urol. 2018 Apr 11. pii: 10.1038/s41585-018-0005.
    Abstract     Related articles   

  467. GOU L, Liu M, Xia J, Wan Q, et al
    BMP9 Promotes the Proliferation and Migration of Bladder Cancer Cells through Up-Regulating lncRNA UCA1.
    Int J Mol Sci. 2018;19.
    Abstract     Related articles   

  468. PU X, Zhu L, Fu Y, Fan Z, et al
    Companied P16 genetic and protein status together providing useful information on the clinical outcome of urinary bladder cancer.
    Medicine (Baltimore). 2018;97:e0353.
    Abstract     Related articles   

  469. HORN T, Krege S, Retz M
    [Advanced bladder cancer : From chemo- to immunotherapy].
    Urologe A. 2018 Apr 10. pii: 10.1007/s00120-018-0626.
    Abstract     Related articles   

  470. TSURUTA M, Ueda S, Yew PY, Fukuda I, et al
    Bladder cancer-associated cancer-testis antigen-derived long peptides encompassing both CTL and promiscuous HLA class II-restricted Th cell epitopes induced CD4(+) T cells expressing converged T-cell receptor genes in vitro.
    Oncoimmunology. 2018;7:e1415687.
    Abstract     Related articles   

  471. MARCH-VILLALBA JA, Panach-Navarrete J, Herrero-Cervera MJ, Alino-Pellicer S, et al
    hTERT mRNA expression in urine as a useful diagnostic tool in bladder cancer. Comparison with cytology and NMP22 BladderCheck Test(R).
    Actas Urol Esp. 2018 Apr 6. pii: S0210-4806(18)30050.
    Abstract     Related articles   

  472. KLAPHEKE A, Yap SA, Pan K, Cress RD, et al
    Sociodemographic disparities in chemotherapy treatment and impact on survival among patients with metastatic bladder cancer.
    Urol Oncol. 2018 Apr 5. pii: S1078-1439(18)30084.
    Abstract     Related articles   

  473. YANG H, Li G, Cheng B, Jiang R, et al
    ZFAS1 functions as an oncogenic long noncoding RNA in bladder cancer.
    Biosci Rep. 2018 Apr 20. pii: BSR20180475. doi: 10.1042/BSR20180475.
    Abstract     Related articles   

  474. MOHAMED HAH, Salem MA, Elnaggar MS, Gabr A, et al
    Trimodalities for bladder cancer in elderly: Transurethral resection, hypofractionated radiotherapy and gemcitabine.
    Cancer Radiother. 2018 Apr 17. pii: S1278-3218(18)30042.
    Abstract     Related articles   

  475. SJOSTROM C, Thorstenson A, Strock V, Hosseini-Aliabad A, et al
    Treatment according to guidelines may bridge the gender gap in outcome for patients with stage T1 urinary bladder cancer.
    Scand J Urol. 2018 Apr 20:1-8. doi: 10.1080/21681805.2018.1462254.
    Abstract     Related articles   

  476. DEININGER S, Hennenlotter J, Rausch S, Docktor K, et al
    No influence of smoking status on the performance of urine markers for the detection of bladder cancer.
    J Cancer Res Clin Oncol. 2018 Apr 19. pii: 10.1007/s00432-018-2639.
    Abstract     Related articles   

  477. JULIUS D, Geerdes Fenge HF, Weber MA
    [Dyspnea after instillation therapy for bladder cancer].
    Radiologe. 2018 Apr 19. pii: 10.1007/s00117-018-0382.
    Abstract     Related articles   

  478. AN Q, Zhou L, Xu N
    Long noncoding RNA FOXD2-AS1 accelerates the gemcitabine-resistance of bladder cancer by sponging miR-143.
    Biomed Pharmacother. 2018;103:415-420.
    Abstract     Related articles   

  479. AZEVEDO R, Soares J, Gaiteiro C, Peixoto A, et al
    Glycan affinity magnetic nanoplatforms for urinary glycobiomarkers discovery in bladder cancer.
    Talanta. 2018;184:347-355.
    Abstract     Related articles   

  480. WANG X, Wang W, Zhang Q, Gu D, et al
    Tagging SNPs in the HOTAIR gene are associated with bladder cancer risk in a Chinese population.
    Gene. 2018 Apr 16. pii: S0378-1119(18)30408-6. doi: 10.1016/j.gene.2018.
    Abstract     Related articles   

  481. RACIOPPI M, Di Gianfrancesco L, Ragonese M, Palermo G, et al
    The challenges of Bacillus of Calmette-Guerin (BCG) therapy for high risk non muscle invasive bladder cancer treatment in older patients.
    J Geriatr Oncol. 2018 Apr 16. pii: S1879-4068(18)30133.
    Abstract     Related articles   

  482. AREVALO N, Mendez R, Barrera J
    "Inchworm sign" in urinary bladder cancer.
    Abdom Radiol (NY). 2018 Apr 19. pii: 10.1007/s00261-018-1614.
    Abstract     Related articles   

  483. LYU L, Huang LQ, Huang T, Xiang W, et al
    Cell-penetrating peptide conjugates of gambogic acid enhance the antitumor effect on human bladder cancer EJ cells through ROS-mediated apoptosis.
    Drug Des Devel Ther. 2018;12:743-756.
    Abstract     Related articles   

  484. LIN YC, Chen WJ, Huang CY, Shiue HS, et al
    Polymorphisms of Arsenic (+3 oxidation state) Methyltransferase and Arsenic Methylation Capacity Affect the Risk of Bladder Cancer.
    Toxicol Sci. 2018 Apr 14. pii: 4970754. doi: 10.1093.
    Abstract     Related articles   

  485. JOCHEMS SHJ, van Osch FHM, Reulen RC, van Hensbergen M, et al
    Fruit and vegetable intake and the risk of recurrence in patients with non-muscle invasive bladder cancer: a prospective cohort study.
    Cancer Causes Control. 2018 Apr 17. pii: 10.1007/s10552-018-1029.
    Abstract     Related articles   

  486. HE Y, Wang N, Zhou X, Wang J, et al
    Prognostic value of ki67 in BCG-treated non-muscle invasive bladder cancer: a meta-analysis and systematic review.
    BMJ Open. 2018;8:e019635.
    Abstract     Related articles   

  487. JIANG X, Lei T, Zhang M
    Expression and Functions of Formyl Peptide Receptor 1 in Drug-Resistant Bladder Cancer.
    Technol Cancer Res Treat. 2018;17:1533034618769413.
    Abstract     Related articles   

  488. OLBERT P, Goebell PJ, Hegele A
    [Follow-up of bladder cancer : The right examinations at the right time].
    Urologe A. 2018 Apr 16. pii: 10.1007/s00120-018-0641.
    Abstract     Related articles   

  489. NAIKI T, Naiki-Ito A, Iida K, Etani T, et al
    GPX2 promotes development of bladder cancer with squamous cell differentiation through the control of apoptosis.
    Oncotarget. 2018;9:15847-15859.
    Abstract     Related articles   

  490. ROHAILLA S, Kitchlu A, Wheatcroft M, Razak F, et al
    Mycotic aneurysm formation after bacillus Calmette-Guerin instillation for recurrent bladder cancer.
    CMAJ. 2018;190:E467-E471.
    Abstract     Related articles   

  491. AGRAWAL U, Kumari N, Vasudeva P, Mohanty NK, et al
    Overexpression of COX2 indicates poor survival in urothelial bladder cancer.
    Ann Diagn Pathol. 2018;34:50-55.
    Abstract     Related articles   

  492. GUO J, Hu J, Cao R, Chen Q, et al
    Androgen Receptor Is Inactivated and Degraded in Bladder Cancer Cells by Phenyl Glucosamine via miR-449a Restoration.
    Med Sci Monit. 2018;24:2294-2301.
    Abstract     Related articles   

  493. WU SX, Huang J, Liu ZW, Chen HG, et al
    A Genomic-clinicopathologic Nomogram for the Preoperative Prediction of Lymph Node Metastasis in Bladder Cancer.
    EBioMedicine. 2018 Mar 31. pii: S2352-3964(18)30121.
    Abstract     Related articles   

  494. TYSON MD 2ND, Barocas DA
    Quality of Life After Radical Cystectomy.
    Urol Clin North Am. 2018;45:249-256.
    Abstract     Related articles   

  495. REDDY M, Kader K
    Follow-up Management of Cystectomy Patients.
    Urol Clin North Am. 2018;45:241-247.
    Abstract     Related articles   

  496. AVULOVA S, Chang SS
    Role and Indications of Organ-Sparing "Radical" Cystectomy: The Importance of Careful Patient Selection and Counseling.
    Urol Clin North Am. 2018;45:199-214.
    Abstract     Related articles   

  497. MAY D, Gills J, Delacroix SE Jr.
    Robotic Cystectomy.
    Urol Clin North Am. 2018;45:183-188.
    Abstract     Related articles   

  498. CAMPBELL JG, Smelser WW, Lee EK
    Contemporary Preoperative and Intraoperative Management of the Radical Cystectomy Patient.
    Urol Clin North Am. 2018;45:169-181.
    Abstract     Related articles   

  499. LUO Y, Shi X, Li W, Mo L, et al
    Evaluation of the clinical value of hematological parameters in patients with urothelial carcinoma of the bladder.
    Medicine (Baltimore). 2018;97:e0351.
    Abstract     Related articles   

  500. HUI K, Wu S, Yue Y, Gu Y, et al
    RASAL2 inhibits tumor angiogenesis via p-AKT/ETS1 signaling in bladder cancer.
    Cell Signal. 2018 Apr 24. pii: S0898-6568(18)30092.
    Abstract     Related articles   

  501. ALVAREZ-ARGUEDAS S, Uranga S, Martin M, Elizalde J, et al
    Therapeutic efficacy of the live-attenuated Mycobacterium tuberculosis vaccine, MTBVAC, in a preclinical model of bladder cancer.
    Transl Res. 2018 Apr 6. pii: S1931-5244(18)30051.
    Abstract     Related articles   

  502. LEE YH, Lin YC
    Anti-EGFR Indocyanine Green-Mitomycin C-Loaded Perfluorocarbon Double Nanoemulsion: A Novel Nanostructure for Targeted Photochemotherapy of Bladder Cancer Cells.
    Nanomaterials (Basel). 2018;8.
    Abstract     Related articles   

  503. IFTIMIE S, Garcia-Heredia A, Pujol-Bosch F, Pont-Salvado A, et al
    Serum Paraoxonase-1 Concentration as a Potential Predictor of Urinary Bladder Cancer Recurrence. A Five Year Follow-Up Study.
    Arch Med Res. 2018 Apr 23. pii: S0188-4409(18)30121.
    Abstract     Related articles   

  504. VAN DOEVEREN T, van Leeuwen PJ, Aben KKH, van der Aa M, et al
    Reduce bladder cancer recurrence in patients treated for upper urinary tract urothelial carcinoma: The REBACARE-trial.
    Contemp Clin Trials Commun. 2018;9:121-129.
    Abstract     Related articles   

  505. HUANG C, Huang Z, Bai P, Luo G, et al
    Expression of pyruvate kinase M2 in human bladder cancer and its correlation with clinical parameters and prognosis.
    Onco Targets Ther. 2018;11:2075-2082.
    Abstract     Related articles   

  506. LI P, Yang X, Yuan W, Yang C, et al
    CircRNA-Cdr1as Exerts Anti-Oncogenic Functions in Bladder Cancer by Sponging MicroRNA-135a.
    Cell Physiol Biochem. 2018;46:1606-1616.
    Abstract     Related articles   

  507. HASHEMI M, Bahari G, Bizhani F, Danesh H, et al
    Evaluation of 4-bp insertion/deletion polymorphism within the 3'UTR of SGSM3 in bladder cancer using mismatch PCR-RFLP method: A preliminary report.
    J Cell Biochem. 2018 Apr 25. doi: 10.1002/jcb.26764.
    Abstract     Related articles   

  508. ZHANG XF, Zhang XQ, Chang ZX, Wu CC, et al
    microRNA145 modulates migration and invasion of bladder cancer cells by targeting Ncadherin.
    Mol Med Rep. 2018 Apr 20. doi: 10.3892/mmr.2018.8910.
    Abstract     Related articles   

  509. GUO Y, Liu Z, Li K, Cao G, et al
    Paris Polyphylla-Derived Saponins Inhibit Growth of Bladder Cancer Cells by Inducing Mutant P53 Degradation While Up-Regulating CDKN1A Expression.
    Curr Urol. 2018;11:131-138.
    Abstract     Related articles   

  510. BOSSCHIETER J, Lutz C, Segerink LI, Vis AN, et al
    The diagnostic accuracy of methylation markers in urine for the detection of bladder cancer: a systematic review.
    Epigenomics. 2018 Apr 25. doi: 10.2217/epi-2017-0156.
    Abstract     Related articles   

  511. WU S, Zhao X, Wang Y, Zhong Z, et al
    Pretreatment Neutrophil-Lymphocyte Ratio as a Predictor in Bladder Cancer and Metastatic or Unresectable Urothelial Carcinoma Patients: a Pooled Analysis of Comparative Studies.
    Cell Physiol Biochem. 2018;46:1352-1364.
    Abstract     Related articles   

  512. MOSCHINI M, Montorsi F
    Preoperative Prediction of Node Metastases in Bladder Cancer Patients Using Genomic and Clinicopathologic Data.
    EBioMedicine. 2018 Apr 7. pii: S2352-3964(18)30134.
    Abstract     Related articles   

  513. MARI A, Kimura S, Foerster B, Abufaraj M, et al
    A systematic review and meta-analysis of lymphovascular invasion in patients treated with radical cystectomy for bladder cancer.
    Urol Oncol. 2018 Apr 20. pii: S1078-1439(18)30114.
    Abstract     Related articles   

  514. KHETRAPAL P, Lee MWL, Tan WS, Dong L, et al
    The role of circulating tumour cells and nucleic acids in blood for the detection of bladder cancer: A systematic review.
    Cancer Treat Rev. 2018;66:56-63.
    Abstract     Related articles   

  515. TAO L, Qiu J, Slavin S, Ou Z, et al
    Recruited T cells promote the bladder cancer metastasis via up-regulation of the estrogen receptor beta/IL-1/c-MET signals.
    Cancer Lett. 2018 Apr 20. pii: S0304-3835(18)30248.
    Abstract     Related articles   

  516. BALAN D, Martha O, Chibelean CB, Tataru S, et al
    Comparison of 10-year overall survival between patients with G1 and G2 grade Ta bladder tumors.
    Medicine (Baltimore). 2018;97:e0522.
    Abstract     Related articles   

  517. MISCHINGER J, Abdelhafez MF, Rausch S, Todenhofer T, et al
    Perioperative morbidity, bowel function and oncologic outcome after radical cystectomy and ileal orthotopic neobladder reconstruction: Studer-pouch versus I-pouch.
    Eur J Surg Oncol. 2018;44:178-184.
    Abstract     Related articles   

  518. PALOU J, Pisano F, Sylvester R, Joniau S, et al
    Recurrence, progression and cancer-specific mortality according to stage at re-TUR in T1G3 bladder cancer patients treated with BCG: not as bad as previously thought.
    World J Urol. 2018 May 2. pii: 10.1007/s00345-018-2299.
    Abstract     Related articles   

  519. SHIMIZU T, Tomogane M, Miyashita M, Ukimura O, et al
    Low dose gemcitabine increases the cytotoxicity of human Vgamma9Vdelta2 T cells in bladder cancer cells in vitro and in an orthotopic xenograft model.
    Oncoimmunology. 2018;7:e1424671.
    Abstract     Related articles   

  520. NAGAYA T, Okuyama S, Ogata F, Maruoka Y, et al
    Near infrared photoimmunotherapy targeting bladder cancer with a canine anti-epidermal growth factor receptor (EGFR) antibody.
    Oncotarget. 2018;9:19026-19038.
    Abstract     Related articles   

  521. IDE H, Inoue S, Mizushima T, Jiang G, et al
    Androgen Receptor Signaling Reduces Radiosensitivity in Bladder Cancer.
    Mol Cancer Ther. 2018 May 2. pii: 1535-7163.MCT-17-1061.
    Abstract     Related articles   

  522. TANG G, Zhen Y, Xie W, Wang Y, et al
    Preoperative hemoglobin-platelet ratio can significantly predict progression and mortality outcomes in patients with T1G3 bladder cancer undergoing transurethral resection of bladder tumor.
    Oncotarget. 2018;9:18627-18636.
    Abstract     Related articles   

  523. LU M, Liu X
    Comparison of GreenLight Laser Photoselective Vaporization and Thulium Laser Enucleation for Nonmuscle Invasive Bladder Cancer.
    Photomed Laser Surg. 2018 May 2. doi: 10.1089/pho.2018.4440.
    Abstract     Related articles   

  524. KIM D, Lee MH, Koo MA, Kwon BJ, et al
    Suppression of T24 human bladder cancer cells by ROS from locally delivered hematoporphyrin-containing polyurethane films.
    Photochem Photobiol Sci. 2018 May 2. doi: 10.1039/c7pp00424.
    Abstract     Related articles   

  525. FUKUMOTO K, Kikuchi E, Mikami S, Hayakawa N, et al
    Clinical Role of Programmed Cell Death-1 Expression in Patients with Non-muscle-invasive Bladder Cancer Recurring After Initial Bacillus Calmette-Guerin Therapy.
    Ann Surg Oncol. 2018 May 1. pii: 10.1245/s10434-018-6498.
    Abstract     Related articles   

  526. BREAU RH, Lavallee LT, Cnossen S, Witiuk K, et al
    Tranexamic Acid versus Placebo to Prevent Blood Transfusion during Radical Cystectomy for Bladder Cancer (TACT): Study Protocol for a Randomized Controlled Trial.
    Trials. 2018;19:261.
    Abstract     Related articles   

  527. CHENG J, Chen J, Zhang X, Mei H, et al
    Overexpression of CRNDE promotes the progression of bladder cancer.
    Biomed Pharmacother. 2018;99:638-644.
    Abstract     Related articles   

  528. MAAS M, Walz S, Stuhler V, Aufderklamm S, et al
    Molecular markers in disease detection and follow-up of patients with non-muscle invasive bladder cancer.
    Expert Rev Mol Diagn. 2018 Apr 30. doi: 10.1080/14737159.2018.1469979.
    Abstract     Related articles   

  529. KOUTSIOUMPA M, Chen HW, O'Brien N, Koinis F, et al
    MKAD-21 suppresses the oncogenic activity of the miR-21/PPP2R2A/ERK molecular network in bladder cancer.
    Mol Cancer Ther. 2018 Apr 27. pii: 1535-7163.MCT-17-1049.
    Abstract     Related articles   

  530. KWAN ML, Garren B, Nielsen ME, Tang L, et al
    Lifestyle and nutritional modifiable factors in the prevention and treatment of bladder cancer.
    Urol Oncol. 2018 Apr 24. pii: S1078-1439(18)30115.
    Abstract     Related articles   

  531. LOJK J, Bregar VB, Strojan K, Hudoklin S, et al
    Increased endocytosis of magnetic nanoparticles into cancerous urothelial cells versus normal urothelial cells.
    Histochem Cell Biol. 2018;149:45-59.
    Abstract     Related articles   

  532. ANDERSON B
    Bladder cancer: overview and disease management. Part 1: non-muscle-invasive bladder cancer.
    Br J Nurs. 2018;27:S27-S37.
    Abstract     Related articles   

  533. LI C, Wang Z, Feng N, Dong J, et al
    Human HLAF adjacent transcript 10 promotes the formation of cancer initiating cells and cisplatin resistance in bladder cancer.
    Mol Med Rep. 2018 May 9. doi: 10.3892/mmr.2018.9005.
    Abstract     Related articles   

  534. PAN P, Chen T, Zhang Y, Qi Z, et al
    LIN28A inhibits lysosomeassociated membrane glycoprotein 1 protein expression in embryonic stem and bladder cancer cells.
    Mol Med Rep. 2018 May 3. doi: 10.3892/mmr.2018.8965.
    Abstract     Related articles   

  535. WU CL, Ho JY, Hung SH, Yu DS, et al
    miR-429 expression in bladder cancer and its correlation with tumor behavior and clinical outcome.
    Kaohsiung J Med Sci. 2018;34:335-340.
    Abstract     Related articles   

  536. SHIN DW, Park HS, Lee SH, Jeon SH, et al
    Health-Related Quality of Life, Perceived Social Support, and Depression in Disease-Free Survivors Who Underwent Curative Surgery Only for Prostate, Kidney and Bladder cancer: Comparison among survivors and with the General Population.
    Cancer Res Treat. 2018 May 4. pii: crt.2018.053. doi: 10.4143/crt.2018.
    Abstract     Related articles   

  537. CHANTADA-ABAL V, Chantada-Tirado C, Lamas-Diaz L, Carames-Masana F, et al
    [Sequential treatment with Mitomycin C and BCG in non muscle invasive bladder cancer.]
    Arch Esp Urol. 2018;71:453-457.
    Abstract     Related articles   

  538. AMINSHARIFI A, Brousell SC, Chang A, Leon J, et al
    Heat-targeted drug delivery: A promising approach for organsparing treatment of bladder cancer.THERMODOX(R).
    Arch Esp Urol. 2018;71:447-452.
    Abstract     Related articles   

  539. LEON-MATA J, Dominguez JL, Redorta JP, Sousa Gonzalez D, et al
    Analysis of tolerance and security of chemo hyperthermia with Mitomycin C for the treatment of non-muscle invasive bladder cancer.
    Arch Esp Urol. 2018;71:426-437.
    Abstract     Related articles   

  540. COENEN JJMJH, van Valenberg FJP, Arends TJH, Witjes JA, et al
    [Chemohyperthermia using MMC in non-muscle-invasive bladder cancer: Current status and future perspectives.]
    Arch Esp Urol. 2018;71:400-408.
    Abstract     Related articles   

  541. SANCHEZ GONZALEZ A, Rodriguez Faba O, Mosquera L, Sabiote L, et al
    [BCG and bladder cancer: Past, present and future.]
    Arch Esp Urol. 2018;71:332-341.
    Abstract     Related articles   

  542. SOUSA ESCANDON A
    Something is changing in the diagnosis and treatment of non-muscle invasive bladder cancers (NMIBC).
    Arch Esp Urol. 2018;71:325-327.
    Abstract     Related articles   

  543. CAO Y, He Y, Chen H, He S, et al
    Phase I study of gemcitabine-cisplatin versus pemetrexed cisplatin for patients with advanced or metastatic bladder cancer.
    J BUON. 2018;23:475-481.
    Abstract     Related articles   

  544. LENFANT L, Verhoest G, Campi R, Parra J, et al
    Perioperative outcomes and complications of intracorporeal vs extracorporeal urinary diversion after robot-assisted radical cystectomy for bladder cancer: a real-life, multi-institutional french study.
    World J Urol. 2018 May 9. pii: 10.1007/s00345-018-2313.
    Abstract     Related articles   

  545. ZAAK D, Ohlmann C, Stenzl A
    [Current and established diagnostic modalities for bladder cancer].
    Urologe A. 2018 May 9. pii: 10.1007/s00120-018-0650.
    Abstract     Related articles   

  546. YOSHIDA T, Singh AK, Bishai WR, McConkey DJ, et al
    Organoid culture of bladder cancer cells.
    Investig Clin Urol. 2018;59:149-151.
    Abstract     Related articles   

  547. NAKANO M, Omae K, Takebayashi T, Tanaka S, et al
    An epidemic of bladder cancer: ten cases of bladder cancer in male Japanese workers exposed to ortho-toluidine.
    J Occup Health. 2018 May 9. doi: 10.1539/joh.2017-0220.
    Abstract     Related articles   

  548. ZHANG Y, Fang L, Zang Y, Xu Z, et al
    Identification of Core Genes and Key Pathways via Integrated Analysis of Gene Expression and DNA Methylation Profiles in Bladder Cancer.
    Med Sci Monit. 2018;24:3024-3033.
    Abstract     Related articles   

  549. LUAN T, Zou R, Huang L, Li N, et al
    Hsa-miR-3658 Promotes Cell Proliferation, Migration and Invasion by Effecting LASS2 in Bladder Cancer.
    Clin Lab. 2018;64:515-525.
    Abstract     Related articles   

  550. D'ANDREA D, Hassler MR, Abufaraj M, Soria F, et al
    Progressive tissue biomarker profiling in non-muscle-invasive bladder cancer.
    Expert Rev Anticancer Ther. 2018 May 9:1-9. doi: 10.1080/14737140.2018.1474104.
    Abstract     Related articles   

  551. CHU HA, Crawford-Brown D
    Correction: Chu et al. Inorganic Arsenic in Drinking Water and Bladder Cancer: A Meta-Analysis for Dose-Response Assessment. Int. J. Environ. Res. Public Health 2006, 3(4), 316(-)322.
    Int J Environ Res Public Health. 2018;15.
    Abstract     Related articles   

  552. FLANNERY K, Cao X, He J, Zhong Y, et al
    Survival Rates and Health Care Costs for Patients With Advanced Bladder Cancer Treated and Untreated With Chemotherapy.
    Clin Genitourin Cancer. 2018 Mar 27. pii: S1558-7673(18)30211.
    Abstract     Related articles   

  553. YOROZUYA W, Nishiyama N, Shindo T, Kyoda Y, et al
    Bacillus Calmette-Guerin may have clinical benefit for glandular or squamous differentiation in non-muscle invasive bladder cancer patients: retrospective multicenter study.
    Jpn J Clin Oncol. 2018 May 4. pii: 4992852. doi: 10.1093.
    Abstract     Related articles   

  554. KWEON TD, Lee KY
    Spinal anesthesia is associated with lower recurrence rates after resection of non-muscle invasive bladder cancer.
    Transl Androl Urol. 2018;7:283-286.
    Abstract     Related articles   

  555. DREJER D, Jensen JB, Bryan RT
    Red patches during bladder cancer surveillance: to biopsy or not to biopsy?
    Transl Androl Urol. 2018;7:280-282.
    Abstract     Related articles   

  556. DIMITROPOULOS K, Tzortzis V
    Could there be a relationship between type of anesthesia and oncological parameters after transurethral resection of bladder cancer?
    Transl Androl Urol. 2018;7:287-288.
    Abstract     Related articles   

  557. CHRISTOPH F, Schostak M
    Age does not matter: the relevance of immediate instillation therapy with Mitomycin C in non-muscle invasive bladder cancer.
    Transl Androl Urol. 2018;7:289-291.
    Abstract     Related articles   

  558. MESSING EM
    Psychological Stress and Suicide in Bladder Cancer Patients.
    Bladder Cancer. 2018;4:245-246.
    Abstract     Related articles   

  559. GALSKY MD, Pal SK, Lin SW, Ogale S, et al
    Real-World Effectiveness of Chemotherapy in Elderly Patients With Metastatic Bladder Cancer in the United States.
    Bladder Cancer. 2018;4:227-238.
    Abstract     Related articles   

  560. DE MATURANA EL, Rava M, Anumudu C, Saez O, et al
    Bladder Cancer Genetic Susceptibility. A Systematic Review.
    Bladder Cancer. 2018;4:215-226.
    Abstract     Related articles   

  561. LEWIS GD, Haque W, Verma V, Butler EB, et al
    The Role of Adjuvant Radiation Therapy in Locally Advanced Bladder Cancer.
    Bladder Cancer. 2018;4:205-213.
    Abstract     Related articles   

  562. KAISER J, Li H, North SA, Leibowitz-Amit R, et al
    The Prognostic Role of the Change in Neutrophil-to-Lymphocyte Ratio During Neoadjuvant Chemotherapy in Patients with Muscle-Invasive Bladder Cancer: A Retrospective, Multi-Institutional Study.
    Bladder Cancer. 2018;4:185-194.
    Abstract     Related articles   

  563. ZUIVERLOON TCM, de Jong FC, Costello JC, Theodorescu D, et al
    Systematic Review: Characteristics and Preclinical Uses of Bladder Cancer Cell Lines.
    Bladder Cancer. 2018;4:169-183.
    Abstract     Related articles   

  564. ZAREBA P, Duivenvoorden WCM, Pinthus JH
    Thromboembolism in Patients with Bladder Cancer: Incidence, Risk Factors and Prevention.
    Bladder Cancer. 2018;4:139-147.
    Abstract     Related articles   

  565. AL JOHI RS, Seifeldein GS, Moeen AM, Aboulhagag NA, et al
    Diffusion weighted magnetic resonance imaging in bladder cancer, is it time to replace biopsy?
    Cent European J Urol. 2018;71:31-37.
    Abstract     Related articles   

  566. AKITAKE M, Kiyoshima K, Yokomizo A, Shiga K, et al
    A rational risk assessment for intravesical recurrence in primary low-grade Ta bladder cancer: A retrospective analysis of 245 cases.
    Mol Clin Oncol. 2018;8:785-790.
    Abstract     Related articles   

  567. HORI S, Miyake M, Tatsumi Y, Morizawa Y, et al
    Gamma-Klotho exhibits multiple roles in tumor growth of human bladder cancer.
    Oncotarget. 2018;9:19508-19524.
    Abstract     Related articles   

  568. GAI JW, Wahafu W, Song L, Ping H, et al
    Expression of CD74 in bladder cancer and its suppression in association with cancer proliferation, invasion and angiogenesis in HT-1376 cells.
    Oncol Lett. 2018;15:7631-7638.
    Abstract     Related articles   

  569. SATHIANATHEN NJ, Fan Y, Jarosek SL, Lawrentschuk NL, et al
    Finasteride does not prevent bladder cancer: A secondary analysis of the Medical Therapy for Prostatic Symptoms Study.
    Urol Oncol. 2018 May 3. pii: S1078-1439(18)30116.
    Abstract     Related articles   

  570. CRIJNEN J, de Reijke TM
    Emerging intravesical drugs for the treatment of non muscle-invasive bladder cancer.
    Expert Opin Emerg Drugs. 2018 May 5. doi: 10.1080/14728214.2018.1474201.
    Abstract     Related articles   

  571. DING XL, Yang DL, Yan RP, Li ZP, et al
    [Value of European Organisation for Research and Treatment of Cancer score system for predication of immediate postoperative intravesical instillation of pirarubicin after transurethral resection of non-muscle invasive bladder cancer].
    Zhonghua Zhong Liu Za Zhi. 2018;40:308-312.
    Abstract     Related articles   

  572. OTSUKA M, Taguchi S, Nakagawa T, Morikawa T, et al
    Clinical significance of random bladder biopsy in primary T1 bladder cancer.
    Mol Clin Oncol. 2018;8:665-670.
    Abstract     Related articles   

  573. YANG Y, Xu J, Zhang Q
    Detection of urinary survivin using a magnetic particles-based chemiluminescence immunoassay for the preliminary diagnosis of bladder cancer and renal cell carcinoma combined with LAPTM4B.
    Oncol Lett. 2018;15:7923-7933.
    Abstract     Related articles   

  574. CHEN D, Chen J, Guo Y, Li Y, et al
    Cinobufacini promotes apoptosis of bladder cancer cells by influencing the expression of autophagy-related genes.
    Oncol Lett. 2018;15:7104-7110.
    Abstract     Related articles   

  575. ZHENG Z, Zhu D, Zhao F, Han J, et al
    Upregulated GAPLINC predicts a poor prognosis in bladder cancer patients and promotes tumor proliferation and invasion.
    Oncol Lett. 2018;15:6770-6776.
    Abstract     Related articles   

  576. CHEN JF, Yu BX, Ma L, Lv XY, et al
    RON is overexpressed in bladder cancer and contributes to tumorigenic phenotypes in 5637 cells.
    Oncol Lett. 2018;15:6547-6554.
    Abstract     Related articles   

  577. KYRITSI F, Loffredo CA, Zheng YL, Philips G, et al
    Urinary Bladder Cancer in Egypt: Are There Gender Differences in Its Histopathological Presentation?
    Adv Urol. 2018;2018:3453808.
    Abstract     Related articles   

  578. LIN W, Xie J, Xu N, Huang L, et al
    Glaucocalyxin A induces G2/M cell cycle arrest and apoptosis through the PI3K/Akt pathway in human bladder cancer cells.
    Int J Biol Sci. 2018;14:418-426.
    Abstract     Related articles   

  579. DONG L, Lin F, Wu W, Liu Y, et al
    Verteporfin inhibits YAP-induced bladder cancer cell growth and invasion via Hippo signaling pathway.
    Int J Med Sci. 2018;15:645-652.
    Abstract     Related articles   

  580. VAN DER POL CB, Sahni VA, Eberhardt SC, Oto A, et al
    ACR Appropriateness Criteria((R)) Pretreatment Staging of Muscle-Invasive Bladder Cancer.
    J Am Coll Radiol. 2018;15.
    Abstract     Related articles   

  581. OUZAID I, Xylinas E
    Prevention of IVR: a need for investigation.
    Jpn J Clin Oncol. 2018;48:295-296.
    Abstract     Related articles   

  582. FANG CY, Chen JS, Chang SK, Shen CH, et al
    Reversine induces autophagic cell death through the AMP-activated protein kinase pathway in urothelial carcinoma cells.
    Anticancer Drugs. 2018;29:29-39.
    Abstract     Related articles   

  583. FUESSEL S, Lohse-Fischer A, Vu Van D, Salomo K, et al
    Quantification of MicroRNAs in Urine-Derived Specimens.
    Methods Mol Biol. 2018;1655:201-226.
    Abstract     Related articles   

  584. YOSHIDA T, Okuyama H, Endo H, Inoue M, et al
    Spheroid Cultures of Primary Urothelial Cancer Cells: Cancer Tissue-Originated Spheroid (CTOS) Method.
    Methods Mol Biol. 2018;1655:145-153.
    Abstract     Related articles   

  585. WHONGSIRI P, Phoyen S, Boonla C
    Oxidative Stress in Urothelial Carcinogenesis: Measurements of Protein Carbonylation and Intracellular Production of Reactive Oxygen Species.
    Methods Mol Biol. 2018;1655:109-117.
    Abstract     Related articles   

  586. JAGUVA VASUDEVAN AA, Goering W, Haussinger D, Munk C, et al
    Detection of APOBEC3 Proteins and Catalytic Activity in Urothelial Carcinoma.
    Methods Mol Biol. 2018;1655:97-107.
    Abstract     Related articles   

  587. MBANEFO EC, Hsieh MH
    Defining the Pathways of Urogenital Schistosomiasis-Associated Urothelial Carcinogenesis through Transgenic and Bladder Wall Egg Injection Models.
    Methods Mol Biol. 2018;1655:67-76.
    Abstract     Related articles   

  588. SJODAHL G
    Molecular Subtype Profiling of Urothelial Carcinoma Using a Subtype-Specific Immunohistochemistry Panel.
    Methods Mol Biol. 2018;1655:53-64.
    Abstract     Related articles   

  589. ALAMYAR M, Zwarthoff EC
    Analysis of Point Mutations in Clinical Samples of Urothelial Carcinoma.
    Methods Mol Biol. 2018;1655:19-28.
    Abstract     Related articles   

  590. LI R, Petros FG, Davis JW
    Extended Pelvic Lymph Node Dissection in Bladder Cancer.
    J Endourol. 2018;32.
    Abstract     Related articles   

  591. WOOLBRIGHT BL, Ayres M, Taylor JA 3rd
    Metabolic changes in bladder cancer.
    Urol Oncol. 2018 May 14. pii: S1078-1439(18)30132.
    Abstract     Related articles   

  592. ZHU X, Li Y, Zhao S, Zhao S, et al
    LSINCT5 activates Wnt/beta-catenin signaling by interacting with NCYM to promote bladder cancer progression.
    Biochem Biophys Res Commun. 2018 May 14. pii: S0006-291X(18)31133.
    Abstract     Related articles   

  593. TRAN-HARDING K, Nair RT, Ganesh H
    Renal Granulomatosis Post Intravesical Bacillus Calmette-Guerin Therapy for Non-muscle-invasive Bladder Cancer.
    J Clin Imaging Sci. 2018;8:18.
    Abstract     Related articles   

  594. FALKE J, Hulsbergen-van de Kaa CA, Maj R, Oosterwijk E, et al
    A placebo-controlled efficacy study of the intravesical immunomodulators TMX-101 and TMX-202 in an orthotopic bladder cancer rat model.
    World J Urol. 2018 May 16. pii: 10.1007/s00345-018-2334.
    Abstract     Related articles   

  595. GE P, Wang L, Lu M, Mao L, et al
    Oncological Outcome of Primary and Secondary Muscle-Invasive Bladder Cancer: A Systematic Review and Meta-analysis.
    Sci Rep. 2018;8:7543.
    Abstract     Related articles   

  596. LAM TBL
    Optimizing the diagnosis of pelvic lymph node metastasis in bladder cancer using computed tomography and magnetic resonance imaging.
    Cancer Commun (Lond). 2018;38:2.
    Abstract     Related articles   

  597. GOONEWARDENA SAS, Jayarajah U, Kuruppu SN, Herath HMKB, et al
    Clinical outcomes in a cohort of patients with T1 high grade urothelial bladder cancer not receiving intravesical bacillus Calmette-Guerin: a 15 year experience
    Ceylon Med J. 2018;63:37-39.
    Abstract     Related articles   

  598. BABA M, Kageyama S, Yoshida T, Fujiwara R, et al
    Intravesical bacillus Calmette-Guerin therapy after second transurethral resection for primary T1 bladder cancer.
    Int J Clin Oncol. 2018 May 14. pii: 10.1007/s10147-018-1292.
    Abstract     Related articles   

  599. MARTIN JW, Vernez SL, Lotan Y, Abdelhalim A, et al
    Pathological characteristics and prognostic indicators of different histopathological types of urinary bladder cancer following radical cystectomy in a large single-center Egyptian cohort.
    World J Urol. 2018 May 14. pii: 10.1007/s00345-018-2331.
    Abstract     Related articles   

  600. XU W, Xia H, Liu W, Zheng W, et al
    Exploration of genetics commonness between bladder cancer and breast cancer based on a silcio analysis on disease subtypes.
    Technol Health Care. 2018 Apr 27. pii: THC174699. doi: 10.3233/THC-174699.
    Abstract     Related articles   

  601. PARDINI B, Cordero F, Naccarati A, Viberti C, et al
    microRNA profiles in urine by next-generation sequencing can stratify bladder cancer subtypes.
    Oncotarget. 2018;9:20658-20669.
    Abstract     Related articles   

  602. LEVI L, Groh M, De Castro N, Bergeron A, et al
    [BCG infection following intravesicular immunotherapy for bladder cancer].
    Rev Mal Respir. 2018 May 10. pii: S0761-8425(18)30073.
    Abstract     Related articles   

  603. WANG Y, Hu D, Yu H, Shen Y, et al
    Comparison of the Diagnostic Value of Monoexponential, Biexponential, and Stretched Exponential Diffusion-weighted MRI in Differentiating Tumor Stage and Histological Grade of Bladder Cancer.
    Acad Radiol. 2018 May 9. pii: S1076-6332(18)30199.
    Abstract     Related articles   

  604. LIU XP, Yin XH, Yan XH, Zeng XT, et al
    The Clinical Relevance of Fragile Histidine Triad Protein (FHIT) in Patients with Bladder Cancer.
    Med Sci Monit. 2018;24:3113-3118.
    Abstract     Related articles   

  605. JIN CY, Molagoda IMN, Karunarathne WAHM, Kang SH, et al
    TRAIL attenuates sulforaphane-mediated Nrf2 and sustains ROS generation, leading to apoptosis of TRAIL-resistant human bladder cancer cells.
    Toxicol Appl Pharmacol. 2018 May 21. pii: S0041-008X(18)30233.
    Abstract     Related articles   

  606. WEBER C
    A biobank for bladder cancer.
    Nat Cell Biol. 2018 May 21. pii: 10.1038/s41556-018-0114.
    Abstract     Related articles   

  607. YUEN JWM, Mak DSY, Chan ES, Gohel MDI, et al
    Tumor inhibitory effects of intravesical Ganoderma lucidum instillation in the syngeneic orthotopic MB49/C57 bladder cancer mice model.
    J Ethnopharmacol. 2018 May 18. pii: S0378-8741(18)31199.
    Abstract     Related articles   

  608. MICHELS CTJ, Wijburg CJ, Leijte E, Witjes JA, et al
    A cost-effectiveness modeling study of robot-assisted (RARC) versus open radical cystectomy (ORC) for bladder cancer to inform future research.
    Eur Urol Focus. 2018 May 18. pii: S2405-4569(18)30104.
    Abstract     Related articles   

  609. BILSEN MP, van Meijgaarden KE, de Jong HK, Joosten SA, et al
    A novel view on the pathogenesis of complications after intravesical BCG for bladder cancer.
    Int J Infect Dis. 2018 May 17. pii: S1201-9712(18)34414.
    Abstract     Related articles   

  610. KAYAMA E, Kikuchi E, Fukumoto K, Shirotake S, et al
    History of Non-Muscle-Invasive Bladder Cancer May Have a Worse Prognostic Impact in cT2-4aN0M0 Bladder Cancer Patients Treated With Radical Cystectomy.
    Clin Genitourin Cancer. 2018 Apr 28. pii: S1558-7673(18)30303.
    Abstract     Related articles   

  611. BENNETT MH, Feldmeier J, Smee R, Milross C, et al
    Hyperbaric oxygenation for tumour sensitisation to radiotherapy.
    Cochrane Database Syst Rev. 2018;4:CD005007.
    Abstract     Related articles   

  612. VALLEJO-BENITEZ A, Rodriguez-Zarco E, Pabon-Carrasco S, Espinal PS, et al
    [Small cell bladder carcinoma in age extremes: Report of two cases.]
    Arch Esp Urol. 2018;71:204-207.
    Abstract     Related articles   

  613. TURAN T, Efiloglu O, Gunaydin B, Ozkanli S, et al
    Comparative differences between T1a/b and T1e/m as substages in T1 urothelial carcinoma of the bladder.
    Int Braz J Urol. 2018;44:267-272.
    Abstract     Related articles   

  614. TANG S, Hao H, Fang D, Zheng W, et al
    Prostate cancer incidentally discovered at the time of radical cystoprostatectomy does not decrease overall survival: Results from a large Chinese medical center.
    Int Braz J Urol. 2018;44:258-266.
    Abstract     Related articles   

  615. DUDEK AM, van Kampen JGM, Witjes JA, Kiemeney LALM, et al
    LINC00857 expression predicts and mediates the response to platinum-based chemotherapy in muscle-invasive bladder cancer.
    Cancer Med. 2018 Jun 1. doi: 10.1002/cam4.1570.
    Abstract     Related articles   

  616. ROUANNE M, Roumiguie M, Houede N, Masson-Lecomte A, et al
    Development of immunotherapy in bladder cancer: present and future on targeting PD(L)1 and CTLA-4 pathways.
    World J Urol. 2018 Jun 1. pii: 10.1007/s00345-018-2332.
    Abstract     Related articles   

  617. JIN Z, Yao J, Xie N, Cai L, et al
    Melittin Constrains the Expression of Identified Key Genes Associated with Bladder Cancer.
    J Immunol Res. 2018;2018:5038172.
    Abstract     Related articles   

  618. VAN DER HEIJDEN AG, Mengual L, Ingelmo-Torres M, Lozano JJ, et al
    Urine cell-based DNA methylation classifier for monitoring bladder cancer.
    Clin Epigenetics. 2018;10:71.
    Abstract     Related articles   

  619. ZHOU L, Wei E, Zhou B, Bi G, et al
    Anti-proliferative benefit of curcumol on human bladder cancer cells via inactivating EZH2 effector.
    Biomed Pharmacother. 2018;104:798-805.
    Abstract     Related articles   

  620. SHINDO T, Niinuma T, Nishiyama N, Shinkai N, et al
    Epigenetic silencing of miR-200b is associated with cisplatin resistance in bladder cancer.
    Oncotarget. 2018;9:24457-24469.
    Abstract     Related articles   

  621. EBBING J, Heckmann RC, Collins JW, Miller K, et al
    Oncological outcomes, quality of life outcomes and complications of partial cystectomy for selected cases of muscle-invasive bladder cancer.
    Sci Rep. 2018;8:8360.
    Abstract     Related articles   

  622. HA HK, Koo PJ, Kim SJ
    Diagnostic Accuracy of F-18 FDG PET/CT for Preoperative Lymph Node Staging in Newly Diagnosed Bladder Cancer Patients: A Systematic Review and Meta-Analysis.
    Oncology. 2018;95:31-38.
    Abstract     Related articles   

  623. VAN OSCH FHM, Jochems SHJ, Reulen RC, Pirrie SJ, et al
    The association between smoking cessation before and after diagnosis and non-muscle-invasive bladder cancer recurrence: a prospective cohort study.
    Cancer Causes Control. 2018 May 30. pii: 10.1007/s10552-018-1046.
    Abstract     Related articles   

  624. RAHMAT JN, Esuvaranathan K, Mahendran R
    Bacillus Calmette-Guerin induces rapid gene expression changes in human bladder cancer cell lines that may modulate its survival.
    Oncol Lett. 2018;15:9231-9241.
    Abstract     Related articles   

  625. WANG Y, Liu J, Yang X, Liu Y, et al
    Bacillus Calmette-Guerin and anti-PD-L1 combination therapy boosts immune response against bladder cancer.
    Onco Targets Ther. 2018;11:2891-2899.
    Abstract     Related articles   

  626. ZIEGLER J, Ho J, Gibson IW, Nayak JG, et al
    Disseminated Mycobacterium bovis infection post-kidney transplant following remote intravesical BCG therapy for bladder cancer.
    Transpl Infect Dis. 2018 May 29:e12931. doi: 10.1111/tid.12931.
    Abstract     Related articles   

  627. JURACEK J, Stanik M, Peltanova B, Adamcova S, et al
    [Urinary MicroRNAs as Potential Biomarkers of Bladder Cancer].
    Klin Onkol. 2018;31.
    Abstract     Related articles   

  628. XU Y, Tong Y, Ying J, Lei Z, et al
    Chrysin induces cell growth arrest, apoptosis, and ER stress and inhibits the activation of STAT3 through the generation of ROS in bladder cancer cells.
    Oncol Lett. 2018;15:9117-9125.
    Abstract     Related articles   

  629. WANG JP, Leng JY, Zhang RK, Zhang L, et al
    Functional analysis of gene expression profiling-based prediction in bladder cancer.
    Oncol Lett. 2018;15:8417-8423.
    Abstract     Related articles   

  630. WAKAI K, Utsumi T, Yoneda K, Oka R, et al
    Development and external validation of a nomogram to predict high-grade papillary bladder cancer before first-time transurethral resection of the bladder tumor.
    Int J Clin Oncol. 2018 May 26. pii: 10.1007/s10147-018-1299.
    Abstract     Related articles   

  631. ANDOLINO C, Hess C, Prince T, Williams H, et al
    Drug-induced keratin 9 interaction with Hsp70 in bladder cancer cells.
    Cell Stress Chaperones. 2018 May 25. pii: 10.1007/s12192-018-0913.
    Abstract     Related articles   

  632. MESSING EM, Tangen CM, Lerner SP, Sahasrabudhe DM, et al
    Effect of Intravesical Instillation of Gemcitabine vs Saline Immediately Following Resection of Suspected Low-Grade Non-Muscle-Invasive Bladder Cancer on Tumor Recurrence: SWOG S0337 Randomized Clinical Trial.
    JAMA. 2018;319:1880-1888.
    Abstract     Related articles   

  633. KAFFENBERGER SD, Miller DC, Nielsen ME
    Simplifying Treatment and Reducing Recurrence for Patients With Early-Stage Bladder Cancer.
    JAMA. 2018;319:1864-1865.
    Abstract     Related articles   

  634. BOLAT D, Celik S, Aydin ME, Aydogdu O, et al
    Assessment of the quality of life and sexual functions of patients followed-up for non-muscle invasive bladder cancer: preliminary results of the prospective-descriptive study.
    Turk J Urol. 2018 Mar 9:1-6. doi: 10.5152/tud.2018.30040.
    Abstract     Related articles   

  635. CHEN H, Li X, Broderick N, Liu Y, et al
    Identification and characterization of bladder cancer by low-resolution fiber-optic Raman spectroscopy.
    J Biophotonics. 2018 May 24:e201800016. doi: 10.1002/jbio.201800016.
    Abstract     Related articles   

  636. SHANG Z, Wang J, Wang X, Yan H, et al
    Preoperative serum apolipoprotein A-I levels predict long-term survival in non-muscle-invasive bladder cancer patients.
    Cancer Manag Res. 2018;10:1177-1190.
    Abstract     Related articles   

  637. ASCHENBRENNER DS
    Bladder Cancer Drug Approved to Treat Stage III Non-Small Cell Lung Cancer.
    Am J Nurs. 2018;118:26-27.
    Abstract     Related articles   

  638. BARTH I, Schneider U, Grimm T, Karl A, et al
    Progression of urothelial carcinoma in situ of the urinary bladder: a switch from luminal to basal phenotype and related therapeutic implications.
    Virchows Arch. 2018;472:749-758.
    Abstract     Related articles   

  639. ROBINSON SP, Farooq A, Laniado M, Motiwala H, et al
    The demographic features, clinical outcomes, prognosis and treatment options for patients with sarcomatoid carcinoma of the urinary bladder: a single centre experience.
    Int Braz J Urol. 2018;44:45-52.
    Abstract     Related articles   

  640. FAIREY AS, Mclarty R
    Orthotopic bladder substitution for bladder cancer patients undergoing radical cystectomy: A call to action.
    Can Urol Assoc J. 2018;12:187.
    Abstract     Related articles   

  641. MEKAYTEN M, Yutkin V, Duvdevani M, Pode D, et al
    High frequency of bladder cancer after nephroureterectomy: justification for adjuvant intravesical treatment?
    Res Rep Urol. 2018;10:33-38.
    Abstract     Related articles   

  642. LI D, Hao X, Song Y
    An integrated analysis of key microRNAs, regulatory pathways and clinical relevance in bladder cancer.
    Onco Targets Ther. 2018;11:3075-3085.
    Abstract     Related articles   

  643. ZHU Y, Liang S, Pan H, Cheng Z, et al
    Inhibition of miR-1247 on cell proliferation and invasion in bladder cancer through its downstream target of RAB36.
    J Biosci. 2018;43:365-373.
    Abstract     Related articles   

  644. CHRISTODOULOU M, Reeves KJ, Hodgson C, Zeniou A, et al
    Outcomes of radiosensitisation in elderly patients with advanced bladder cancer.
    Radiother Oncol. 2018 Jun 2. pii: S0167-8140(18)30281.
    Abstract     Related articles   

  645. WEBER L, Schulz WA, Philippou S, Eckardt J, et al
    Characterization of the Olfactory Receptor OR10H1 in Human Urinary Bladder Cancer.
    Front Physiol. 2018;9:456.
    Abstract     Related articles   

  646. JIANG S, Tian F, Wang Q, Cheng W, et al
    High expression of spindle and kinetochore- associated protein 1 predicts early recurrence and progression of non-muscle invasive bladder cancer.
    Cancer Biomark. 2018 May 25. pii: CBM181202. doi: 10.3233/CBM-181202.
    Abstract     Related articles   

  647. JUNG A, Nielsen ME, Crandell JL, Palmer MH, et al
    Quality of Life in Non-Muscle-Invasive Bladder Cancer Survivors: A Systematic Review.
    Cancer Nurs. 2018 Jun 1. doi: 10.1097/NCC.0000000000000606.
    Abstract     Related articles   

  648. RAJWA P, Zyczkowski M, Paradysz A, Bujak K, et al
    Evaluation of the prognostic value of LMR, PLR, NLR, and dNLR in urothelial bladder cancer patients treated with radical cystectomy.
    Eur Rev Med Pharmacol Sci. 2018;22:3027-3037.
    Abstract     Related articles   

  649. DONG ZC, Zhang D, Wang SB, Lin ZQ, et al
    Target inhibition on GSK-3beta by miR-9 to modulate proliferation and apoptosis of bladder cancer cells.
    Eur Rev Med Pharmacol Sci. 2018;22:3018-3026.
    Abstract     Related articles   

  650. WU SQ, Xu R, Li XF, Zhao XK, et al
    Prognostic roles of tumor associated macrophages in bladder cancer: a system review and meta-analysis.
    Oncotarget. 2018;9:25294-25303.
    Abstract     Related articles   

  651. SNELL KIE, Ward DG, Gordon NS, Goldsmith JC, et al
    Exploring the roles of urinary HAI-1, EpCAM & EGFR in bladder cancer prognosis & risk stratification.
    Oncotarget. 2018;9:25244-25253.
    Abstract     Related articles   

  652. AUDENET F, Farkas AM, Anastos H, Galsky MD, et al
    Immune phenotype of peripheral blood mononuclear cells in patients with high-risk non-muscle invasive bladder cancer.
    World J Urol. 2018 Jun 2. pii: 10.1007/s00345-018-2359.
    Abstract     Related articles   

  653. YU Y, Cao H, Zhang M, Shi F, et al
    Prognostic value of DNA methylation for bladder cancer.
    Clin Chim Acta. 2018;484:207-212.
    Abstract     Related articles   

  654. YANG GL, Zhang LH, Liu Q, Wang ZL, et al
    Commentary on "A novel treatment strategy for newly diagnosed high-grade T1 bladder cancer: Gemcitabine and cisplatin adjuvant chemotherapy-A single-institution experience."
    Urol Oncol. 2018 May 30. pii: S1078-1439(18)30164.
    Abstract     Related articles   

  655. DANESHMAND S, Bazargani ST, Bivalacqua TJ, Holzbeierlein JM, et al
    Blue light cystoscopy for the diagnosis of bladder cancer: Results from the US prospective multicenter registry.
    Urol Oncol. 2018 May 30. pii: S1078-1439(18)30135.
    Abstract     Related articles   

  656. HUANG CY, Lin YC, Shiue HS, Chen WJ, et al
    Comparison of Arsenic Methylation Capacity and Polymorphisms of Arsenic Methylation Genes between Bladder Cancer and Upper Tract Urothelial Carcinoma.
    Toxicol Lett. 2018 May 30. pii: S0378-4274(18)30231.
    Abstract     Related articles   

  657. JIN H, Sun W, Zhang Y, Yan H, et al
    MicroRNA-411 Downregulation Enhances Tumor Growth by Upregulating MLLT11 Expression in Human Bladder Cancer.
    Mol Ther Nucleic Acids. 2018;11:312-322.
    Abstract     Related articles   

  658. DIAS LP, Luzo ACM, Volpe BB, Duran M, et al
    Effects of intravesical therapy with platelet-rich plasma (PRP) and Bacillus Calmette-Guerin (BCG) in non-muscle invasive bladder cancer.
    Tissue Cell. 2018;52:17-27.
    Abstract     Related articles   

  659. NAIK N, Lin M, Lin P
    Genitourinary involvement of lymphomas on FDG-PET.
    Br J Radiol. 2018;91:20170273.
    Abstract     Related articles   

  660. WHALEN KE, Eagle RC Jr, Vrabec TR
    CASE OF METASTATIC UROTHELIAL CARCINOMA OF THE RETINA AND VITREOUS.
    Retin Cases Brief Rep. 2018;12:177-180.
    Abstract     Related articles   

  661. TAN WS, Tan WP, Tan MY, Khetrapal P, et al
    Novel urinary biomarkers for the detection of bladder cancer: A systematic review.
    Cancer Treat Rev. 2018;69:39-52.
    Abstract     Related articles   

  662. RETZ M, Karl A
    [Bladder cancer : Current diagnosis and treatment modalities].
    Urologe A. 2018;57:655-656.
    Abstract     Related articles   

  663. RASHIDIAN H, Zendehdel K, Daroudi R, Ebadzadeh MR, et al
    Epidemiology and Hospitalization Cost of Bladder Cancer in Kerman Province, Southeastern Iran.
    Iran J Public Health. 2018;47:567-574.
    Abstract     Related articles   

  664. RINALDETTI S, Rempel E, Worst TS, Eckstein M, et al
    Subclassification, survival prediction and drug target analyses of chemotherapy-naive muscle-invasive bladder cancer with a molecular screening.
    Oncotarget. 2018;9:25935-25945.
    Abstract     Related articles   

  665. SU G, He Q, Wang J
    Clinical Values of Long Non-coding RNAs in Bladder Cancer: A Systematic Review.
    Front Physiol. 2018;9:652.
    Abstract     Related articles   

  666. TOLLE A, Blobel CC, Jung K
    Circulating miRNAs in blood and urine as diagnostic and prognostic biomarkers for bladder cancer: an update in 2017.
    Biomark Med. 2018 Jun 13. doi: 10.2217/bmm-2017-0392.
    Abstract     Related articles   

  667. ZO RB, Long Z
    MiR-124-3p suppresses bladder cancer by targeting DNA methyltransferase 3B.
    J Cell Physiol. 2018 Jun 12. doi: 10.1002/jcp.26591.
    Abstract     Related articles   

  668. RAFIEMANESH H, Lotfi Z, Bakhtazad S, Ghoncheh M, et al
    The epidemiological and histological trend of bladder cancer in Iran.
    J Cancer Res Ther. 2018;14:532-536.
    Abstract     Related articles   

  669. YANG J, Li W, Zhang Z, Shen J, et al
    PSCArs2294008 T polymorphism increases the risk of bladder cancer in Bai, Dai, and Han ethnicity in China and a potential mechanism.
    Genes Genomics. 2018;40:531-541.
    Abstract     Related articles   

  670. MAZDAK H, Tolou-Ghamari Z
    Preliminary study of prevalence for bladder cancer in Isfahan Province, Iran.
    Arab J Urol. 2018;16:206-210.
    Abstract     Related articles   

  671. CHEN Y, Li W, Zeng Z, Tang Y, et al
    (-)-Gochnatiolide B, synthesized from dehydrocostuslactone, exhibits potent anti-bladder cancer activity in vitro and in vivo.
    Sci Rep. 2018;8:8807.
    Abstract     Related articles   

  672. POIRION OB, Chaudhary K, Garmire LX
    Deep Learning data integration for better risk stratification models of bladder cancer.
    AMIA Jt Summits Transl Sci Proc. 2018;2017:197-206.
    Abstract     Related articles   

  673. HARIHARAN N, Ashcraft KA, Svatek RS, Livi CB, et al
    Adipose Tissue-Secreted Factors Alter Bladder Cancer Cell Migration.
    J Obes. 2018;2018:9247864.
    Abstract     Related articles   

  674. GOURD E
    EMA restricts use of anti-PD-1 drugs for bladder cancer.
    Lancet Oncol. 2018 Jun 7. pii: S1470-2045(18)30433.
    Abstract     Related articles   

  675. WANG JF, Zhou XF, Fang DB, Wu ZM, et al
    [The effect of tri-modality therapy on the treatment of muscle-invasive bladder cancer].
    Zhonghua Yi Xue Za Zhi. 2018;98:1614-1616.
    Abstract     Related articles   

  676. BOSSCHIETER J, Hentschel A, Savci-Heijink CD, Patrick van der Voorn J, et al
    Reproducibility and Prognostic Performance of the 1973 and 2004 World Health Organization Classifications for Grade in Non-muscle-invasive Bladder Cancer: A Multicenter Study in 328 Bladder Tumors.
    Clin Genitourin Cancer. 2018 May 11. pii: S1558-7673(18)30196.
    Abstract     Related articles   

  677. JENA R
    Bladder Cancer Virtual Special Issue.
    Clin Oncol (R Coll Radiol). 2018 Jun 5. pii: S0936-6555(18)30276.
    Abstract     Related articles   

  678. VARTOLOMEI MD, Porav-Hodade D, Ferro M, Mathieu R, et al
    Prognostic role of pretreatment neutrophil-to-lymphocyte ratio (NLR) in patients with non-muscle-invasive bladder cancer (NMIBC): A systematic review and meta-analysis.
    Urol Oncol. 2018 Jun 5. pii: S1078-1439(18)30166.
    Abstract     Related articles   

  679. LI Z, Lin C, Zhao L, Zhou L, et al
    Oncogene miR-187-5p is associated with cellular proliferation, migration, invasion, apoptosis and an increased risk of recurrence in bladder cancer.
    Biomed Pharmacother. 2018;105:461-469.
    Abstract     Related articles   

  680. WEN H, Lee S, Zhu WG, Lee OJ, et al
    Glucose-derived acetate and ACSS2 as key players in cisplatin resistance in bladder cancer.
    Biochim Biophys Acta. 2018 Jun 5. pii: S1388-1981(18)30126.
    Abstract     Related articles   

  681. WANG Z, Li H, Chi Q, Qiu Y, et al
    Clinical Significance of Serological and Urological Levels of Bladder Cancer-Specific Antigen-1 (BLCA-1) in Bladder Cancer.
    Med Sci Monit. 2018;24:3882-3887.
    Abstract     Related articles   

  682. FRANSEN VAN DE PUTTE EE, Otto W, Hartmann A, Bertz S, et al
    Metric substage according to micro and extensive lamina propria invasion improves prognostics in T1 bladder cancer.
    Urol Oncol. 2018 Jun 4. pii: S1078-1439(18)30159.
    Abstract     Related articles   

  683. MARINONI F, Destro F, Selvaggio GGO, Riccipetitoni G, et al
    Urothelial carcinoma in children: A case series.
    Bull Cancer. 2018;105:556-561.
    Abstract     Related articles   

  684. HONKISZ SI, Naughton JF, Weng HY, Fourez LM, et al
    Evaluation of two-dimensional ultrasonography and computed tomography in the mapping and measuring of canine urinary bladder tumors.
    Vet J. 2018;232:23-26.
    Abstract     Related articles   

  685. HARTMAN R, Kawashima A
    Lower tract neoplasm: Update of imaging evaluation.
    Eur J Radiol. 2017 Nov 1. pii: S0720-048X(17)30415.
    Abstract     Related articles   

  686. KANEKO S, Li X
    X chromosome protects against bladder cancer in females via a KDM6A-dependent epigenetic mechanism.
    Sci Adv. 2018;4:eaar5598.
    Abstract     Related articles   

  687. FANKHAUSER CD, Mostafid H
    Genetic polymorphisms may explain association between alcohol consumption and bladder cancer risk in East Asian men.
    Transl Androl Urol. 2018;7.
    Abstract     Related articles   

  688. SANGUEDOLCE F, Cormio L
    The complex relationship between upper urinary tract and bladder cancer: clinical and predictive issues.
    Transl Androl Urol. 2018;7.
    Abstract     Related articles   

  689. LIM C, Cohn JR, Cohn JA
    Can a diagnosis of bladder cancer motivate positive lifestyle changes-and prevent recurrent disease?
    Transl Androl Urol. 2018;7.
    Abstract     Related articles   

  690. ZHANG L, Feng C, Zhou Y, Zhou Q, et al
    Dysregulated genes targeted by microRNAs and metabolic pathways in bladder cancer revealed by bioinformatics methods.
    Oncol Lett. 2018;15:9617-9624.
    Abstract     Related articles   

  691. CHEN Z, Zhou L, Liu X, Wang L, et al
    Loss of Fezf2 promotes malignant progression of bladder cancer by regulating the NF-kappaB signaling pathway.
    Lab Invest. 2018 Jun 20. pii: 10.1038/s41374-018-0077.
    Abstract     Related articles   

  692. CLINTON TN, Lotan Y
    The use of blue light flexible cystoscopy with hexaminolevulinate & the diagnosis of bladder cancer.
    Future Oncol. 2018 Jun 21. doi: 10.2217/fon-2018-0328.
    Abstract     Related articles   

  693. FITZPATRICK R, Baverstock R
    Muscle invasive bladder cancer presenting as recurrent autonomic dysreflexia - a wolf in wolf's clothing.
    J Spinal Cord Med. 2018 Jun 20:1-4. doi: 10.1080/10790268.2018.1487188.
    Abstract     Related articles   

  694. HE C, Zhang Q, Gu R, Lou Y, et al
    miR-96 regulates migration and invasion of bladder cancer through epithelial-mesenchymal transition in response to transforming growth factor-beta1.
    J Cell Biochem. 2018 Jun 19. doi: 10.1002/jcb.27172.
    Abstract     Related articles   

  695. LIN MG, Hong YK, Zhang Y, Lin BB, et al
    Mechanism of lncRNA DUXAP8 in promoting proliferation of bladder cancer cells by regulating PTEN.
    Eur Rev Med Pharmacol Sci. 2018;22:3370-3377.
    Abstract     Related articles   

  696. WANG Y, Li LJ, Qiu MX, Gong BS, et al
    Effects of paclitaxel combined with miR-448 on growth and proliferation of bladder cancer EJ cells.
    Eur Rev Med Pharmacol Sci. 2018;22:3363-3369.
    Abstract     Related articles   

  697. LICHTENEGGER E, Koll F, Haas H, Mantwill K, et al
    The oncolytic Adenovirus XVir-N-31 as a novel therapy in muscle-invasive bladder cancer.
    Hum Gene Ther. 2018 Jun 19. doi: 10.1089/hum.2018.
    Abstract     Related articles   

  698. ZHONG J, Switchenko J, Jegadeesh NK, Cassidy RJ, et al
    Comparison of Outcomes in Patients With Muscle-invasive Bladder Cancer Treated With Radical Cystectomy Versus Bladder Preservation.
    Am J Clin Oncol. 2018 Jun 16. doi: 10.1097/COC.0000000000000471.
    Abstract     Related articles   

  699. KOK VC, Zhang HW, Lin CT, Huang SC, et al
    Positive association between hypertension and urinary bladder cancer: epidemiologic evidence involving 79,236 propensity score-matched individuals.
    Ups J Med Sci. 2018 Jun 18:1-7. doi: 10.1080/03009734.2018.1473534.
    Abstract     Related articles   

  700. LIN WY, Wu CT, Chen MF, Chang YH, et al
    Cystectomy for bladder cancer in elderly patients is not associated with increased 30- and 90-day mortality or readmission, length of stay, and cost: propensity score matching using a population database.
    Cancer Manag Res. 2018;10:1413-1418.
    Abstract     Related articles   

  701. GHODOUSSIPOUR S, Daneshmand S
    Current controversies on the role of lymphadenectomy for bladder cancer.
    Urol Oncol. 2018 Jun 14. pii: S1078-1439(18)30157.
    Abstract     Related articles   

  702. LORAS A, Trassierra M, Sanjuan-Herraez D, Martinez-Bisbal MC, et al
    Bladder cancer recurrence surveillance by urine metabolomics analysis.
    Sci Rep. 2018;8:9172.
    Abstract     Related articles   

  703. WOOLBRIGHT BL, Choudhary D, Mikhalyuk A, Trammel C, et al
    The Role of Pyruvate Dehydrogenase Kinase-4 (PDK4) in Bladder Cancer and Chemoresistance.
    Mol Cancer Ther. 2018 Jun 15. pii: 1535-7163.MCT-18-0063.
    Abstract     Related articles   

  704. THIEL T, Ryk C, Renstrom-Koskela L, Steineck G, et al
    Intravesical BCG treatment causes a long-lasting reduction of recurrence and progression in patients with high-risk non-muscle-invasive bladder cancer.
    World J Urol. 2018 Jun 15. pii: 10.1007/s00345-018-2375.
    Abstract     Related articles   

  705. WU P, Zhang G, Zhao J, Chen J, et al
    Profiling the Urinary Microbiota in Male Patients With Bladder Cancer in China.
    Front Cell Infect Microbiol. 2018;8:167.
    Abstract     Related articles   

  706. IEMURA Y, Fukui S, Matsumura Y, Kagebayashi Y, et al
    [Bladder Rupture during Intravesical BCG Therapy : A Case Report].
    Hinyokika Kiyo. 2018;64:25-28.
    Abstract     Related articles   

  707. KULAC I, Arslankoz S, Netto GJ, Ertoy Baydar D, et al
    Reduced immunohistochemical PTEN staining is associated with higher progression rate and recurrence episodes in non-invasive low-grade papillary urothelial carcinoma of the bladder.
    Virchows Arch. 2018;472:969-974.
    Abstract     Related articles   

  708. NORTH D, Jaw J, Hill P, Bateman S, et al
    Nephrogenic Adenoma Complicating Renal Transplantation: A Case Report and Discussion.
    Transplant Proc. 2017;49:2381-2383.
    Abstract     Related articles   

  709. TANAKA H, Yoshida S, Koga F, Toda K, et al
    Impact of Immunohistochemistry-Based Subtypes in Muscle-Invasive Bladder Cancer on Response to Chemoradiotherapy.
    Int J Radiat Oncol Biol Phys. 2018 Jun 27. pii: S0360-3016(18)31021.
    Abstract     Related articles   

  710. APFELTHALER C, Skoll K, Ciola R, Gabor F, et al
    A Doxorubicin loaded colloidal delivery system for the intravesical therapy of non-muscle invasive bladder cancer using wheat germ agglutinin as targeter.
    Eur J Pharm Biopharm. 2018 Jun 27. pii: S0939-6411(18)30082.
    Abstract     Related articles   

  711. BEN WAFI S, Kallel A, Ben Fradj MK, Sallemi A, et al
    Haplotype-based association of Vascular Endothelial Growth Factor gene polymorphisms with urothelial bladder cancer risk in Tunisian population.
    J Clin Lab Anal. 2018 Jun 29:e22610. doi: 10.1002/jcla.22610.
    Abstract     Related articles   

  712. JOHNSON SB, Yu JB
    Bladder Preserving Trimodality Therapy for Muscle-Invasive Bladder Cancer.
    Curr Oncol Rep. 2018;20:66.
    Abstract     Related articles   

  713. RINALDETTI S, Wirtz R, Worst TS, Hartmann A, et al
    FOXM1 predicts disease progression in non-muscle invasive bladder cancer.
    J Cancer Res Clin Oncol. 2018 Jun 29. pii: 10.1007/s00432-018-2694.
    Abstract     Related articles   

  714. DUDEK AM, Vermeulen SH, Kolev D, Grotenhuis AJ, et al
    Identification of an enhancer region within the TP63/LEPREL1 locus containing genetic variants associated with bladder cancer risk.
    Cell Oncol (Dordr). 2018 Jun 28. pii: 10.1007/s13402-018-0393.
    Abstract     Related articles   

  715. WILLIAMS SB, Shan Y, Jazzar U, Mehta HB, et al
    Comparing Survival Outcomes and Costs Associated With Radical Cystectomy and Trimodal Therapy for Older Adults With Muscle-Invasive Bladder Cancer.
    JAMA Surg. 2018 Jun 27. pii: 2685879. doi: 10.1001/jamasurg.2018.1680.
    Abstract     Related articles   

  716. LIN N, Wu YP, Lin YZ, Tao X, et al
    Risk factors for upper tract urothelial recurrence following local excision of bladder cancer.
    Cancer Med. 2018 Jun 28. doi: 10.1002/cam4.1642.
    Abstract     Related articles   


  717. Erdafitinib Efficacious in Bladder Cancer.
    Cancer Discov. 2018 Jun 27. pii: 2159-8290.CD-NB2018.
    Abstract     Related articles   

  718. WANG J, Fang R, Wang L, Chen G, et al
    Identification of Carbonic Anhydrase IX as a Novel Target for Endoscopic Molecular Imaging of Human Bladder Cancer.
    Cell Physiol Biochem. 2018;47:1565-1577.
    Abstract     Related articles   

  719. FLETCHER SA, Harmouch SS, Krimphove MJ, Cole AP, et al
    Characterizing trends in treatment modalities for localized muscle-invasive bladder cancer in the pre-immunotherapy era.
    World J Urol. 2018 Jun 14. pii: 10.1007/s00345-018-2371.
    Abstract     Related articles   

  720. RINGUETTE-GOULET C, Bolduc S, Pouliot F
    Modeling human bladder cancer.
    World J Urol. 2018 Jun 14. pii: 10.1007/s00345-018-2369.
    Abstract     Related articles   

  721. KRABBE LM, Margulis V, Schrader AJ, Shariat SF, et al
    Molecularly-driven precision medicine for advanced bladder cancer.
    World J Urol. 2018 Jun 8. pii: 10.1007/s00345-018-2354.
    Abstract     Related articles   

  722. XIA Y, Yuan M, Li S, Thuan UT, et al
    Apigenin suppresses IL-1beta-induced expression of urokinase-type plasminogen activator receptor by inhibiting MAPK-mediated AP-1 and NF-small ka, CyrillicB signaling in human bladder cancer T24 cells.
    J Agric Food Chem. 2018 Jun 27. doi: 10.1021/acs.jafc.8b02351.
    Abstract     Related articles   

  723. GARCIA-PERDOMO HA, Montes-Cardona CE, Guacheta M, Castillo DF, et al
    Muscle-invasive bladder cancer organ-preserving therapy: systematic review and meta-analysis.
    World J Urol. 2018 Jun 25. pii: 10.1007/s00345-018-2384.
    Abstract     Related articles   

  724. BJURLIN MA
    Management of Recurrent Non-Muscle Invasive Bladder Cancer.
    Rev Urol. 2018;20:38-40.
    Abstract     Related articles   

  725. VELAZQUEZ N
    Bladder Cancer Academy 2018 Selected Summaries.
    Rev Urol. 2018;20:31-37.
    Abstract     Related articles   

  726. LI J, Cheng Y, Liu G, Ji Z, et al
    The association of pretreatment serum albumin with outcomes in bladder cancer: a meta-analysis.
    Onco Targets Ther. 2018;11:3449-3459.
    Abstract     Related articles   

  727. BOURN J, Cekanova M
    Cyclooxygenase inhibitors potentiate receptor tyrosine kinase therapies in bladder cancer cells in vitro.
    Drug Des Devel Ther. 2018;12:1727-1742.
    Abstract     Related articles   

  728. YANG Z, Zhang R, Ge Y, Qin X, et al
    Somatic FGFR3 Mutations Distinguish a Subgroup of Muscle-Invasive Bladder Cancers with Response to Neoadjuvant Chemotherapy.
    EBioMedicine. 2018 Jun 22. pii: S2352-3964(18)30218.
    Abstract     Related articles   

  729. FENG SQ, Zhang XY, Fan HT, Sun QJ, et al
    Up-regulation of LncRNA MEG3 inhibits cell migration and invasion and enhances cisplatin chemosensitivity of bladder cancer cells.
    Neoplasma. 2018 Jun 26. doi: 10.4149/neo_2018_180125.
    Abstract     Related articles   

  730. GUO H, Li F, Xu W, Chen J, et al
    Mucoadhesive Cationic Polypeptide Nanogel with Enhanced Penetration for Efficient Intravesical Chemotherapy of Bladder Cancer.
    Adv Sci (Weinh). 2018;5:1800004.
    Abstract     Related articles   

  731. ZHOU X, Ji H, Zhang H, Xiong T, et al
    Treatment and outcomes of urethral recurrence after orthotopic neobladder replacement in patients with bladder cancer - practice in a single centre.
    J Int Med Res. 2018 Jan 1:300060518782015. doi: 10.1177/0300060518782015.
    Abstract     Related articles   

  732. DAVIDSON MB, Pan D
    Erratum to "An updated meta-analysis of pioglitazone exposure and bladder cancer and comparison to the drug's effect on cardiovascular disease and non-alcoholic steatohepatitis" [Diab. Res. Clin. Pract. 135 (2018) 102-110].
    Diabetes Res Clin Pract. 2018 Jun 20. pii: S0168-8227(18)30968.
    Abstract     Related articles   

  733. ISLAMOGLU E, Anil H, Erol I, Tas S, et al
    Robotic radical cystectomy for the management of bladder cancer: Analysis of operative and pathological outcomes of eighteen patient.
    Turk J Urol. 2018;44:311-315.
    Abstract     Related articles   

  734. MI Y, Zhao Y, Shi F, Zhang M, et al
    Diagnostic accuracy of urine cytokeratin 20 for bladder cancer: A meta-analysis.
    Asia Pac J Clin Oncol. 2018 Jun 22. doi: 10.1111/ajco.13024.
    Abstract     Related articles   

  735. SORIA F, Droller MJ, Lotan Y, Gontero P, et al
    An up-to-date catalog of available urinary biomarkers for the surveillance of non-muscle invasive bladder cancer.
    World J Urol. 2018 Jun 21. pii: 10.1007/s00345-018-2380.
    Abstract     Related articles   

  736. VOSKUILEN CS, Fransen van de Putte EE, Perez-Reggeti JI, van Werkhoven E, et al
    Prostate sparing cystectomy for bladder cancer: A two-center study.
    Eur J Surg Oncol. 2018 Jun 8. pii: S0748-7983(18)31115.
    Abstract     Related articles   

  737. SALTZMAN AF, Cost NG
    Current Treatment of Pediatric Bladder and Prostate Rhabdomyosarcoma.
    Curr Urol Rep. 2018;19:11.
    Abstract     Related articles   

  738. HOU T, Zhou L, Wang L, Kazobinka G, et al
    Leupaxin Promotes Bladder Cancer Proliferation, Metastasis, and Angiogenesis Through the PI3K/AKT Pathway.
    Cell Physiol Biochem. 2018;47:2250-2260.
    Abstract     Related articles   

  739. LI Z, Li Y, Lu Q, Chen J, et al
    Value of repeat radical transurethral resection for selected patients with muscle-invasive bladder cancer.
    ANZ J Surg. 2018 Jul 5. doi: 10.1111/ans.14709.
    Abstract     Related articles   

  740. HAMEED DA, Yassa HA, Agban MN, Hanna RT, et al
    Correction to: Genetic aberrations of the K-ras proto-oncogene in bladder cancer in relation to pesticide exposure.
    Environ Sci Pollut Res Int. 2018 Jul 3. pii: 10.1007/s11356-018-2639.
    Abstract     Related articles   

  741. MUKHERJEE N, Svatek R
    Cancer Immune Therapy: Prognostic Significance and Implications for Therapy of PD-1 in BCG-Relapsing Bladder Cancer.
    Ann Surg Oncol. 2018 Jul 3. pii: 10.1245/s10434-018-6610.
    Abstract     Related articles   

  742. KOJIMA T, Nishiyama H, Ozono S, Hinotsu S, et al
    Clinical evaluation of two consecutive UroVysion fluorescence in situ hybridization tests to detect intravesical recurrence of bladder cancer: a prospective blinded comparative study in Japan.
    Int J Clin Oncol. 2018 Jul 3. pii: 10.1007/s10147-018-1311.
    Abstract     Related articles   

  743. OBARA W, Hara I, Kato Y, Kato R, et al
    Immunotherapy with cancer peptides in combination with intravesical bacillus Calmette-Guerin for patients with non-muscle invasive bladder cancer.
    Cancer Immunol Immunother. 2018 Jul 3. pii: 10.1007/s00262-018-2197.
    Abstract     Related articles   

  744. YAN H, Xie H, Ying Y, Li J, et al
    Pioglitazone use in patients with diabetes and risk of bladder cancer: a systematic review and meta-analysis.
    Cancer Manag Res. 2018;10:1627-1638.
    Abstract     Related articles   

  745. SEVCENCO S, Maj-Hes AB, Hruby S, Ponhold L, et al
    Apparent diffusion coefficient values obtained by unenhanced MRI predicts disease-specific survival in bladder cancer.
    Clin Radiol. 2018 Jun 30. pii: S0009-9260(18)30215.
    Abstract     Related articles   

  746. HURLE R, Buffi N, Lista G, Cardone P, et al
    Long-term outcomes of high grade T1 bladder cancer treated with intravesical Bacille Calmette-Guerin therapy: a single-institutional experience.
    Minerva Urol Nefrol. 2018 Jul 3. pii: S0393-2249.18.03042.
    Abstract     Related articles   

  747. JAMALI E, Barani S, Yousefinejad F, Ariafar A, et al
    KIRs gene content diversity in Iranians with urothelial bladder cancer.
    Mol Biol Rep. 2018 Jul 2. pii: 10.1007/s11033-018-4221.
    Abstract     Related articles   

  748. HANZE J, Kessel F, Di Fazio P, Hofmann R, et al
    Effects of multi and selective targeted tyrosine kinase inhibitors on function and signaling of different bladder cancer cells.
    Biomed Pharmacother. 2018;106:316-325.
    Abstract     Related articles   

  749. LIU Y, Ding M, Liao X, Gao Q, et al
    High expression of enhancer RNA MARC1 or its activation by DHT is associated with the malignant behavior in bladder cancer.
    Exp Cell Res. 2018 Jun 28. pii: S0014-4827(18)30373.
    Abstract     Related articles   

  750. DONG BW, Zhang WB, Qi SM, Yan CY, et al
    Transactivation of PTGS2 by PAX5 signaling potentiates cisplatin resistance in muscle-invasive bladder cancer cells.
    Biochem Biophys Res Commun. 2018 Jun 28. pii: S0006-291X(18)31470.
    Abstract     Related articles   

  751. LEMANSKA-PEREK A, Lis-Kuberka J, Lepczynski A, Dratwa-Chalupnik A, et al
    Potential plasma biomarkers of bladder cancer identified by proteomic analysis: A pilot study.
    Adv Clin Exp Med. 2018 Jul 2. doi: 10.17219/acem/79296.
    Abstract     Related articles   

  752. LEE JY, Yun SJ, Jeong P, Piao XM, et al
    Identification of differentially expressed miRNAs and miRNA-targeted genes in bladder cancer.
    Oncotarget. 2018;9:27656-27666.
    Abstract     Related articles   

  753. WEI W, Wang M, Li Y, Meng Q, et al
    Muscarinic cholinergic signaling and overactive bladder-like symptoms associated with invasive bladder cancer.
    Oncol Lett. 2018;16:775-784.
    Abstract     Related articles   

  754. SHIN SS, Noh DH, Hwang B, Lee JW, et al
    Inhibitory effect of Au@Pt-NSs on proliferation, migration, and invasion of EJ bladder carcinoma cells: involvement of cell cycle regulators, signaling pathways, and transcription factor-mediated MMP-9 expression.
    Int J Nanomedicine. 2018;13:3295-3310.
    Abstract     Related articles   

  755. RAMSEY SA
    A Method for Cross-Species Visualization and Analysis of RNA-Sequence Data.
    Methods Mol Biol. 2018;1702:291-305.
    Abstract     Related articles   

  756. ARYA SK, Estrela P
    Electrochemical ELISA-based platform for bladder cancer protein biomarker detection in urine.
    Biosens Bioelectron. 2018;117:620-627.
    Abstract     Related articles   

  757. TANG Z
    Effects of human enhancer of filamentation 1 (HEF1) gene on the proliferation, invasion and metastasis of bladder cancer cells.
    J BUON. 2018;23:782-786.
    Abstract     Related articles   

  758. ZHONG X, Long Z, Wu S, Xiao M, et al
    LncRNA-SNHG7 regulates proliferation, apoptosis and invasion of bladder cancer cells assurance guidelines.
    J BUON. 2018;23:776-781.
    Abstract     Related articles   

  759. DE JONG JJ, Stoop H, Nieboer D, Boormans JL, et al
    Concordance of PD-L1 expression in matched urothelial bladder cancer specimens.
    Histopathology. 2018 Jul 12. doi: 10.1111/his.13710.
    Abstract     Related articles   

  760. SOUBRA A, Gencturk M, Froelich J, Balaji P, et al
    FDG-PET/CT for Assessing the Response to Neoadjuvant Chemotherapy in Bladder Cancer Patients.
    Clin Genitourin Cancer. 2018 May 31. pii: S1558-7673(18)30344.
    Abstract     Related articles   

  761. LIU X, Liu X, Wu Y, Fang Z, et al
    MicroRNA-34a Attenuates Metastasis and Chemoresistance of Bladder Cancer Cells by Targeting the TCF1/LEF1 Axis.
    Cell Physiol Biochem. 2018;48:87-98.
    Abstract     Related articles   

  762. KARAVANA SY, Senyigit ZA, Caliskan C, Sevin G, et al
    Gemcitabine hydrochloride microspheres used for intravesical treatment of superficial bladder cancer: a comprehensive in vitro/ex vivo/in vivo evaluation.
    Drug Des Devel Ther. 2018;12:1959-1975.
    Abstract     Related articles   

  763. YOSHIMURA H, Okano T, Inui K, Nakamura H, et al
    Ultrasonographic findings in a patient with reactive arthritis induced by intravesical BCG therapy for bladder cancer.
    J Med Ultrason (2001). 2018 Jul 10. pii: 10.1007/s10396-018-0889.
    Abstract     Related articles   

  764. FERRO M, Vartolomei MD, Russo GI, Cantiello F, et al
    An increased body mass index is associated with a worse prognosis in patients administered BCG immunotherapy for T1 bladder cancer.
    World J Urol. 2018 Jul 10. pii: 10.1007/s00345-018-2397.
    Abstract     Related articles   

  765. PETTENATI C, Ingersoll MA
    Mechanisms of BCG immunotherapy and its outlook for bladder cancer.
    Nat Rev Urol. 2018 Jul 10. pii: 10.1038/s41585-018-0055.
    Abstract     Related articles   

  766. MCALPINE K, Fergusson DA, Breau RH, Reynolds LF, et al
    Radiotherapy with radical cystectomy for bladder cancer: A systematic review and meta-analysis.
    Can Urol Assoc J. 2018 May 28. pii: cuaj.5244. doi: 10.5489/cuaj.5244.
    Abstract     Related articles   

  767. DO J, Lee SW, Jeh SU, Hwa JS, et al
    Overnight continuous saline irrigation after transurethral resection for non-muscle-invasive bladder cancer is helpful in prevention of early recurrence.
    Can Urol Assoc J. 2018 Jun 8. pii: cuaj.5122. doi: 10.5489/cuaj.5122.
    Abstract     Related articles   

  768. ZHANG D, Wang Z, Wang L, Wang Z, et al
    High-Performance Identification of Human Bladder Cancer Using Signal Self-Amplifiable Photoacoustic Nanoprobe.
    ACS Appl Mater Interfaces. 2018 Jul 10. doi: 10.1021/acsami.8b08357.
    Abstract     Related articles   

  769. ANNELS NE, Arif M, Simpson GR, Denyer M, et al
    Oncolytic Immunotherapy for Bladder Cancer Using Coxsackie A21 Virus.
    Mol Ther Oncolytics. 2018;9:1-12.
    Abstract     Related articles   

  770. YILMAZ Y, Kahya MC, Dilek FH, Kose O, et al
    Can tumor recurrence be reduced with plasma-kinetic vaporization of the area around the tumor in nonmuscle invasive bladder cancer?
    Investig Clin Urol. 2018;59:223-231.
    Abstract     Related articles   

  771. FALKE J, Parkkinen J, Vaahtera L, Hulsbergen-van de Kaa CA, et al
    Curcumin as Treatment for Bladder Cancer: A Preclinical Study of Cyclodextrin-Curcumin Complex and BCG as Intravesical Treatment in an Orthotopic Bladder Cancer Rat Model.
    Biomed Res Int. 2018;2018:9634902.
    Abstract     Related articles   

  772. PANDEY S, Bourn J, Cekanova M
    Mutations of p53 decrease sensitivity to the anthracycline treatments in bladder cancer cells.
    Oncotarget. 2018;9:28514-28531.
    Abstract     Related articles   

  773. HU B, Yan Y, Tong F, Xu L, et al
    Lumbrokinase/paclitaxel nanoparticle complex: potential therapeutic applications in bladder cancer.
    Int J Nanomedicine. 2018;13:3625-3640.
    Abstract     Related articles   

  774. ZHANG M, Du H, Huang Z, Zhang P, et al
    Thymoquinone induces apoptosis in bladder cancer cell via endoplasmic reticulum stress-dependent mitochondrial pathway.
    Chem Biol Interact. 2018 Jul 2. pii: S0009-2797(18)30167.
    Abstract     Related articles   

  775. PAREKH DJ, Reis IM, Castle EP, Gonzalgo ML, et al
    Robot-assisted radical cystectomy versus open radical cystectomy in patients with bladder cancer (RAZOR): an open-label, randomised, phase 3, non-inferiority trial.
    Lancet. 2018;391:2525-2536.
    Abstract     Related articles   


  776. 9 - Tossicita Da Trattamento Radioterapico E Da Terapia Sistemica Per Neoplasia Vescicale.
    Tumori. 2018;104.
    Abstract     Related articles   


  777. 8 - Pianificazione E Somministrazione Del Trattamento Radioterapico.
    Tumori. 2018;104.
    Abstract     Related articles   


  778. 7 - Terapia Nella Malattia In Progressione E Metastatica.
    Tumori. 2018;104.
    Abstract     Related articles   


  779. 2 - Epidemiologia E Classificazione Istopatologica.
    Tumori. 2018;104.
    Abstract     Related articles   


  780. 11 - Follow-Up.
    Tumori. 2018;104.
    Abstract     Related articles   


  781. Linee Guida AIRO-AIRB 2018: Neoplasie della Vescica.
    Tumori. 2018;104.
    Abstract     Related articles   


  782. 10 - Nuove Tecnologie in Radioterapia E Prospettive Future.
    Tumori. 2018;104.
    Abstract     Related articles   


  783. 6 - Terapia Trimodale Nel Trattamento Conservativo Della Neoplasia Vescicale.
    Tumori. 2018;104.
    Abstract     Related articles   


  784. 5 - Trattamento Chirurgico Della Malattia Muscolo-Invasiva E Localmente Avanzata (MIBC).
    Tumori. 2018;104.
    Abstract     Related articles   


  785. 4 - Trattamento Chirurgico Della Malattia Non Muscolo-Invasiva (NMIBC).
    Tumori. 2018;104.
    Abstract     Related articles   


  786. 3 - Diagnosi E Stadiazione.
    Tumori. 2018;104.
    Abstract     Related articles   

  787. LIU ZH, Shi JY, Wang HY, Ye HY, et al
    [CT texture analysis in bladder carcinoma: histologic grade characterization].
    Zhonghua Zhong Liu Za Zhi. 2018;40:379-383.
    Abstract     Related articles   

  788. NAZZANI S, Preisser F, Mazzone E, Tian Z, et al
    In-hospital length of stay after major surgical oncological procedures.
    Eur J Surg Oncol. 2018;44:969-974.
    Abstract     Related articles   

  789. KANO H, Miwa S, Koshida K, Kawai K, et al
    Successful Treatment of a Large Superficial Bladder Cancer with Neoadjuvant Arterial Infusion Chemotherapy: A Case Report.
    Case Rep Oncol. 2018;11:383-387.
    Abstract     Related articles   

  790. ZHANG XG, Zhang T, Li CY, Zhang MH, et al
    CD164 promotes tumor progression and predicts the poor prognosis of bladder cancer.
    Cancer Med. 2018 Jul 18. doi: 10.1002/cam4.1607.
    Abstract     Related articles   

  791. HAUTMANN R, Bolenz C
    Declining Use of Orthotopic Reconstruction for Bladder Cancer.
    Ann Surg Oncol. 2018 Jul 18. pii: 10.1245/s10434-018-6570.
    Abstract     Related articles   

  792. FAN TW, Malhi H, Varghese B, Cen S, et al
    Computed tomography-based texture analysis of bladder cancer: differentiating urothelial carcinoma from micropapillary carcinoma.
    Abdom Radiol (NY). 2018 Jul 18. pii: 10.1007/s00261-018-1694.
    Abstract     Related articles   

  793. SWALARZ M, Swalarz G, Juszczak K, Maciukiewicz P, et al
    Correlation between malnutrition, body mass index and complications in patients with urinary bladder cancer who underwent radical cystectomy.
    Adv Clin Exp Med. 2018 Jul 18. doi: 10.17219/acem/89863.
    Abstract     Related articles   

  794. KRAFFT U, Reis H, Ingenwerth M, Kovalszky I, et al
    Nuclear Localization of Robo is Associated with Better Survival in Bladder Cancer.
    Pathol Oncol Res. 2018 Jul 17. pii: 10.1007/s12253-018-0447.
    Abstract     Related articles   

  795. SAHEB SHARIF-ASKARI N, Bendardaf R, Saheb Sharif-Askari F, El Tabbal AM, et al
    Incidence of bladder cancer in Benghazi, Libya over the past three decades.
    Sci Rep. 2018;8:10822.
    Abstract     Related articles   

  796. STEINBERG RL, Thomas LJ, O'Donnell MA
    Combination Intravesical Chemotherapy for Non-muscle-invasive Bladder Cancer.
    Eur Urol Focus. 2018 Jul 13. pii: S2405-4569(18)30171.
    Abstract     Related articles   

  797. HIGASHIYAMA A, Komori T, Juri H, Inada Y, et al
    Detectability of residual invasive bladder cancer in delayed (18)F-FDG PET imaging with oral hydration using 500 mL of water and voiding-refilling.
    Ann Nucl Med. 2018 Jul 16. pii: 10.1007/s12149-018-1280.
    Abstract     Related articles   

  798. TREE AC, Jones K, Hafeez S, Sharabiani MTA, et al
    Dose-limiting Urinary Toxicity With Pembrolizumab Combined With Weekly Hypofractionated Radiation Therapy in Bladder Cancer.
    Int J Radiat Oncol Biol Phys. 2018;101:1168-1171.
    Abstract     Related articles   

  799. CHEN M, Wu R, Li G, Liu C, et al
    Motor neuron and pancreas homeobox 1/HLXB9 promotes sustained proliferation in bladder cancer by upregulating CCNE1/2.
    J Exp Clin Cancer Res. 2018;37:154.
    Abstract     Related articles   

  800. HARTANA CA, Ahlen Bergman E, Broome A, Berglund S, et al
    Tissue-resident memory T cells are epigenetically cytotoxic with signs of exhaustion in human urinary bladder cancer.
    Clin Exp Immunol. 2018 Jul 15. doi: 10.1111/cei.13183.
    Abstract     Related articles   

  801. CHU J, Li N, Li F
    A risk score staging system based on the expression of seven genes predicts the outcome of bladder cancer.
    Oncol Lett. 2018;16:2091-2096.
    Abstract     Related articles   

  802. GUO P, Shang W, Peng L, Wang L, et al
    A gel system for single instillation of non-muscle-invasive bladder Cancer: A "divide-and-rule" strategy.
    J Control Release. 2018;285:46-55.
    Abstract     Related articles   

  803. PENG D, Ge G, Gong Y, Zhan Y, et al
    Vitamin C increases 5-hydroxymethylcytosine level and inhibits the growth of bladder cancer.
    Clin Epigenetics. 2018;10:94.
    Abstract     Related articles   

  804. HOSNY K, Luk A
    Urinary schistosomiasis presented as bladder malignancy with pulmonary metastases: a case report.
    Ann R Coll Surg Engl. 2018;100:e145-e146.
    Abstract     Related articles   

  805. SOUSA ESCANDON A, Leon Mata J, Sousa Gonzalez D, Alvarez Casal M, et al
    Neoadjuvant chemohyperthermia: Our experience after 10 years.
    Arch Esp Urol. 2018;71:438-446.
    Abstract     Related articles   

  806. GUERRERO-RAMOS F, Castellano-Gauna D, Garcia-Rojo E, Duarte-Ojeda JM, et al
    [Mitomycin C HIVEC. Update and results in high risk patients.]
    Arch Esp Urol. 2018;71:417-425.
    Abstract     Related articles   

  807. SOLSONA E
    [EMDA with MMC. Critical review.]
    Arch Esp Urol. 2018;71:409-416.
    Abstract     Related articles   

  808. BARCLAY J, Creswell J, Leon J
    Cancer immunotherapy and the PD-1/PD-L1 checkpoint pathway.
    Arch Esp Urol. 2018;71:393-399.
    Abstract     Related articles   

  809. RIOS GONZALEZ E, Martinez-Pineiro L
    [New endovesical chemotherapy drugs and application vehicles.]
    Arch Esp Urol. 2018;71:384-392.
    Abstract     Related articles   

  810. DOMINGUEZ-ESCRIG JL
    [Immediate post TURBT MMC instillation.]
    Arch Esp Urol. 2018;71:376-383.
    Abstract     Related articles   

  811. CARBALLIDO JA, Rodriguez Monsalve M
    [Mechanism of action of intravesical BCG. Biological bases and clinical applicability.]
    Arch Esp Urol. 2018;71:358-375.
    Abstract     Related articles   

  812. SANCHEZ VAZQUEZ A, Pereira Arias JG, Gamarra Quintanilla M, Urdaneta Salegui F, et al
    [BCG therapy in NMIBC: How much and for how long?.]
    Arch Esp Urol. 2018;71:349-357.
    Abstract     Related articles   

  813. ASHTON A, Murthy Kusuma VR, Crew J, Mostafid AH, et al
    BCG therapy in NMIBC: How much and for how long?.
    Arch Esp Urol. 2018;71:342-348.
    Abstract     Related articles   

  814. UNDA-URZAIZ M
    [Future advances in the endovesical treatment of NMIBC.]
    Arch Esp Urol. 2018;71:328-331.
    Abstract     Related articles   

  815. MOEEN AM, Safwat AS, Gadelmoula MM, Moeen SM, et al
    Does the site of the orthotopic neobladder outlet matter? A prospective randomized comparative study.
    Eur J Surg Oncol. 2018;44:847-852.
    Abstract     Related articles   

  816. HUSSMANN D, Hansen LL
    Methylation-Sensitive High Resolution Melting (MS-HRM).
    Methods Mol Biol. 2018;1708:551-571.
    Abstract     Related articles   

  817. GARJE R, Chau JJ, Chung J, Wanat K, et al
    Acute Flare of Bullous Pemphigus With Pembrolizumab Used for Treatment of Metastatic Urothelial Cancer.
    J Immunother. 2018;41:42-44.
    Abstract     Related articles   

  818. BUS SJEA, Leus NG, Oosterveld BJ, Van Gellekom MPR, et al
    An evaluation of our experience in position verification of catheters used for interstitial high-dose-rate brachytherapy of solitary bladder tumors.
    Brachytherapy. 2018;17:24-30.
    Abstract     Related articles   

  819. HU J, Chen JB, Cui Y, Zhu YW, et al
    Association of metformin intake with bladder cancer risk and oncologic outcomes in type 2 diabetes mellitus patients: A systematic review and meta-analysis.
    Medicine (Baltimore). 2018;97:e11596.
    Abstract     Related articles   

  820. POCH MA, Patel S, Garcia-Getting R
    The present and future enhanced recovery after surgery for bladder cancer.
    Int Braz J Urol. 2018;44.
    Abstract     Related articles   

  821. HADAMI K, Dakka N, Bensaid M, El Ahanidi H, et al
    Evaluation of glutathione S-transferase pi 1 expression and gene promoter methylation in Moroccan patients with urothelial bladder cancer.
    Mol Genet Genomic Med. 2018 Jul 24. doi: 10.1002.
    Abstract     Related articles   

  822. CARTA A, Pavanello S, Mastrangelo G, Fedeli U, et al
    Impact of Occupational Exposures and Genetic Polymorphisms on Recurrence and Progression of Non-Muscle-Invasive Bladder Cancer.
    Int J Environ Res Public Health. 2018;15.
    Abstract     Related articles   

  823. LI J, Li Y, Meng F, Fu L, et al
    Knockdown of long non-coding RNA LINC00511 suppresses proliferation and promotes apoptosis of bladder cancer cells via suppressing Wnt/beta-catenin signaling pathway.
    Biosci Rep. 2018 Jul 24. pii: BSR20171701. doi: 10.1042/BSR20171701.
    Abstract     Related articles   

  824. GIULIANELLI R, Gentile BC, Mirabile G, Albanesi L, et al
    Narrow Band Imaging reduces persistence of cancer in patients with pT1 high grade bladder cancer.
    Eur J Surg Oncol. 2018 Jun 18. pii: S0748-7983(18)31125.
    Abstract     Related articles   

  825. RAMAKRISHNAN S, Huss W, Foster B, Ohm J, et al
    Transcriptional changes associated with in vivo growth of muscle-invasive bladder cancer cell lines in nude mice.
    Am J Clin Exp Urol. 2018;6:138-148.
    Abstract     Related articles   

  826. KUTWIN P, Konecki T, Borkowska EM, Traczyk-Borszynska M, et al
    Urine miRNA as a potential biomarker for bladder cancer detection - a meta-analysis.
    Cent European J Urol. 2018;71:177-185.
    Abstract     Related articles   

  827. FANTINI D, Meeks JJ
    The BBN model: a mouse bladder cancer model featuring basal-subtype gene expression and MLL3/MLL4 genetic disruption.
    Oncoscience. 2018;5.
    Abstract     Related articles   

  828. VAN VALENBERG FJP, Strauss-Ayali D, Agmon-Gerstein Y, Friedman A, et al
    Assessment of the efficacy of repeated instillations of mitomycin C mixed with a thermosensitive hydrogel in an orthotopic rat bladder cancer model.
    Ther Adv Urol. 2018;10:213-221.
    Abstract     Related articles   

  829. SHIN SS, Ko MC, Park YJ, Hwang B, et al
    Hydrangenol inhibits the proliferation, migration, and invasion of EJ bladder cancer cells via p21(WAF1)-mediated G1-phase cell cycle arrest, p38 MAPK activation, and reduction in Sp-1-induced MMP-9 expression.
    EXCLI J. 2018;17:531-543.
    Abstract     Related articles   

  830. RABY SEM, Choudhury A
    Radiotherapy for High-grade T1 Bladder Cancer.
    Eur Urol Focus. 2018 Jul 19. pii: S2405-4569(18)30183.
    Abstract     Related articles   

  831. LIEM EIML, Freund JE, Savci-Heijink CD, de la Rosette JJMCH, et al
    Validation of Confocal Laser Endomicroscopy Features of Bladder Cancer: The Next Step Towards Real-time Histologic Grading.
    Eur Urol Focus. 2018 Jul 19. pii: S2405-4569(18)30178.
    Abstract     Related articles   

  832. NI F, Yan CY, Zhou S, Hui PY, et al
    Repression of GRIM19 expression potentiates cisplatin chemoresistance in advanced bladder cancer cells via disrupting ubiquitination-mediated Bcl-xL degradation.
    Cancer Chemother Pharmacol. 2018 Jul 21. pii: 10.1007/s00280-018-3651.
    Abstract     Related articles   

  833. MIERNIK A
    [Nonmuscle invasive bladder cancer : Efficacy of electromotive drug administration].
    Urologe A. 2018 Jul 20. pii: 10.1007/s00120-018-0737.
    Abstract     Related articles   

  834. LAKKIS NA, Adib SM, Hamadeh GN, El-Jarrah RT, et al
    Bladder Cancer in Lebanon: Incidence and Comparison to Regional and Western Countries.
    Cancer Control. 2018;25:1073274818789359.
    Abstract     Related articles   

  835. ZHANG G, Zhang Y, Dong D, Wang F, et al
    MCT1 regulates aggressive and metabolic phenotypes in bladder cancer.
    J Cancer. 2018;9:2492-2501.
    Abstract     Related articles   

  836. LI M, Liu Y, Zhang X, Liu J, et al
    Transcriptomic analysis of high-throughput sequencing about circRNA, lncRNA and mRNA in bladder cancer.
    Gene. 2018 Jul 16. pii: S0378-1119(18)30815-1. doi: 10.1016/j.gene.2018.
    Abstract     Related articles   

  837. THOMAS DE, Kaimakliotis HZ, Rice KR, Pereira JA, et al
    Commentary on "Prognostic effect of carcinoma in situ in muscle-invasive urothelial carcinoma patients receiving neoadjuvant chemotherapy."
    Urol Oncol. 2018;36:345.
    Abstract     Related articles   

  838. SOAVE A, Riethdorf S, Dahlem R, Minner S, et al
    Commentary on "Detection and oncological effect of circulating tumor cells in patients with variant urothelial carcinoma histology treated with radical cystectomy."
    Urol Oncol. 2018;36:347-348.
    Abstract     Related articles   

  839. DASON S, Goh AC
    Updates on Robotic Intracorporeal Urinary Diversions.
    Curr Urol Rep. 2018;19:28.
    Abstract     Related articles   

  840. YI Y, Wu A, Cameron AP
    Nephrogenic adenoma of the bladder: a single institution experience assessing clinical factors.
    Int Braz J Urol. 2018;44:506-511.
    Abstract     Related articles   

  841. KIM SY, Kwon WA, Shin SP, Seo HK, et al
    Electrostatic interaction of tumor-targeting adenoviruses with aminoclay acquires enhanced infectivity to tumor cells inside the bladder and has better cytotoxic activity.
    Drug Deliv. 2018;25:49-58.
    Abstract     Related articles   

  842. RICHARDSON DB, Cardis E, Daniels RD, Gillies M, et al
    Site-specific Solid Cancer Mortality After Exposure to Ionizing Radiation: A Cohort Study of Workers (INWORKS).
    Epidemiology. 2018;29:31-40.
    Abstract     Related articles   

  843. NECCHI A, Lo Vullo S, Raggi D, Perrone F, et al
    Neoadjuvant sorafenib, gemcitabine, and cisplatin administration preceding cystectomy in patients with muscle-invasive urothelial bladder carcinoma: An open-label, single-arm, single-center, phase 2 study.
    Urol Oncol. 2018;36:8.
    Abstract     Related articles   

  844. ZHU YD, Lu MY
    Increased expression of TNFRSF14 indicates good prognosis and inhibits bladder cancer proliferation by promoting apoptosis.
    Mol Med Rep. 2018 Jul 23. doi: 10.3892/mmr.2018.9306.
    Abstract     Related articles   

  845. HUANG Y, Li G, Wang K, Mu Z, et al
    Collagen Type VI Alpha 3 Chain Promotes Epithelial-Mesenchymal Transition in Bladder Cancer Cells via Transforming Growth Factor beta (TGF-beta)/Smad Pathway.
    Med Sci Monit. 2018;24:5346-5354.
    Abstract     Related articles   

  846. GUPTE A, Matcha A, Lauzardo M
    Mycobacterium bovis BCG spinal osteomyelitis in a patient with bladder cancer without a history of BCG instillation.
    BMJ Case Rep. 2018;2018.
    Abstract     Related articles   

  847. BOSSCHIETER J, Nieuwenhuijzen JA, Vis AN, van Ginkel T, et al
    An immediate, single intravesical instillation of mitomycin C is of benefit in patients with non-muscle-invasive bladder cancer irrespective of prognostic risk groups.
    Urol Oncol. 2018 Jul 28. pii: S1078-1439(18)30195.
    Abstract     Related articles   

  848. JAYARAJAH U, Herath KB, Fernando MH, Kuruppu SN, et al
    A clinico-pathological study of non-urothelial bladder cancers in a cohort of patients from a tertiary care urology unit in Sri Lanka
    Ceylon Med J. 2018;63:92-94.
    Abstract     Related articles   

  849. KIDA K, Shimizu Y, Ogawa K, Kanamaru S, et al
    [Distant Metastasis in Patients with Non-Muscle Invasive Bladder Cancer without Local Recurrence : Report of Two Rare Cases].
    Hinyokika Kiyo. 2018;64:271-275.
    Abstract     Related articles   

  850. EL-ARABEY AA
    Correction to: New insight for metformin against bladder cancer.
    Genes Environ. 2018;40:16.
    Abstract     Related articles   

  851. STAKISAITIS D, Jukneviciene M, Ulys A, Zaliuniene D, et al
    ABO blood group polymorphism has an impact on prostate, kidney and bladder cancer in association with longevity.
    Oncol Lett. 2018;16:1321-1331.
    Abstract     Related articles   

  852. BABJUK M, Burger M, Comperat EM, Gontero P, et al
    Indication for a Single Postoperative Instillation of Chemotherapy in Non-muscle-invasive Bladder Cancer: What Factors Should Be Considered?
    Eur Urol Focus. 2018 Jul 27. pii: S2405-4569(18)30189.
    Abstract     Related articles   

  853. KIMURA S, Soria F, D'Andrea D, Foerster B, et al
    Prognostic Value of Serum Cholinesterase in Non-muscle-invasive Bladder Cancer.
    Clin Genitourin Cancer. 2018 Jul 6. pii: S1558-7673(18)30415.
    Abstract     Related articles   

  854. LI Z, Hong S, Liu Z
    LncRNA LINC00641 predicts prognosis and inhibits bladder cancer progression through miR-197-3p/KLF10/PTEN/PI3K/AKT cascade.
    Biochem Biophys Res Commun. 2018 Jul 27. pii: S0006-291X(18)31622.
    Abstract     Related articles   

  855. PATERSON C, Jensen BT, Jensen JB, Nabi G, et al
    Unmet informational and supportive care needs of patients with muscle invasive bladder cancer: A systematic review of the evidence.
    Eur J Oncol Nurs. 2018;35:92-101.
    Abstract     Related articles   

  856. BAYRAM D, Armagan I, Ozgocmen M, Senol N, et al
    Determination of Apoptotic Effect of Juglone on Human Bladder Cancer TCC-SUP and RT-4 Cells: An In Vitro Study.
    J Environ Pathol Toxicol Oncol. 2018;37:173-181.
    Abstract     Related articles   

  857. QIN Z, Wang Y, Tang J, Zhang L, et al
    High LINC01605 expression predicts poor prognosis and promotes tumor progression via upregulation of MMP9 in bladder cancer.
    Biosci Rep. 2018 Jul 27. pii: BSR20180562. doi: 10.1042/BSR20180562.
    Abstract     Related articles   

  858. HUANG Y, Zhou S, He C, Deng J, et al
    Phenformin alone or combined with gefitinib inhibits bladder cancer via AMPK and EGFR pathways.
    Cancer Commun (Lond). 2018;38:50.
    Abstract     Related articles   

  859. LIN YC, Chen WJ, Huang CY, Shiue HS, et al
    Corrigendum to "Polymorphisms of Arsenic (+3 Oxidation State) Methyltransferase and Arsenic Methylation Capacity Affect the Risk of Bladder Cancer".
    Toxicol Sci. 2018;164:644.
    Abstract     Related articles   

  860. SHERIF A
    The long perspective in emergence of neoadjuvant chemotherapy for bladder cancer in Ontario, Canada-space for improvement with regular and organized multidisciplinary team meetings.
    Transl Androl Urol. 2018;7:508-510.
    Abstract     Related articles   

  861. KOSHKIN VS, Grivas P
    Perioperative chemotherapy for muscle-invasive bladder cancer: the importance of multidisciplinary management for evidence-based practice and transformative research.
    Transl Androl Urol. 2018;7:504-507.
    Abstract     Related articles   

  862. BAYRAMOV B, Gunes S, Buyukalpelli R, Aydin O, et al
    Promoter methylation analysis of CDH1 and p14ARF genes in patients with urothelial bladder cancer.
    Onco Targets Ther. 2018;11:4189-4196.
    Abstract     Related articles   

  863. DARRIET F, Bernioles P, Loukil A, Saidani N, et al
    Fluorescence in situ hybridization microscopic detection of Bacilli Calmette Guerin mycobacteria in aortic lesions: A case report.
    Medicine (Baltimore). 2018;97:e11321.
    Abstract     Related articles   

  864. STIGLIANO A, Lardo P, Cerquetti L, Aschelter AM, et al
    Treatment responses to antiangiogenetic therapy and chemotherapy in nonsecreting paraganglioma (PGL4) of urinary bladder with SDHB mutation: A case report.
    Medicine (Baltimore). 2018;97:e10904.
    Abstract     Related articles   

  865. NIU Q, Lu Y, Wu Y, Xu S, et al
    The effect of marital status on the survival of patients with bladder urothelial carcinoma: A SEER database analysis.
    Medicine (Baltimore). 2018;97:e11378.
    Abstract     Related articles   

  866. YU C, Stefanson O, Liu Y, Wang ZA, et al
    Novel Method of Plasmid DNA Delivery to Mouse Bladder Urothelium by Electroporation.
    J Vis Exp. 2018;.
    Abstract     Related articles   

  867. BOLAT D, Gunlusoy B, Aydogdu O, Aydin ME, et al
    Comparing the short - term outcomes and complications of monopolar and bipolar transurethral resection of bladder tumors in patients with coronary artery disese: a prospective, randomized, controlled study.
    Int Braz J Urol. 2018;44:717-725.
    Abstract     Related articles   

  868. GARRIDO-ABAD P, Rodriguez-Cabello MA, Gonzalez-Gordaliza C, Vera-Beron R, et al
    BCG instillations can mimic prostate cancer on multiparametric MRI.
    Int Braz J Urol. 2018;44:835-837.
    Abstract     Related articles   

  869. SAADEH YS, Hollon TC, Fisher-Hubbard A, Savastano LE, et al
    Primary diffuse leptomeningeal melanomatosis: Description and recommendations.
    J Clin Neurosci. 2018;50:139-143.
    Abstract     Related articles   

  870. ZATTONI F, Morlacco A, Zattoni F
    Preoperative chronic kidney disease before radical cystectomy as predictor of oncological outcomes: a pick of the iceberg?
    World J Urol. 2018;36:993.
    Abstract     Related articles   

  871. SALTSMAN JA, Malek MM, Reuter VE, Hammond WJ, et al
    Urothelial neoplasms in pediatric and young adult patients: A large single-center series.
    J Pediatr Surg. 2018;53:306-309.
    Abstract     Related articles   

  872. PATRIARCA C, Hurle R, Colombo P, Colecchia M, et al
    In reply to: Lawless et al. Stalk versus base invasion in pT1 papillary cancers of the bladder: improved substaging system predicting the risk of progression.
    Histopathology. 2018;72:361-362.
    Abstract     Related articles   

  873. ROBERTSON AG, Kim J, Al-Ahmadie H, Bellmunt J, et al
    Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer.
    Cell. 2018;174:1033.
    Abstract     Related articles   

  874. WANG XS, Zhao MQ, Zhang L, Kong DJ, et al
    Cell-free DNA in blood and urine as a diagnostic tool for bladder cancer: a meta-analysis.
    Am J Transl Res. 2018;10:1935-1948.
    Abstract     Related articles   

  875. GUPTA A, Gupta A, Gupta S, Chauhan U, et al
    Are incidentally detected gall bladder cancers really incidental? A report of two cases from a developing nation.
    Trop Doct. 2018 Aug 8:49475518788486. doi: 10.1177/0049475518788486.
    Abstract     Related articles   

  876. SUGIURA S, Noto N, Koizumi M, Takamoto D, et al
    [Post-Operative Immediate Single Instillation of Chemotherapy as Prevention of Recurrence after Transurethral Resection of Intermediate-High Risk Non-Muscle-Invasive Bladder Cancer].
    Hinyokika Kiyo. 2018;64:297-301.
    Abstract     Related articles   

  877. ZHANG Q, Chen Z
    Sensitization of cisplatin resistant bladder tumor by combination of cisplatin treatment and co-culture of dendritic cells with apoptotic bladder cancer cells.
    Cell Mol Biol (Noisy-le-grand). 2018;64:102-107.
    Abstract     Related articles   

  878. GHATALIA P, Zibelman M, Geynisman DM, Plimack E, et al
    Approved checkpoint inhibitors in bladder cancer: which drug should be used when?
    Ther Adv Med Oncol. 2018;10:1758835918788310.
    Abstract     Related articles   

  879. XIE WZ, Jin YH, Leng WD, Wang XH, et al
    Periodontal Disease and Risk of Bladder Cancer: A Meta-Analysis of 298476 Participants.
    Front Physiol. 2018;9:979.
    Abstract     Related articles   

  880. PENG L, Shang W, Guo P, He K, et al
    Phage Display-Derived Peptide-based Dual-Modality Imaging Probe for Bladder Cancer Diagnosis and Resection Post-Instillation: A Preclinical Study.
    Mol Cancer Ther. 2018 Aug 6. pii: 1535-7163.MCT-18-0212.
    Abstract     Related articles   

  881. SAEMUNDSSON Y, Simoulis A, Liedberg F
    Sanctuary Testicular Bladder Cancer Metastasis 10 Years After Radical Cystectomy and Adjuvant Chemotherapy.
    Clin Genitourin Cancer. 2018 Jul 17. pii: S1558-7673(18)30449.
    Abstract     Related articles   

  882. CREIGHTON CJ
    The clinical applications of the cancer genome atlas project for bladder cancer.
    Expert Rev Anticancer Ther. 2018 Aug 6. doi: 10.1080/14737140.2018.1508999.
    Abstract     Related articles   

  883. ABBAOUI B, Lucas CR, Riedl KM, Clinton SK, et al
    Cruciferous Vegetables, Isothiocyanates and Bladder Cancer Prevention.
    Mol Nutr Food Res. 2018 Aug 5:e1800079. doi: 10.1002/mnfr.201800079.
    Abstract     Related articles   

  884. ARAI S, Hara T, Matsui Y, Koido K, et al
    Tolerability and Efficacy of Neoadjuvant Chemotherapy with a Tri-Weekly Interval Methotrexate, Doxorubicin, Vinblastine, and Cisplatin Regimen for Patients with Locally Advanced Bladder Cancer.
    Case Rep Oncol. 2018;11:450-460.
    Abstract     Related articles   

  885. WU S, Zheng J, Li Y, Wu Z, et al
    Development and Validation of an MRI-Based Radiomics Signature for the Preoperative Prediction of Lymph Node Metastasis in Bladder Cancer.
    EBioMedicine. 2018 Aug 2. pii: S2352-3964(18)30272.
    Abstract     Related articles   

  886. VARTOLOMEI MD, Ferro M, Cantiello F, Lucarelli G, et al
    Validation of Neutrophil-to-lymphocyte Ratio in a Multi-institutional Cohort of Patients With T1G3 Non-muscle-invasive Bladder Cancer.
    Clin Genitourin Cancer. 2018 Jul 6. pii: S1558-7673(18)30183.
    Abstract     Related articles   

  887. YU C, Longfei L, Long W, Feng Z, et al
    LncRNA PVT1 regulates VEGFC through inhibiting miR-128 in bladder cancer cells.
    J Cell Physiol. 2018 Aug 4. doi: 10.1002/jcp.26929.
    Abstract     Related articles   

  888. AHLEN BERGMAN E, Hartana CA, Johansson M, Linton LB, et al
    Increased CD4(+) T cell lineage commitment determined by CpG methylation correlates with better prognosis in urinary bladder cancer patients.
    Clin Epigenetics. 2018;10:102.
    Abstract     Related articles   

  889. LI Z, Zhou L, Lin C, Pan X, et al
    MiR-302b regulates cell functions and acts as a potential biomarker to predict recurrence in bladder cancer.
    Life Sci. 2018 Jul 31. pii: S0024-3205(18)30443.
    Abstract     Related articles   

  890. BELLMUNT J
    Stem-Like Signature Predicting Disease Progression in Early Stage Bladder Cancer. The Role of E2F3 and SOX4.
    Biomedicines. 2018;6.
    Abstract     Related articles   

  891. CHEN D, Li SG, Chen JY, Xiao M, et al
    MiR-183 maintains canonical Wnt signaling activity and regulates growth and apoptosis in bladder cancer via targeting AXIN2.
    Eur Rev Med Pharmacol Sci. 2018;22:4828-4836.
    Abstract     Related articles   

  892. ALANEE S, Alvarado-Cabrero I, Murugan P, Kumar R, et al
    Update of the International Consultation on Urological Diseases on bladder cancer 2018: non-urothelial cancers of the urinary bladder.
    World J Urol. 2018 Aug 1. pii: 10.1007/s00345-018-2421.
    Abstract     Related articles   

  893. SZYMANSKA B, Matuszewski M, Dembowski J, Zdrojowy R, et al
    Uroplakin IIIa Is a Marker in Bladder Cancer but Seems Not to Reflect Chemical Carcinogenesis.
    Biomed Res Int. 2018;2018:8315410.
    Abstract     Related articles   

  894. SALMINEN A, Jambor I, Merisaari H, Ettala O, et al
    (11)C-acetate PET/MRI in bladder cancer staging and treatment response evaluation to neoadjuvant chemotherapy: a prospective multicenter study (ACEBIB trial).
    Cancer Imaging. 2018;18:25.
    Abstract     Related articles   

  895. LIN HN, Gu XY, Zhang SW, Zeng HM, et al
    [Analysis on incidence and mean age at diagnosis for Global Cancer].
    Zhonghua Zhong Liu Za Zhi. 2018;40:543-549.
    Abstract     Related articles   

  896. JALON-MONZON A, Gonzalez-Ruiz de Leon C, Alvarez-Mugica M, Mendez-Ramirez S, et al
    [Usefulness of cold ureteral biopsy during radical cystectomy as a predictor of recurrence risk: Review of our series.]
    Arch Esp Urol. 2018;71:486-494.
    Abstract     Related articles   

  897. SKOWRON MA, Melnikova M, van Roermund JGH, Romano A, et al
    Multifaceted Mechanisms of Cisplatin Resistance in Long-Term Treated Urothelial Carcinoma Cell Lines.
    Int J Mol Sci. 2018;19.
    Abstract     Related articles   

  898. HAMILOU Z, Lavaud P, Loriot Y
    Atezolizumab in urothelial bladder carcinoma.
    Future Oncol. 2018;14:331-341.
    Abstract     Related articles   

  899. WALTERS L, Martin O, Price J, Sula MM, et al
    Expression of receptor tyrosine kinase targets PDGFR-beta, VEGFR2 and KIT in canine transitional cell carcinoma.
    Vet Comp Oncol. 2018;16:E117-E122.
    Abstract     Related articles   

  900. ZHOU Q, Ding W, Weng Y, Ding G, et al
    NOS3 895G>T and CBR3 730G>A Are Associated with Recurrence Risk in Non-Muscle-Invasive Bladder Cancer with Intravesical Instillations of THP.
    Chemotherapy. 2018;63:191-197.
    Abstract     Related articles   

  901. SARGOS P, Baumann BC, Eapen L, Christodouleas J, et al
    Risk factors for loco-regional recurrence after radical cystectomy of muscle-invasive bladder cancer: A systematic-review and framework for adjuvant radiotherapy.
    Cancer Treat Rev. 2018;70:88-97.
    Abstract     Related articles   

  902. STONE BV, Ayangbesan A, Taylor BL, Golombos DM, et al
    Urinary pH and the risk of recurrence in patients with non-muscle invasive bladder cancer.
    Can J Urol. 2018;25:9407-9412.
    Abstract     Related articles   

  903. DING M, Zhan H, Liao X, Li A, et al
    Enhancer RNA - P2RY2e induced by estrogen promotes malignant behaviors of bladder cancer.
    Int J Biol Sci. 2018;14:1268-1276.
    Abstract     Related articles   

  904. YE Z, Chen J, Hong Y, Xin W, et al
    The efficacy and safety of intravesical gemcitabine vs Bacille Calmette-Guerin for adjuvant treatment of non-muscle invasive bladder cancer: a meta-analysis.
    Onco Targets Ther. 2018;11:4641-4649.
    Abstract     Related articles   

  905. WANG HR, Zhang WY, Liu XH, Hu H, et al
    [Clinical application of partial cystectomy with augmentation cystoplasty for invasive bladder cancer in elderly patients].
    Beijing Da Xue Xue Bao Yi Xue Ban. 2018;50:626-629.
    Abstract     Related articles   

  906. ZHOU JH, Wang D, Wang HR, Hou XL, et al
    [Cytotoxic effects of gammadeltaT cells on bladder cancer cells and expression of MICA/B in bladder cancer].
    Beijing Da Xue Xue Bao Yi Xue Ban. 2018;50:595-601.
    Abstract     Related articles   

  907. CHAKRAVARTHI BVSK, Rodriguez Pena MDC, Agarwal S, Chandrashekar DS, et al
    A Role for De Novo Purine Metabolic Enzyme PAICS in Bladder Cancer Progression.
    Neoplasia. 2018;20:894-904.
    Abstract     Related articles   

  908. POLAT F, Yilmaz M, Budak Diler S
    The Association of MYNN and TERC Gene Polymorphisms and Bladder Cancer in a Turkish Population.
    Urol J. 2018 Aug 14. pii: 4083/1263.
    Abstract     Related articles   

  909. DALKILIC A, Bayar G, Kilinc MF
    A Comparison of EORTC And CUETO Risk Tables in Terms of the Prediction of Recurrence and Progression in All Non-Muscle-Invasive Bladder Cancer Patients.
    Urol J. 2018 Aug 14. pii: 4091/1262.
    Abstract     Related articles   

  910. CROZIER J, Papa N, Perera M, Ngo B, et al
    Comparative sensitivity and specificity of imaging modalities in staging bladder cancer prior to radical cystectomy: a systematic review and meta-analysis.
    World J Urol. 2018 Aug 17. pii: 10.1007/s00345-018-2439.
    Abstract     Related articles   

  911. JALLAD S, Thomas P, Newport MJ, Kern F, et al
    Baseline cytokine profiles of tuberculin-specific CD4+ T-cells in non-muscle invasive bladder cancer may predict outcomes of BCG immunotherapy.
    Cancer Immunol Res. 2018 Aug 17. pii: 2326-6066.CIR-18-0046.
    Abstract     Related articles   

  912. YANG Y, Zhang LJ, Bai XG, Xu HJ, et al
    Synergistic antitumour effects of triptolide plus gemcitabine in bladder cancer.
    Biomed Pharmacother. 2018;106:1307-1316.
    Abstract     Related articles   

  913. HUA X, Xu J, Deng X, Xu J, et al
    New Compound ChlA-F Induces Autophagy-dependent Anti-cancer Effect via Upregulating Sestrin-2 in Human Bladder Cancer.
    Cancer Lett. 2018 Aug 14. pii: S0304-3835(18)30525.
    Abstract     Related articles   

  914. PEARCE S, Daneshmand S
    Enhanced Endoscopy in Bladder Cancer.
    Curr Urol Rep. 2018;19:84.
    Abstract     Related articles   

  915. WANG L, Zhao J, Yang C, Kuang R, et al
    Prognostic Implication of Urothelial Stem Cell Markers Differs According to Primary Tumour Location in Non-Muscle-Invasive Bladder Cancer.
    Cell Physiol Biochem. 2018;48:2364-2373.
    Abstract     Related articles   

  916. MESSING EM
    Financial Toxicity of Having Bladder Cancer.
    Bladder Cancer. 2018;4:351-352.
    Abstract     Related articles   

  917. BLACK PC, Goebell PJ, Kamat AM, Nawroth R, et al
    New Horizons in Bladder Cancer Research: Report of the 15th Meeting of the International Bladder Cancer Network (IBCN) in Lisbon, Portugal, October 21-23, 2017.
    Bladder Cancer. 2018;4:339-342.
    Abstract     Related articles   

  918. JAKOBSSON L, Chebil G, Marzouka NA, Liedberg F, et al
    Low Frequency of Intratumor Heterogeneity in Bladder Cancer Tissue Microarrays.
    Bladder Cancer. 2018;4:327-337.
    Abstract     Related articles   

  919. VARTOLOMEI L, Ferro M, Mirone V, Shariat SF, et al
    Systematic Review: Depression and Anxiety Prevalence in Bladder Cancer Patients.
    Bladder Cancer. 2018;4:319-326.
    Abstract     Related articles   

  920. JOCHEMS SHJ, van Osch FHM, Reulen RC, van Hensbergen M, et al
    Total Fluid Intake and the Risk of Recurrence in Patients With Non-Muscle Invasive Bladder Cancer: A Prospective Cohort Study.
    Bladder Cancer. 2018;4:303-310.
    Abstract     Related articles   

  921. KARSH L, Shore N, Soloway M, Bhat G, et al
    Double-Blind, Randomized, Placebo-controlled Studies Evaluating Apaziquone (E09, Qapzola) Intravesical Instillation Post Transurethral Resection of Bladder Tumors for the Treatment of Low-risk Non-Muscle Invasive Bladder Cancer.
    Bladder Cancer. 2018;4:293-301.
    Abstract     Related articles   

  922. GOODSPEED A, Jean A, Theodorescu D, Costello JC, et al
    A Gene Expression Signature Predicts Bladder Cancer Cell Line Sensitivity to EGFR Inhibition.
    Bladder Cancer. 2018;4:269-282.
    Abstract     Related articles   

  923. VLACHOSTERGIOS PJ, Jakubowski CD, Niaz MJ, Lee A, et al
    Antibody-Drug Conjugates in Bladder Cancer.
    Bladder Cancer. 2018;4:247-259.
    Abstract     Related articles   

  924. TSAI CH, Chen YT, Chang YH, Hsueh C, et al
    Systematic verification of bladder cancer-associated tissue protein biomarker candidates in clinical urine specimens.
    Oncotarget. 2018;9:30731-30747.
    Abstract     Related articles   

  925. MONTEIRO LL, Witjes JA, Agarwal PK, Anderson CB, et al
    ICUD-SIU International Consultation on Bladder Cancer 2017: management of non-muscle invasive bladder cancer.
    World J Urol. 2018 Aug 14. pii: 10.1007/s00345-018-2438.
    Abstract     Related articles   

  926. MATULAY JT, Kamat AM
    Advances in risk stratification of bladder cancer to guide personalized medicine.
    F1000Res. 2018;7.
    Abstract     Related articles   

  927. BUCEVIC POPOVIC V, Situm M, Chow CT, Chan LS, et al
    The urinary microbiome associated with bladder cancer.
    Sci Rep. 2018;8:12157.
    Abstract     Related articles   

  928. LI H, Chen W, Ma J, Zang R, et al
    Involved-field irradiation for elderly bladder cancer patients.
    Curr Probl Cancer. 2018 Aug 4. pii: S0147-0272(18)30188.
    Abstract     Related articles   

  929. HURST C, Rosenberg J, Knowles M
    SnapShot: Bladder Cancer.
    Cancer Cell. 2018;34:350-350.
    Abstract     Related articles   

  930. ZHAO Q, Gao S, Du Q, Liu Y, et al
    Long non-coding RNA SNHG20 promotes bladder cancer via activating the Wnt/beta-catenin signalling pathway.
    Int J Mol Med. 2018 Aug 10. doi: 10.3892/ijmm.2018.3819.
    Abstract     Related articles   

  931. FERNANDEZ MI, Brausi M, Clark PE, Cookson MS, et al
    Epidemiology, prevention, screening, diagnosis, and evaluation: update of the ICUD-SIU joint consultation on bladder cancer.
    World J Urol. 2018 Aug 13. pii: 10.1007/s00345-018-2436.
    Abstract     Related articles   

  932. SHAIKHET L, Bunimovich-Mendrazitsky S
    Stability Analysis of Delayed Immune Response BCG Infection in Bladder Cancer Treatment Model by Stochastic Perturbations.
    Comput Math Methods Med. 2018;2018:9653873.
    Abstract     Related articles   

  933. XUE Y, Yang L, Li J, Yan Y, et al
    Combination chemotherapy with Zyflamend reduced the acquired resistance of bladder cancer cells to cisplatin through inhibiting NFkappaB signaling pathway.
    Onco Targets Ther. 2018;11:4413-4429.
    Abstract     Related articles   

  934. PERERA M, McGrath S, Sengupta S, Crozier J, et al
    Pelvic lymph node dissection during radical cystectomy for muscle-invasive bladder cancer.
    Nat Rev Urol. 2018 Aug 13. pii: 10.1038/s41585-018-0066.
    Abstract     Related articles   

  935. LI X, Tian Z, Jin H, Xu J, et al
    Decreased c-Myc mRNA Stability via miR-141-3p/AUF1 Axis Is Crucial for p63alpha Inhibition of Cyclin D1 Transcription and Bladder Cancer Cell Tumorigenicity.
    Mol Cell Biol. 2018 Aug 13. pii: MCB.00273-18. doi: 10.1128/MCB.00273.
    Abstract     Related articles   

  936. MIYATA Y, Matsuo T, Araki K, Nakamura Y, et al
    Anticancer Effects of Green Tea and the Underlying Molecular Mechanisms in Bladder Cancer.
    Medicines (Basel). 2018;5.
    Abstract     Related articles   

  937. BRAVI F, Spei ME, Polesel J, Di Maso M, et al
    Mediterranean Diet and Bladder Cancer Risk in Italy.
    Nutrients. 2018;10.
    Abstract     Related articles   

  938. BI J, Liu H, Cai Z, Dong W, et al
    Circ-BPTF promotes bladder cancer progression and recurrence through the miR-31-5p/RAB27A axis.
    Aging (Albany NY). 2018 Aug 9. pii: 101520. doi: 10.18632/aging.101520.
    Abstract     Related articles   

  939. MOUW KW
    Towards biomarker-informed trimodality therapy (TMT) approaches for muscle-invasive bladder cancer.
    Int J Radiat Oncol Biol Phys. 2018 Aug 10. pii: S0360-3016(18)33521.
    Abstract     Related articles   

  940. LI J, Qiu M, An Y, Huang J, et al
    miR-7-5p acts as a tumor suppressor in bladder cancer by regulating the hedgehog pathway factor Gli3.
    Biochem Biophys Res Commun. 2018 Aug 9. pii: S0006-291X(18)31670.
    Abstract     Related articles   

  941. GILFRICH C, Maurer O, Spachmann PJ, Dombrowski MK, et al
    Wake-up call for more doctor-patient communication and an increase in public information campaigns on the risk factor of smoking with regard to the development and prognosis of bladder cancer.
    World J Urol. 2018 Aug 11. pii: 10.1007/s00345-018-2435.
    Abstract     Related articles   

  942. ALAMEDDINE M, Kineish O, Ritch C
    Predicting Response to Intravesical Therapy in Non-muscle-invasive Bladder Cancer.
    Eur Urol Focus. 2018 Aug 8. pii: S2405-4569(18)30216.
    Abstract     Related articles   

  943. HUANG W, Lu Y, Wang F, Huang X, et al
    Downregulation of circular RNA hsa_circ_0000144 inhibits bladder cancer progression via stimulating miR-217 and suppressing RUNX2 expression.
    Gene. 2018 Aug 8. pii: S0378-1119(18)30897-7. doi: 10.1016/j.gene.2018.
    Abstract     Related articles   

  944. MOHAMMED B, Paul OJ, Mustapha A, Soufiane M, et al
    [Bladder exstrophy with adenocarcinoma in an adult patient: a case report].
    Pan Afr Med J. 2018;29:197.
    Abstract     Related articles   

  945. ZHOU R, Zang G, Yu Q, Pang K, et al
    Transurethral fluorescence cystoscopy guidance for total resection of bladder tumor.
    J Biol Regul Homeost Agents. 2018;32:669-672.
    Abstract     Related articles   

  946. MACRI F, Di Pietro S, Mangano C, Pugliese M, et al
    Quantitative evaluation of canine urinary bladder transitional cell carcinoma using contrast-enhanced ultrasonography.
    BMC Vet Res. 2018;14:84.
    Abstract     Related articles   

  947. INOUE S, Ide H, Fujita K, Mizushima T, et al
    Expression of Phospho-ELK1 and Its Prognostic Significance in Urothelial Carcinoma of the Upper Urinary Tract.
    Int J Mol Sci. 2018;19.
    Abstract     Related articles   

  948. KATSILA T, Liontos M, Patrinos GP, Bamias A, et al
    The New Age of -omics in Urothelial Cancer - Re-wording Its Diagnosis and Treatment.
    EBioMedicine. 2018;28:43-50.
    Abstract     Related articles   

  949. LI Z, Wang KE, Zhou XL, Zhou J, et al
    Long Non-Coding RNA Cancer Susceptibility Candidate 2a (CASC2a) Is a Marker of Early Recurrence After Radical Cystectomy in Patients with Urothelial Carcinoma of the Bladder.
    Med Sci Monit. 2018;24:438-447.
    Abstract     Related articles   

  950. WEI X, Lu J, Siddiqui KM, Li F, et al
    Does previous abdominal surgery adversely affect perioperative and oncologic outcomes of laparoscopic radical cystectomy?
    World J Surg Oncol. 2018;16:10.
    Abstract     Related articles   

  951. LI YP, Zhu JF, Huang KT, Wang RR, et al
    Reduction of Tat-interacting Protein 30 Expression Could be a Prognostic Marker in Bladder Urothelial Cancer.
    Chin Med J (Engl). 2018;131:188-193.
    Abstract     Related articles   

  952. WANG X, Liu Y, Liu W, Zhang Y, et al
    Ubenimex, an APN inhibitor, could serve as an antitumor drug in RT112 and 5637 cells by operating in an Aktassociated manner.
    Mol Med Rep. 2018;17:4531-4539.
    Abstract     Related articles   

  953. WIECZOREK E, Reszka E
    mRNA, microRNA and lncRNA as novel bladder tumor markers.
    Clin Chim Acta. 2018;477:141-153.
    Abstract     Related articles   

  954. SOUKUP V, Capoun O, Pesl M, Sobotka R, et al
    Placental Growth Factor in Bladder Cancer Compared to the Diagnostic Accuracy and Prognostic Performance of Vascular Endothelial Growth Factor A.
    Anticancer Res. 2018;38:239-246.
    Abstract     Related articles   

  955. HEERS H, Gut JM, Hegele A, Hofmann R, et al
    Non-invasive Detection of Bladder Tumors Through Volatile Organic Compounds: A Pilot Study with an Electronic Nose.
    Anticancer Res. 2018;38:833-837.
    Abstract     Related articles   

  956. MIYATA Y, Matsuo T, Nakamura Y, Yasuda T, et al
    Expression of Class III Beta-tubulin Predicts Prognosis in Patients with Cisplatin-resistant Bladder Cancer Receiving Paclitaxel-based Second-line Chemotherapy.
    Anticancer Res. 2018;38:1629-1635.
    Abstract     Related articles   

  957. MICHALSKA M, Schultze-Seemann S, Kuckuck I, Katzenwadel A, et al
    Impact of Methadone on Cisplatin Treatment of Bladder Cancer Cells.
    Anticancer Res. 2018;38:1369-1375.
    Abstract     Related articles   

  958. KIM S, Lee AJ, Yeo MK, Na YG, et al
    Clinicopathological Profiling of LC3B, an Autophagy Marker, and ESRRA (Estrogen-related Receptor-alpha) in Muscle-invasive Bladder Cancer.
    Anticancer Res. 2018;38:2429-2437.
    Abstract     Related articles   

  959. MATSUNAGA W, Ichikawa M, Nakamura A, Ishikawa T, et al
    Lentiviral Vector-mediated Gene Transfer in Human Bladder Cancer Cell Lines.
    Anticancer Res. 2018;38:2015-2020.
    Abstract     Related articles   

  960. MAKINO T, Izumi K, Natsagdorj A, Iwamoto H, et al
    Significance of Perioperative Chemotherapy in Squamous Cell Carcinoma of the Upper and Lower Urinary Tract.
    Anticancer Res. 2018;38:2241-2245.
    Abstract     Related articles   

  961. REXIN P, Tauchert A, Hanze J, Heers H, et al
    The Immune Checkpoint Molecule CD200 Is Associated with Tumor Grading and Metastasis in Bladder Cancer.
    Anticancer Res. 2018;38:2749-2754.
    Abstract     Related articles   

  962. OWARI T, Miyake M, Nakai Y, Morizawa Y, et al
    A Genitourinary Cancer-specific Scoring System for the Prediction of Survival in Patients with Bone Metastasis: A Retrospective Analysis of Prostate Cancer, Renal Cell Carcinoma, and Urothelial Carcinoma.
    Anticancer Res. 2018;38:3097-3103.
    Abstract     Related articles   

  963. MOURMOURAS N, Philippou A, Christopoulos P, Kostoglou K, et al
    Differential Expression of IGF-I Transcripts in Bladder Cancer.
    Anticancer Res. 2018;38:3453-3459.
    Abstract     Related articles   

  964. POSFAI B, Kuthi L, Varga L, Laczo I, et al
    The Colorful Palette of Neuroendocrine Neoplasms in the Genitourinary Tract.
    Anticancer Res. 2018;38:3243-3254.
    Abstract     Related articles   

  965. NAKAMURA R, Kakuhara H, Kikuchi K, Segawa T, et al
    Partial Bladder Boost Using Lipiodol Marking During Image-guided Radiotherapy for Bladder Cancer.
    Anticancer Res. 2018;38:4827-4831.
    Abstract     Related articles   

  966. TSAI KW, Kuo WT, Jeng SY
    Tight Junction Protein 1 Dysfunction Contributes to Cell Motility in Bladder Cancer.
    Anticancer Res. 2018;38:4607-4615.
    Abstract     Related articles   

  967. GOUSSIA AC, Papoudou-Bai A, Charchanti A, Kitsoulis P, et al
    Alterations of p53 and Rb Pathways Are Associated with High Proliferation in Bladder Urothelial Carcinomas.
    Anticancer Res. 2018;38:3985-3988.
    Abstract     Related articles   

  968. MOCHIZUKI K, Kawai M, Odate T, Tahara I, et al
    Diagnostic Utility of Prostein, Uroplakin II and SATB2 for Diagnosing Carcinoma of Unknown Primary Origin: A Systematic Immunohistochemical Profiling.
    Anticancer Res. 2018;38:4759-4766.
    Abstract     Related articles   

  969. MIYAKE M, Tatsumi Y, Matsumoto H, Nagao K, et al
    Outcomes of subsequent non-muscle invasive bladder cancer treated with intravesical Bacillus Calmette-Guerin after radical nephroureterectomy for upper urinary tract urothelial carcinoma: A propensity matched analysis with primary bladder cancer.
    BJU Int. 2017 Dec 27. doi: 10.1111/bju.14111.
    Abstract     Related articles   

  970. RITCH CR, Balise R, Soodana Prakash N, Alonzo D, et al
    Propensity matched comparative analysis of survival following chemoradiation or radical cystectomy for muscle invasive bladder cancer.
    BJU Int. 2017 Dec 27. doi: 10.1111/bju.14109.
    Abstract     Related articles   

  971. BOSSCHIETER J, van Moorselaar RJA, Vis AN, van Ginkel T, et al
    The Effect of Timing of an Immediate Instillation with Mitomycin C after Transurethral Resection in 941 Non Muscle-invasive Bladder Cancer Patients.
    BJU Int. 2018 Jan 10. doi: 10.1111/bju.14124.
    Abstract     Related articles   

  972. SEISEN T
    Examining the role of centralisation of radical cystectomy for bladder cancer.
    BJU Int. 2018;121:165-167.
    Abstract     Related articles   

  973. SPAHN M, Morlacco A, Boxler S, Joniau S, et al
    Outcome predictors of radical cystectomy in patients with cT4 prostate cancer: A multi-institutional study of 62 patients.
    BJU Int. 2017 Feb 20. doi: 10.1111/bju.13818.
    Abstract     Related articles   

  974. THALMANN GN
    Quality improvement in cystectomy care with enhanced recovery (QUICCER) study.
    BJU Int. 2017;119:4-5.
    Abstract     Related articles   

  975. DASGUPTA P
    NICE guidance and the BJUI.
    BJU Int. 2017;120:743.
    Abstract     Related articles   

  976. VAN HEMELRIJCK M
    Human development and its impact on genitourinary cancers.
    BJU Int. 2017;120:747-748.
    Abstract     Related articles   

  977. MINERVINI A, Vanacore D, Vittori G, Milanesi M, et al
    Florence robotic intracorporeal neobladder (FloRIN): a new reconfiguration strategy developed following the IDEAL guidelines.
    BJU Int. 2018;121:313-317.
    Abstract     Related articles   

  978. STRATTON K
    Cystectomy for cT4 prostate cancer: the most radical treatment.
    BJU Int. 2017;120.
    Abstract     Related articles   

  979. PERERA M, Papa N, Christidis D, McGrath S, et al
    The impact of the global bacille Calmette-Guerin shortage on treatment patterns: population-based data.
    BJU Int. 2018;121:169-172.
    Abstract     Related articles   

  980. MOSSANEN M, Krasnow RE, Lipsitz SR, Preston MA, et al
    Associations of specific postoperative complications with costs after radical cystectomy.
    BJU Int. 2018;121:428-436.
    Abstract     Related articles   

  981. GUO RQ, Hong P, Xiong GY, Zhang L, et al
    Impact of ureteroscopy before radical nephroureterectomy for upper tract urothelial carcinomas on oncological outcomes: a meta-analysis.
    BJU Int. 2018;121:184-193.
    Abstract     Related articles   

  982. CATTO JWF
    Speeding up recovery from radical cystectomy: how low can we go?
    BJU Int. 2017;120:162-163.
    Abstract     Related articles   

  983. KOCH MO
    Detection and oncological effect of circulating tumour cells in patients with variant urothelial carcinoma histology treated with radical cystectomy.
    BJU Int. 2017;119:816.
    Abstract     Related articles   

  984. VON LANDENBERG N, Speed JM, Trinh QD
    Do micropapillary patients benefit from chemotherapy?
    BJU Int. 2017;119:656-658.
    Abstract     Related articles   

  985. DAVIS JW
    Biomarker classification, validation, and what to look for in 2017 and beyond.
    BJU Int. 2017;119:812-814.
    Abstract     Related articles   

  986. SU J, Zhu Q, Yuan L, Zhang Y, et al
    Transumbilical laparoendoscopic single-site radical prostatectomy and cystectomy with the aid of a transurethral port: a feasibility study.
    BJU Int. 2018;121:111-118.
    Abstract     Related articles   

  987. MOSSANEN M, Brown JC, Schrag D
    Well-being beyond the bladder. How do we improve the overall health of patients with bladder cancer?
    BJU Int. 2018;121:489-491.
    Abstract     Related articles   

  988. LOTAN Y, Woldu SL, Sanli O, Black P, et al
    Modeling Cost-Effectiveness of a Biomarker-Based Approach to Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer.
    BJU Int. 2018 Mar 31. doi: 10.1111/bju.14220.
    Abstract     Related articles   

  989. FRANSEN VAN DE PUTTE EE, Bosschieter J, van der Kwast TH, Bertz S, et al
    The WHO 1973 classification system for grade is an Important prognosticator in T1 non-muscle-invasive bladder cancer.
    BJU Int. 2018 Apr 10. doi: 10.1111/bju.14238.
    Abstract     Related articles   

  990. CHA EK, Sfakianos JP, Sukhu R, Yee AM, et al
    Poor prognosis of bladder cancer patients with occult lymph node metastases treated with neoadjuvant chemotherapy.
    BJU Int. 2018 Apr 7. doi: 10.1111/bju.14242.
    Abstract     Related articles   

  991. NA R, Wu Y, Jiang G, Yu H, et al
    Germline Mutations in DNA Repair Genes are Associated with Bladder Cancer Risk and Unfavorable Prognosis.
    BJU Int. 2018 May 4. doi: 10.1111/bju.14370.
    Abstract     Related articles   

  992. GANDHI N, Krishna S, Booth CM, Breau RH, et al
    Diagnostic accuracy of MRI for tumor staging of bladder cancer: Systematic review and Meta-Analysis.
    BJU Int. 2018 May 4. doi: 10.1111/bju.14366.
    Abstract     Related articles   

  993. MASON SJ, Catto JW, Downing A, Bottomley SE, et al
    Evaluating Patient Reported Outcome Measures (PROMs) for bladder cancer: a systematic review using the COSMIN checklist.
    BJU Int. 2018 May 3. doi: 10.1111/bju.14368.
    Abstract     Related articles   

  994. MARI A, Kimura S, Foerster B, Abufaraj M, et al
    A Systematic Review and Meta-Analysis of the impact of Lymphovascular Invasion in Bladder Cancer Transurethral Resection Specimens.
    BJU Int. 2018 May 28. doi: 10.1111/bju.14417.
    Abstract     Related articles   

  995. EREDICS K, Bretterbauer KM, Comploj E, Friedl A, et al
    Bladder cancer in nonagenarians:a multicenter study of 123 patients.
    BJU Int. 2018 May 27. doi: 10.1111/bju.14419.
    Abstract     Related articles   

  996. SMITH A, Daneshmand S, Patel S, Pohar K, et al
    Patient-reported Outcomes of Blue Light Flexible Cystoscopy with Hexaminolevulinate (HAL) in the Surveillance of Bladder Cancer: Results from a Prospective Multi-center Study.
    BJU Int. 2018 Jul 6. doi: 10.1111/bju.14481.
    Abstract     Related articles   

  997. HEIJNSDIJK EAM, Nieboer D, Garg T, Lansdorp-Vogelaar I, et al
    Cost-effectiveness of surveillance schedules in older adults with non-muscle-invasive bladder cancer.
    BJU Int. 2018 Aug 1. doi: 10.1111/bju.14502.
    Abstract     Related articles   

  998. LANE G, Risk M, Fan Y, Krishna S, et al
    Persistent muscle invasive bladder cancer after neoadjuvant chemotherapy: An analysis of SEER-Medicare data.
    BJU Int. 2018 Aug 20. doi: 10.1111/bju.14529.
    Abstract     Related articles   

  999. BREYER J, Wirtz RM, Erben P, Rinaldetti S, et al
    FOXM1 overexpression is associated with adverse outcome and predicts response to intravesical instillation therapy in stage pT1 non-muscle-invasive bladder cancer (NMIBC).
    BJU Int. 2018 Aug 18. doi: 10.1111/bju.14525.
    Abstract     Related articles   

  1000. SAKAGUCHI T, Yoshino H, Yonemori M, Miyamoto K, et al
    Regulation of ITGA3 by the dual-stranded microRNA-199 family as a potential prognostic marker in bladder cancer.
    Br J Cancer. 2018 Feb 13. pii: bjc2017439. doi: 10.1038/bjc.2017.
    Abstract     Related articles   

  1001. MASON SJ, Downing A, Wright P, Hounsome L, et al
    Health-related quality of life after treatment for bladder cancer in England.
    Br J Cancer. 2018 May 14. pii: 10.1038/s41416-018-0084.
    Abstract     Related articles   

  1002. SMITTENAAR P, Walker AK, McGill S, Kartsonaki C, et al
    Harnessing citizen science through mobile phone technology to screen for immunohistochemical biomarkers in bladder cancer.
    Br J Cancer. 2018 Jul 11. pii: 10.1038/s41416-018-0156.
    Abstract     Related articles   

  1003. CHOUDHURY A, Hoskin PJ
    Bladder cancer and the National Cancer Data Base: New insight or misinformation?
    Cancer. 2018 Jan 16. doi: 10.1002/cncr.31210.
    Abstract     Related articles   

  1004. JAZZAR U, Yong S, Klaassen Z, Huo J, et al
    Impact of psychiatric illness on decreased survival in elderly patients with bladder cancer in the United States.
    Cancer. 2018 Apr 16. doi: 10.1002/cncr.31404.
    Abstract     Related articles   

  1005. CORREA AF, Smaldone MC
    Melancholia and cancer: The bladder cancer narrative.
    Cancer. 2018 Apr 16. doi: 10.1002/cncr.31402.
    Abstract     Related articles   

  1006. SMITH AB, Chisolm S, Deal A, Spangler A, et al
    Patient-centered prioritization of bladder cancer research.
    Cancer. 2018 May 4. doi: 10.1002/cncr.31530.
    Abstract     Related articles   

  1007. DAIZUMOTO K, Yoshimaru T, Matsushita Y, Fukawa T, et al
    A DDX31/mutant-p53/EGFR axis promotes multistep progression of muscle invasive bladder cancer.
    Cancer Res. 2018 Feb 13. pii: 0008-5472.CAN-17-2528.
    Abstract     Related articles   

  1008. CHEN A, Fu G, Xu Z, Sun Y, et al
    Detection of Bladder Cancer Via Microfluidic Immunoassay and Single-Cell DNA Copy Number Alteration Analysis of Captured Urinary Exfoliated Tumor Cells.
    Cancer Res. 2018 May 22. pii: 0008-5472.CAN-17-2615.
    Abstract     Related articles   

  1009. JIANG G, Huang C, Li J, Huang H, et al
    Transcriptional and Posttranscriptional Upregulation of p27 Mediates Growth Inhibition of Isorhapontigenin (ISO) on Human Bladder Cancer Cells.
    Carcinogenesis. 2018 Feb 2. pii: 4834629. doi: 10.1093.
    Abstract     Related articles   

  1010. ALLIONE A, Pardini B, Viberti C, Giribaldi G, et al
    MMP23B expression and protein levels in blood and urine are associated with bladder cancer.
    Carcinogenesis. 2018 Jul 20. pii: 5056806. doi: 10.1093.
    Abstract     Related articles   

  1011. VAN KESSEL KE, van der Keur KA, Dyrskjot L, Algaba F, et al
    Molecular markers increase precision of the European Association of Urology non-muscle invasive bladder cancer progression risk groups.
    Clin Cancer Res. 2018 Jan 24. pii: 1078-0432.CCR-17-2719.
    Abstract     Related articles   

  1012. WANG WJ, Li CF, Chu YY, Wang YH, et al
    Inhibition of the EGFR/STAT3/CEBPD Axis Reverses Cisplatin Cross-resistance with Paclitaxel in the Urothelial Carcinoma of the Urinary Bladder.
    Clin Cancer Res. 2017;23:503-513.
    Abstract     Related articles   

  1013. FU H, Zhu Y, Wang Y, Liu Z, et al
    Identification and Validation of Stromal Immunotype Predict Survival and Benefit from Adjuvant Chemotherapy in Patients with Muscle Invasive Bladder Cancer.
    Clin Cancer Res. 2018 Mar 7. pii: 1078-0432.CCR-17-2687.
    Abstract     Related articles   

  1014. LELO A, Prip F, Harris BT, Solomon D, et al
    STAG2 Is a Biomarker for Prediction of Recurrence and Progression in Papillary Non-Muscle-Invasive Bladder Cancer.
    Clin Cancer Res. 2018 Jun 28. pii: 1078-0432.CCR-17-3244.
    Abstract     Related articles   

  1015. LI Q, Damish A, Frazier ZJ, Liu D, et al
    ERCC2 Helicase Domain Mutations Confer Nucleotide Excision Repair Deficiency and Drive Cisplatin Sensitivity in Muscle-Invasive Bladder Cancer.
    Clin Cancer Res. 2018 Jul 6. pii: 1078-0432.CCR-18-1001.
    Abstract     Related articles   

  1016. BIELLI P, Panzeri V, Lattanzio R, Mutascio S, et al
    The splicing factor PTBP1 promotes expression of oncogenic splice variants and predicts poor prognosis in patients with non-muscle invasive bladder cancer.
    Clin Cancer Res. 2018 Jul 16. pii: 1078-0432.CCR-17-3850.
    Abstract     Related articles   

  1017. RAJA R, Kuziora M, Brohawn P, Higgs BW, et al
    Early reduction in ctDNA predicts survival in lung and bladder cancer patients treated with durvalumab.
    Clin Cancer Res. 2018 Aug 9. pii: 1078-0432.CCR-18-0386.
    Abstract     Related articles   

  1018. SCHRAML J, Silva JDC, Babjuk M
    Current concept of transurethral resection of bladder cancer: from re-transurethral resection of bladder cancer to en-bloc resection.
    Curr Opin Urol. 2018 Aug 9. doi: 10.1097/MOU.0000000000000542.
    Abstract     Related articles   

  1019. ANDREASSEN BK, Grimsrud TK, Haug ES
    Bladder cancer survival: Women better off in the long run.
    Eur J Cancer. 2018;95:52-58.
    Abstract     Related articles   

  1020. SAITO R, Kobayashi T, Ogawa O
    Re: Comprehensive Molecular Characterization of Muscle-invasive Bladder Cancer.
    Eur Urol. 2017 Dec 20. pii: S0302-2838(17)31042.
    Abstract     Related articles   

  1021. PANG KH, Noon AP
    Re: Radical Cystectomy (Bladder Removal) Against Intravesical BCG Immunotherapy for High-risk Non-muscle Invasive Bladder Cancer (BRAVO): A Protocol for a Randomised Controlled Feasibility Study.
    Eur Urol. 2017 Dec 19. pii: S0302-2838(17)31039.
    Abstract     Related articles   

  1022. DY GW, Gore JL, Forouzanfar MH, Naghavi M, et al
    Global Burden of Urologic Cancers, 1990-2013.
    Eur Urol. 2017;71:437-446.
    Abstract     Related articles   

  1023. COLLINS JW, Hosseini A, Adding C, Nyberg T, et al
    Early Recurrence Patterns Following Totally Intracorporeal Robot-assisted Radical Cystectomy: Results from the EAU Robotic Urology Section (ERUS) Scientific Working Group.
    Eur Urol. 2017;71:723-726.
    Abstract     Related articles   

  1024. GAKIS G, Black PC, Bochner BH, Boorjian SA, et al
    Systematic Review on the Fate of the Remnant Urothelium after Radical Cystectomy.
    Eur Urol. 2017;71:545-557.
    Abstract     Related articles   

  1025. BABJUK M, Bohle A, Burger M, Capoun O, et al
    EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016.
    Eur Urol. 2017;71:447-461.
    Abstract     Related articles   

  1026. EL-ACHKAR A, Kassouf W
    Re: Propensity Score Analysis of Radical Cystectomy Versus Bladder-sparing Trimodal Therapy in the Setting of a Multidisciplinary Bladder Cancer Clinic.
    Eur Urol. 2018 Feb 14. pii: S0302-2838(18)30088.
    Abstract     Related articles   

  1027. CHEVALIER MF, Bohner P, Pieraerts C, Lhermitte B, et al
    Immunoregulation of Dendritic Cell Subsets by Inhibitory Receptors in Urothelial Cancer.
    Eur Urol. 2017;71:854-857.
    Abstract     Related articles   

  1028. WANG L, Sustic T, Leite de Oliveira R, Lieftink C, et al
    A Functional Genetic Screen Identifies the Phosphoinositide 3-kinase Pathway as a Determinant of Resistance to Fibroblast Growth Factor Receptor Inhibitors in FGFR Mutant Urothelial Cell Carcinoma.
    Eur Urol. 2017;71:858-862.
    Abstract     Related articles   

  1029. CUMBERBATCH MGK, Foerster B, Catto JWF, Kamat AM, et al
    Repeat Transurethral Resection in Non-muscle-invasive Bladder Cancer: A Systematic Review.
    Eur Urol. 2018 Mar 6. pii: S0302-2838(18)30121.
    Abstract     Related articles   

  1030. SARFATY M, Hall PS, Chan KKW, Virik K, et al
    Cost-effectiveness of Pembrolizumab in Second-line Advanced Bladder Cancer.
    Eur Urol. 2018 Mar 22. pii: S0302-2838(18)30182.
    Abstract     Related articles   

  1031. MOSCHINI M, Sargos P
    Re: Adjuvant Sandwich Chemotherapy Plus Radiotherapy vs Adjuvant Chemotherapy Alone for Locally Advanced Bladder Cancer After Radical Cystectomy a Randomized Phase 2 Trial.
    Eur Urol. 2018 Apr 9. pii: S0302-2838(18)30203.
    Abstract     Related articles   

  1032. FABA OR, Breda A, Palou J
    Re: Value of an Immediate Intravesical Instillation of Mitomycin C in Patients with Non-muscle-invasive Bladder Cancer: A Prospective Multicentre Randomised Study in 2243 patients.
    Eur Urol. 2018 Apr 7. pii: S0302-2838(18)30243.
    Abstract     Related articles   

  1033. PANEBIANCO V, Narumi Y, Altun E, Bochner BH, et al
    Multiparametric Magnetic Resonance Imaging for Bladder Cancer: Development of VI-RADS (Vesical Imaging-Reporting And Data System).
    Eur Urol. 2018 May 10. pii: S0302-2838(18)30335.
    Abstract     Related articles   

  1034. THOENY HC, Bellin MF, Comperat EM, Thalmann GN, et al
    Vesical Imaging-Reporting and Data System (VI-RADS): Added Value for Management of Bladder Cancer Patients?
    Eur Urol. 2018 Jun 27. pii: S0302-2838(18)30442.
    Abstract     Related articles   

  1035. ECKSTEIN M, Sikic D, Strissel PL, Erlmeier F, et al
    Evolution of PD-1 and PD-L1 Gene and Protein Expression in Primary Tumors and Corresponding Liver Metastases of Metastatic Bladder Cancer.
    Eur Urol. 2018 Jul 11. pii: S0302-2838(18)30456.
    Abstract     Related articles   

  1036. HOVELSON DH, Udager AM, McDaniel AS, Grivas P, et al
    Targeted DNA and RNA Sequencing of Paired Urothelial and Squamous Bladder Cancers Reveals Discordant Genomic and Transcriptomic Events and Unique Therapeutic Implications.
    Eur Urol. 2018 Jul 19. pii: S0302-2838(18)30475.
    Abstract     Related articles   

  1037. PANEBIANCO V, Barentsz J, Narumi Y, Catto J, et al
    Reply to Andrea Necchi, Antonella Messina, and Alberto Briganti's Letter to the Editor re: Valeria Panebianco, Yoshifumi Narumi, Ersan Altun, et al. Multiparametric Magnetic Resonance Imaging for Bladder Cancer: Development of VI-RADS (Vesical Imaging
    Eur Urol. 2018 Jul 17. pii: S0302-2838(18)30457.
    Abstract     Related articles   

  1038. KRANTZ D, Hartana CA, Winerdal ME, Johansson M, et al
    Neoadjuvant Chemotherapy Reinforces Antitumour T cell Response in Urothelial Urinary Bladder Cancer.
    Eur Urol. 2018 Jul 16. pii: S0302-2838(18)30476.
    Abstract     Related articles   

  1039. YU Y, Jin H, Xu J, Gu J, et al
    XIAP overexpression promotes bladder cancer invasion in vitro and lung metastasis in vivo via enhancing nucleolin-mediated Rho-GDIbeta mRNA stability.
    Int J Cancer. 2017 Dec 18. doi: 10.1002/ijc.31223.
    Abstract     Related articles   

  1040. LIU X, Cheng X, Liu X, He L, et al
    Investigation of the urinary metabolic variations and the application in bladder cancer biomarker discovery.
    Int J Cancer. 2018 Feb 16. doi: 10.1002/ijc.31323.
    Abstract     Related articles   

  1041. TELEKA S, Haggstrom C, Nagel G, Bjorge T, et al
    Risk of bladder cancer by disease severity in relation to metabolic factors and smoking; a prospective pooled cohort study of 800,000 men and women.
    Int J Cancer. 2018 May 14. doi: 10.1002/ijc.31597.
    Abstract     Related articles   

  1042. LIN C, Travis RC, Appleby PN, Tipper S, et al
    Pre-diagnostic circulating insulin-like growth factor-I and bladder cancer risk in the European Prospective Investigation into Cancer and Nutrition.
    Int J Cancer. 2018 Jul 4. doi: 10.1002/ijc.31650.
    Abstract     Related articles   

  1043. KOUTROS S, Baris D, Waddell R, Freeman LEB, et al
    Potential effect modifiers of the arsenic-bladder cancer risk relationship.
    Int J Cancer. 2018 Jul 7. doi: 10.1002/ijc.31720.
    Abstract     Related articles   

  1044. WANG W, Yang C, Nie H, Qiu X, et al
    LIMK2 acts as an oncogene in bladder cancer and its functional SNP in the microRNA-135a binding site affects bladder cancer risk.
    Int J Cancer. 2018 Jul 14. doi: 10.1002/ijc.31757.
    Abstract     Related articles   

  1045. DU P, Ye L, Yang Y, Jiang WG, et al
    [Corrigendum] Candidate of metastasis 1 regulates in vitro growth and invasion of bladder cancer cells.
    Int J Oncol. 2018 Feb 16. doi: 10.3892/ijo.2018.4277.
    Abstract     Related articles   

  1046. LIU J, Zhai R, Zhao J, Kong F, et al
    Programmed cell death 4 overexpression enhances sensitivity to cisplatin via the JNK/c-Jun signaling pathway in bladder cancer.
    Int J Oncol. 2018 Mar 5. doi: 10.3892/ijo.2018.4303.
    Abstract     Related articles   

  1047. LI C, Liu J, Zhang Q, Cui K, et al
    Upregulation of Ecadherin expression mediated by a novel dsRNA suppresses the growth and metastasis of bladder cancer cells by inhibiting beta-catenin/TCF target genes.
    Int J Oncol. 2018 Mar 29. doi: 10.3892/ijo.2018.4346.
    Abstract     Related articles   

  1048. LIU M, Chen Y, Huang B, Mao S, et al
    Tumor-suppressing effects of microRNA-612 in bladder cancer cells by targeting malic enzyme 1 expression.
    Int J Oncol. 2018 Mar 29. doi: 10.3892/ijo.2018.4342.
    Abstract     Related articles   

  1049. YANG X, Yin H, Zhang Y, Li X, et al
    Hypoxia-induced autophagy promotes gemcitabine resistance in human bladder cancer cells through hypoxia-inducible factor 1alpha activation.
    Int J Oncol. 2018 Apr 24. doi: 10.3892/ijo.2018.4376.
    Abstract     Related articles   

  1050. SUGITA S, Enokida H, Yoshino H, Miyamoto K, et al
    HRAS as a potential therapeutic target of salirasib RAS inhibitor in bladder cancer.
    Int J Oncol. 2018 Jun 11. doi: 10.3892/ijo.2018.4435.
    Abstract     Related articles   

  1051. ZHANG L, Yang G, Zhang R, Dong L, et al
    Curcumin inhibits cell proliferation and motility via suppression of TROP2 in bladder cancer cells.
    Int J Oncol. 2018 May 30. doi: 10.3892/ijo.2018.4423.
    Abstract     Related articles   

  1052. CHEN X, Xu Z, Zhu Z, Chen A, et al
    Modulation of G6PD affects bladder cancer via ROS accumulation and the AKT pathway in vitro.
    Int J Oncol. 2018 Jul 25. doi: 10.3892/ijo.2018.4501.
    Abstract     Related articles   

  1053. FUJII Y
    Prediction models for progression of non-muscle-invasive bladder cancer: A review.
    Int J Urol. 2017 Dec 16. doi: 10.1111/iju.13509.
    Abstract     Related articles   

  1054. OTTO W, van Rhijn BW, Breyer J, Bertz S, et al
    Infiltrative lamina propria invasion pattern as an independent predictor for cancer-specific and overall survival of instillation treatment-naive stage T1 high-grade urothelial bladder cancer.
    Int J Urol. 2018 Feb 22. doi: 10.1111/iju.13532.
    Abstract     Related articles   

  1055. MIYAZAKI J, Onozawa M, Takaoka E, Yano I, et al
    Bacillus Calmette-Guerin strain differences as the basis for immunotherapies against bladder cancer.
    Int J Urol. 2018 Mar 5. doi: 10.1111/iju.13538.
    Abstract     Related articles   

  1056. TATSUGAMI K
    Editorial Comment to Prediction models for progression of non-muscle-invasive bladder cancer: A review.
    Int J Urol. 2018;25:218-219.
    Abstract     Related articles   

  1057. NAKAI Y, Inoue K, Tsuzuki T, Shimamoto T, et al
    Oral 5-aminolevulinic acid-mediated photodynamic diagnosis using fluorescence cystoscopy for non-muscle-invasive bladder cancer: A multicenter phase III study.
    Int J Urol. 2018 Jul 12. doi: 10.1111/iju.13718.
    Abstract     Related articles   

  1058. ZHANG D, Zhou C, Li Y, Gao L, et al
    Amyloid precursor protein is overexpressed in bladder cancer and contributes to the malignant bladder cancer cell behaviors.
    Int J Urol. 2018 Jul 18. doi: 10.1111/iju.13726.
    Abstract     Related articles   

  1059. OHTAKA M, Kawahara T, Ishiguro Y, Sharma M, et al
    Expression of receptor activator of nuclear factor kappa B ligand in bladder cancer.
    Int J Urol. 2018 Jul 24. doi: 10.1111/iju.13756.
    Abstract     Related articles   

  1060. ZHANG J, Wang L, Mao S, Liu M, et al
    Transurethral en bloc resection with bipolar button electrode for non-muscle invasive bladder cancer.
    Int Urol Nephrol. 2018 Feb 24. pii: 10.1007/s11255-018-1830.
    Abstract     Related articles   

  1061. BATURA D, Hashemzehi T, Colemeadow J
    A care bundle to improve perioperative mitomycin use in non-muscle-invasive bladder cancer.
    Int Urol Nephrol. 2018 Apr 2. pii: 10.1007/s11255-018-1863.
    Abstract     Related articles   

  1062. CAO J, Wang Q, Wu G, Li S, et al
    miR-129-5p inhibits gemcitabine resistance and promotes cell apoptosis of bladder cancer cells by targeting Wnt5a.
    Int Urol Nephrol. 2018 Aug 16. pii: 10.1007/s11255-018-1959.
    Abstract     Related articles   

  1063. JURI H, Koyama M, Azuma H, Narumi Y, et al
    Are there any metastases to the chest in non-muscle-invasive bladder cancer patients on follow-up computed tomography?
    Int Urol Nephrol. 2018 Aug 16. pii: 10.1007/s11255-018-1952.
    Abstract     Related articles   

  1064. IYER G, Balar AV, Milowsky MI, Bochner BH, et al
    Multicenter Prospective Phase II Trial of Neoadjuvant Dose-Dense Gemcitabine Plus Cisplatin in Patients With Muscle-Invasive Bladder Cancer.
    J Clin Oncol. 2018 May 9:JCO2017750158. doi: 10.1200/JCO.2017.75.0158.
    Abstract     Related articles   

  1065. CHANG SS
    Re: Increasing Age is Not Associated with Toxicity Leading to Discontinuation of Treatment in Patients with Urothelial Non-Muscle-Invasive Bladder Cancer Randomised to Receive 3 Years of Maintenance bacille Calmette-Guerin: Results from European Organ
    J Urol. 2018;199:26.
    Abstract     Related articles   

  1066. CHANG SS
    Re: Challenges in Pathologic Staging of Bladder Cancer: Proposals for Fresh Approaches of Assessing Pathologic Stage in Light of Recent Studies and Observations Pertaining to Bladder Histoanatomic Variances.
    J Urol. 2018;199:25-26.
    Abstract     Related articles   

  1067. NIWA N, Kikuchi E, Matsumoto K, Kosaka T, et al
    Purified protein derivative skin test prior to bacillus Calmette-Guerin therapy may have therapeutic impact in patients with non-muscle-invasive bladder cancer.
    J Urol. 2018 Jan 4. pii: S0022-5347(18)30006-5. doi: 10.1016/j.juro.2017.
    Abstract     Related articles   

  1068. ZARGAR H, Shah JB, van Rhijn BW, Daneshmand S, et al
    Neoadjuvant dose dense MVAC versus GC in patients with cT3-4aN0M0 bladder cancer treated with radical cystectomy.
    J Urol. 2018 Jan 9. pii: S0022-5347(18)30036-3. doi: 10.1016/j.juro.2017.
    Abstract     Related articles   

  1069. ATALA A
    Re: Mg(II)-Catechin Nanoparticles Delivering siRNA Targeting EIF5A2 Inhibit Bladder Cancer Cell Growth In Vitro and In Vivo.
    J Urol. 2017;198:258-259.
    Abstract     Related articles   

  1070. CHANG SS
    Re: Papillary Recurrence of Bladder Cancer at First Evaluation after Induction Bacillus Calmette-Guerin Therapy: Implication for Clinical Trial Design.
    J Urol. 2017;198:255.
    Abstract     Related articles   

  1071. CHANG SS
    Re: Safety and Efficacy of Durvalumab (MEDI4736), an Anti-Programmed Cell Death Ligand-1 Immune Checkpoint Inhibitor, in Patients with Advanced Urothelial Bladder Cancer.
    J Urol. 2018;199:341-342.
    Abstract     Related articles   

  1072. CHANG SS
    Re: The Impact of Re-Transurethral Resection on Clinical Outcomes in a Large Multicentre Cohort of Patients with T1 High-Grade/Grade 3 Bladder Cancer Treated with bacille Calmette-Guerin.
    J Urol. 2018;199:340-342.
    Abstract     Related articles   

  1073. UHLIG A, Amir Hosseini AS, Simon J, Lotz J, et al
    Gender-specific differences in disease-free, cancer-specific and overall survival after radical cystectomy for bladder cancer: a systematic review and meta-analysis.
    J Urol. 2018 Feb 22. pii: S0022-5347(18)39380-7. doi: 10.1016/j.juro.2017.
    Abstract     Related articles   

  1074. PERLIS N, Krahn MD, Boehme KE, Alibhai SM, et al
    The Bladder Utility Symptom Scale (BUSS): A Novel Patient-Reported Outcome Instrument in Bladder Cancer.
    J Urol. 2018 Mar 9. pii: S0022-5347(18)42498-6. doi: 10.1016/j.juro.2018.
    Abstract     Related articles   

  1075. KAPADIA AA, Acevedo AM, Liu JJ, Garzotto M, et al
    Unconventional Bladder Preservation: Factors predicting Failure to Receive Definitive Surgery following Chemotherapy for Non-metastatic Muscle Invasive Bladder Cancer within the National Cancer Database.
    J Urol. 2018 Mar 15. pii: S0022-5347(18)42581-5. doi: 10.1016/j.juro.2018.
    Abstract     Related articles   

  1076. CHANG SS
    Re: Phase III, Double-Blind, Randomized Trial that Compared Maintenance Lapatinib versus Placebo after First-Line Chemotherapy in Patients with Human Epidermal Growth Factor Receptor 1/2-Positive Metastatic Bladder Cancer.
    J Urol. 2018;199:891-892.
    Abstract     Related articles   

  1077. CHANG SS
    Re: Comparative Effectiveness of Treatment Strategies for Bladder Cancer with Clinical Evidence of Regional Lymph Node Involvement.
    J Urol. 2018;199:891-892.
    Abstract     Related articles   

  1078. ATALA A
    Re: Evasion of Immunosurveillance by Genomic Alterations of PPARgamma/RXRalpha in Bladder Cancer.
    J Urol. 2018;199:1115-1116.
    Abstract     Related articles   

  1079. CHANG SS
    Re: Definitions, End Points, and Clinical Trial Designs for Non-Muscle-Invasive Bladder Cancer: Recommendations from the International Bladder Cancer Group.
    J Urol. 2018;199:1111-1112.
    Abstract     Related articles   

  1080. CHANG SS
    Re: Intravesical rAd-IFNalpha/Syn3 for Patients with High-Grade, bacillus Calmette-Guerin-Refractory or Relapsed Non-Muscle-Invasive Bladder Cancer: A Phase II Randomized Study.
    J Urol. 2018;199:1110-1111.
    Abstract     Related articles   

  1081. MAKELA VJ, Kotsar A, Tammela TL, Murtola TJ, et al
    Bladder cancer survival in men using 5-alpha-reductase inhibitors.
    J Urol. 2018 May 3. pii: S0022-5347(18)43085-6. doi: 10.1016/j.juro.2018.
    Abstract     Related articles   

  1082. MAZZA P, Moran GW, Li G, Robins DJ, et al
    Conservative Management Following Clinical Complete Response to Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer: Contemporary Outcomes of a Multi-Institutional Cohort Study.
    J Urol. 2018 May 19. pii: S0022-5347(18)43234-X. doi: 10.1016/j.juro.2018.
    Abstract     Related articles   

  1083. AUDENET F, Waingankar N, Ferket BS, Niglio SA, et al
    Effectiveness of transurethral resection (TUR) plus systemic chemotherapy as definitive treatment for muscle-invasive bladder cancer (MIBC) in population-level data.
    J Urol. 2018 Jun 4. pii: S0022-5347(18)43313-7. doi: 10.1016/j.juro.2018.
    Abstract     Related articles   

  1084. DOWNS TM, Weissert JA, Ravvaz K
    Can we improve non-muscle-invasive bladder cancer (NMIBC) guideline adherence with smarter risk-stratification?
    J Urol. 2018 Jun 12. pii: S0022-5347(18)43357-5. doi: 10.1016/j.juro.2018.
    Abstract     Related articles   

  1085. FANTINI D, Glaser AP, Rimar KJ, Wang Y, et al
    A Carcinogen-induced mouse model recapitulates the molecular alterations of human muscle invasive bladder cancer.
    Oncogene. 2018 Jan 25. pii: 10.1038/s41388-017-0099.
    Abstract     Related articles   

  1086. SHEN P, Jing Y, Zhang R, Cai MC, et al
    Comprehensive genomic profiling of neuroendocrine bladder cancer pinpoints molecular origin and potential therapeutics.
    Oncogene. 2018 Mar 14. pii: 10.1038/s41388-018-0192.
    Abstract     Related articles   

  1087. PENG M, Wang J, Zhang D, Jin H, et al
    PHLPP2 stabilization by p27 mediates its inhibition of bladder cancer invasion by promoting autophagic degradation of MMP2 protein.
    Oncogene. 2018 Jun 21. pii: 10.1038/s41388-018-0374.
    Abstract     Related articles   

  1088. LEE E, Collazo-Lorduy A, Castillo-Martin M, Gong Y, et al
    Identification of microR-106b as a prognostic biomarker of p53-like bladder cancers by ActMiR.
    Oncogene. 2018 Jul 3. pii: 10.1038/s41388-018-0367.
    Abstract     Related articles   

  1089. MA J, Ge J, Xue X, Xiu W, et al
    Targeting bladder cancer using activated T cells armed with bispecific antibodies.
    Oncol Rep. 2018 Jan 11. doi: 10.3892/or.2018.6211.
    Abstract     Related articles   

  1090. LIU S, Jiang H, Wen H, Ding Q, et al
    Knockdown of tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta (YWHAZ) enhances tumorigenesis both in vivo and in vitro in bladder cancer.
    Oncol Rep. 2018 Mar 5. doi: 10.3892/or.2018.6294.
    Abstract     Related articles   

  1091. LIU X, Kong C, Zhang Z
    miR-130b promotes bladder cancer cell proliferation, migration and invasion by targeting VGLL4.
    Oncol Rep. 2018 Mar 6. doi: 10.3892/or.2018.6300.
    Abstract     Related articles   

  1092. XIAO J, Niu S, Zhu J, Lv L, et al
    miR223p enhances multichemoresistance by targeting NET1 in bladder cancer cells.
    Oncol Rep. 2018 Apr 4. doi: 10.3892/or.2018.6355.
    Abstract     Related articles   

  1093. CHEN D, Xu J, Zhang Q
    Detection of survivin expression in bladder cancer and renal cell carcinoma using specific monoclonal antibodies.
    Oncol Rep. 2018 Apr 5. doi: 10.3892/or.2018.6359.
    Abstract     Related articles   

  1094. LI WL, Yu HY, Zhang XJ, Ke M, et al
    Purple sweet potato anthocyanin exerts antitumor effect in bladder cancer.
    Oncol Rep. 2018 May 8. doi: 10.3892/or.2018.6421.
    Abstract     Related articles   

  1095. ZHANG T, Yang F, Li W, Liu B, et al
    Suppression of the SDF1/CXCR4/betacatenin axis contributes to bladder cancer cell growth inhibition in vitro and in vivo.
    Oncol Rep. 2018 Jul 4. doi: 10.3892/or.2018.6546.
    Abstract     Related articles   

  1096. ZHANG H, Qi D, Li J, Peng T, et al
    A novel regulatory circuit of miR152 and DNMT1 in human bladder cancer.
    Oncol Rep. 2018 Jul 10. doi: 10.3892/or.2018.6553.
    Abstract     Related articles   

  1097. GAO F, Wang X, Chen S, Xu T, et al
    CIP2A depletion potentiates the chemosensitivity of cisplatin by inducing increased apoptosis in bladder cancer cells.
    Oncol Rep. 2018 Aug 10. doi: 10.3892/or.2018.6641.
    Abstract     Related articles   

  1098. DEHAYNI Y, Tetou M, Khdach Y, Janane A, et al
    [Prognostic of older age for patients with invasive-muscle-bladder cancer and treated by radical cystectomy].
    Prog Urol. 2018 Jan 9. pii: S1166-7087(17)30679.
    Abstract     Related articles   

  1099. JUNGELS C, Martinez Chanza N, Albisinni S, Mercier M, et al
    Interest of next-generation sequencing in BCG-treated high-risk bladder cancer.
    Prog Urol. 2018 Apr 16. pii: S1166-7087(18)30082.
    Abstract     Related articles   

  1100. MICHEL C, Vordos D, Dumont C, Basset V, et al
    [Impact of neoadjuvant chemotherapy on the peri-operative morbidity of radical cystectomy for muscle invasive bladder cancer].
    Prog Urol. 2018 Jul 8. pii: S1166-7087(18)30169.
    Abstract     Related articles   

  1101. ZUCCHI A, Costantini E
    "Nested Type" Bladder Cancer: Myth or Reality?
    Urol Int. 2018 Jan 17. pii: 000486533. doi: 10.1159/000486533.
    Abstract     Related articles   

  1102. CERRUTO MA, D'Elia C, Siracusano S, Saleh O, et al
    Health-Related Quality of Life after Radical Cystectomy for Bladder Cancer in Elderly Patients with Ileal Orthotopic Neobladder or Ileal Conduit: Results from a Multicentre Cross-Sectional Study Using Validated Questionnaires.
    Urol Int. 2018 Mar 7. pii: 000487644. doi: 10.1159/000487644.
    Abstract     Related articles   

  1103. DOGAN S, Hennig M, Frank T, Struck JP, et al
    Acceptance of Adjuvant and Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer in Germany: A Survey of Current Practice.
    Urol Int. 2018 Mar 6. pii: 000487405. doi: 10.1159/000487405.
    Abstract     Related articles   

  1104. DRAEGER DL, Sievert KD, Hakenberg OW
    Psychosocial Distress in Bladder Cancer Stratified by Gender, Age, Treatment, and Tumour Stage.
    Urol Int. 2018 May 14:1-7. doi: 10.1159/000489502.
    Abstract     Related articles   

  1105. MARI A, D'Andrea D, Kimura S, Resch I, et al
    Sarcopenia as a Predictive Factor for Response to Upfront Cisplatin-Based Chemotherapy in Patients with Muscle-Invasive Urothelial Bladder Cancer.
    Urol Int. 2018;101:1-4.
    Abstract     Related articles   

  1106. TAN P, Xie N, Yang L, Liu L, et al
    Diagnostic Ureteroscopy Prior to Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma Increased the Risk of Intravesical Recurrence.
    Urol Int. 2018;100:92-99.
    Abstract     Related articles   

  1107. XIA L, Taylor BL, Mamtani R, Christodouleas JP, et al
    Associations between Travel Distance, Hospital Volume, and Outcomes Following Radical Cystectomy in Patients with Muscle-Invasive Bladder Cancer.
    Urology. 2018 Jan 2. pii: S0090-4295(17)31331.
    Abstract     Related articles   

  1108. ASHRAFI-ASGARABAD A, Ayubi E, Sullman MJ, Safiri S, et al
    Re: Hussein et al.: Development and Validation of a Quality Assurance Score for Robot-assisted Radical Cystectomy: A 10-Year Analysis (Urology 2016;97:124-129).
    Urology. 2017;101:174.
    Abstract     Related articles   

  1109. GOROSPE L, Garcia-Santana E, Jane-Soler P, Gomez-Martinez MDV, et al
    Cardiac and Skeletal Muscle Metastases From Squamous Cell Carcinoma of the Bladder: Positron Emission Tomography-Computed Tomography Findings.
    Urology. 2017;100:e5-e6.
    Abstract     Related articles   

  1110. RUBENWOLF PC, Hampel C, Roos F, Stein R, et al
    Continent Anal Urinary Diversion in Classic Bladder Exstrophy: 45-Year Experience.
    Urology. 2017;100:249-254.
    Abstract     Related articles   

  1111. BREAM MJ, Maurice MJ, Altschuler J, Zhu H, et al
    Increased Use of Cystectomy in Patients 75 and Older: A Contemporary Analysis of Survival and Perioperative Outcomes From the National Cancer Database.
    Urology. 2017;100:72-78.
    Abstract     Related articles   

  1112. GOLABESK T, Palou J, Rodriguez O, Parada R, et al
    Long-term Bladder and Upper Urinary Tract Follow-up Recurrence and Progression Rates of G1-2 Non-muscle-invasive Urothelial Carcinoma of the Bladder.
    Urology. 2017;100:145-150.
    Abstract     Related articles   

  1113. SCHOMBURG JL, Krishna S, Cotter KJ, Soubra A, et al
    Preoperative Incidence of Deep Venous Thrombosis in Bladder Cancer Patients Undergoing Radical Cystectomy.
    Urology. 2018 Mar 15. pii: S0090-4295(18)30202.
    Abstract     Related articles   

  1114. WYNER LM
    Leo Szilard's Bladder Cancer: Survival in the Nuclear Era.
    Urology. 2018 Mar 12. pii: S0090-4295(18)30178.
    Abstract     Related articles   

  1115. TAPIERO S, Helfand A, Kedar D, Yossepowitch O, et al
    Patient Compliance with Maintenance Intravesical Therapy for Non-Muscle Invasive Bladder Cancer.
    Urology. 2018 May 21. pii: S0090-4295(18)30473.
    Abstract     Related articles   

  1116. ZHANG Z, Zhang G, Gao Z, Li S, et al
    Comprehensive analysis of differentially expressed genes associated with PLK1 in bladder cancer.
    BMC Cancer. 2017;17:861.
    Abstract     Related articles   

  1117. PULIDO M, Roubaud G, Cazeau AL, Mahammedi H, et al
    Safety and efficacy of temsirolimus as second line treatment for patients with recurrent bladder cancer.
    BMC Cancer. 2018;18:194.
    Abstract     Related articles   

  1118. SEVERINO PF, Silva M, Carrascal M, Malagolini N, et al
    Oxidative damage and response to Bacillus Calmette-Guerin in bladder cancer cells expressing sialyltransferase ST3GAL1.
    BMC Cancer. 2018;18:198.
    Abstract     Related articles   

  1119. KWON WA, Joung JY, Lim J, Oh CM, et al
    Risk of second primary Cancer among bladder Cancer patients: a population-based cohort study in Korea.
    BMC Cancer. 2018;18:617.
    Abstract     Related articles   

  1120. XIE H, Zhu Y, Zhang J, Liu Z, et al
    B4GALT1 expression predicts prognosis and adjuvant chemotherapy benefits in muscle-invasive bladder cancer patients.
    BMC Cancer. 2018;18:590.
    Abstract     Related articles   

  1121. LIU Y, Wang H, Zhong J, Wu C, et al
    Decreased expression of SRY-box containing gene 30 is related to malignant phenotypes of human bladder cancer and correlates with poor prognosis.
    BMC Cancer. 2018;18:642.
    Abstract     Related articles   

  1122. LIU H, He W, Wang B, Xu K, et al
    MALBAC-based chromosomal imbalance analysis: a novel technique enabling effective non-invasive diagnosis and monitoring of bladder cancer.
    BMC Cancer. 2018;18:659.
    Abstract     Related articles   

  1123. DHAWAN D, Hahn NM, Ramos-Vara JA, Knapp DW, et al
    Naturally-occurring canine invasive urothelial carcinoma harbors luminal and basal transcriptional subtypes found in human muscle invasive bladder cancer.
    PLoS Genet. 2018;14:e1007571.
    Abstract     Related articles   

  1124. HAN S, Kim D, Shivakumar M, Lee YJ, et al
    The effects of alternative splicing on miRNA binding sites in bladder cancer.
    PLoS One. 2018;13:e0190708.
    Abstract     Related articles   

  1125. SATHE A, Chalaud G, Oppolzer I, Wong KY, et al
    Parallel PI3K, AKT and mTOR inhibition is required to control feedback loops that limit tumor therapy.
    PLoS One. 2018;13:e0190854.
    Abstract     Related articles   

  1126. KIM M, Oh SJ, Kwak C, Kim HH, et al
    Psychometric validation study of the Korean version of the Functional Assessment of Cancer Therapy-Vanderbilt Cystectomy Index.
    PLoS One. 2018;13:e0190570.
    Abstract     Related articles   

  1127. BARBOSA ALA, Vermeulen SHHM, Aben KK, Grotenhuis AJ, et al
    Smoking intensity and bladder cancer aggressiveness at diagnosis.
    PLoS One. 2018;13:e0194039.
    Abstract     Related articles   

  1128. XIA Y, Liu Z, Yu W, Zhou S, et al
    The prognostic significance of long noncoding RNAs in bladder cancer: A meta-analysis.
    PLoS One. 2018;13:e0198602.
    Abstract     Related articles   

  1129. BECKFORD VERA DR, Smith CC, Bixby LM, Glatt DM, et al
    Immuno-PET imaging of tumor-infiltrating lymphocytes using zirconium-89 radiolabeled anti-CD3 antibody in immune-competent mice bearing syngeneic tumors.
    PLoS One. 2018;13:e0193832.
    Abstract     Related articles   

  1130. HARTANA CA, Ahlen Bergman E, Zirakzadeh AA, Krantz D, et al
    Urothelial bladder cancer may suppress perforin expression in CD8+ T cells by an ICAM-1/TGFbeta2 mediated pathway.
    PLoS One. 2018;13:e0200079.
    Abstract     Related articles   

  1131. FERDOSI S, Ho TH, Castle EP, Stanton ML, et al
    Behavior of blood plasma glycan features in bladder cancer.
    PLoS One. 2018;13:e0201208.
    Abstract     Related articles   

  1132. BANSAL A, Yang F, Xi T, Zhang Y, et al
    In vivo wireless photonic photodynamic therapy.
    Proc Natl Acad Sci U S A. 2018;115:1469-1474.
    Abstract     Related articles   


Thank you for your interest in scientific medicine.


AMEDEO Bladder Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design:


;